LMSP00000001,-,N-(tetradecanoyl)-deoxysphing-4-enine-1-sulfonate,C32H63NO5S   ,573.4427,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000002,-,N-(hexadecanoyl)-deoxysphing-4-enine-1-sulfonate,C34H67NO5S   ,601.474,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000003,-,N-(3E-hexadecenoyl)-deoxysphing-4-enine-1-sulfonate,C34H65NO5S   ,599.4583,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000004,Cer(m18:1(4E)/16:0),N-(hexadecanoyl)-1-deoxysphing-4-enine,C34H67NO2   ,521.5172,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000005,Cer(m18:1(4E)/18:0),N-(octadecanoyl)-1-deoxysphing-4-enine,C36H71NO2   ,549.5485,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000006,Cer(m18:1(4E)/20:0),N-(eicosanoyl)-1-deoxysphing-4-enine,C38H75NO2   ,577.5798,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000007,Cer(m18:1(4E)/22:0),N-(docosanoyl)-1-deoxysphing-4-enine,C40H79NO2   ,605.6111,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000008,Cer(m18:1(4E)/24:0),N-(tetracosanoyl)-1-deoxysphing-4-enine,C42H83NO2   ,633.6424,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000009,Cer(m18:1(4E)/26:0),N-(hexacosanoyl)-1-deoxysphing-4-enine,C44H87NO2   ,661.6737,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000010,Cer(m18:1(4E)/24:1(15Z)),N-(15Z-tetracosenoyl)-1-deoxysphing-4-enine,C42H81NO2   ,631.6267,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000011,Cer(m18:1(4E)/26:1(17Z)),N-(17Z-hexacosenoyl)-1-deoxysphing-4-enine,C44H85NO2   ,659.658,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000012,Cer(m18:0/26:1(17Z)),N-(17Z-hexacosenoyl)-1-deoxysphinganine,C44H87NO2   ,661.6737,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000013,Cer(m18:0/24:1(15Z)),N-(15Z-tetracosenoyl)-1-deoxysphinganine,C42H83NO2   ,633.6424,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000014,Cer(m18:0/26:0),N-(hexacosanoyl)-1-deoxysphinganine,C44H89NO2   ,663.6893,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000015,Cer(m18:0/24:0),N-(tetracosanoyl)-1-deoxysphinganine,C42H85NO2   ,635.658,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000016,Cer(m18:0/22:0),N-(docosanoyl)-1-deoxysphinganine,C40H81NO2   ,607.6267,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000017,Cer(m18:0/20:0),N-(eicosanoyl)-1-deoxysphinganine,C38H77NO2   ,579.5954,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000018,Cer(m18:0/18:0),N-(octadecanoyl)-1-deoxysphinganine,C36H73NO2   ,551.5641,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP00000019,Cer(m18:0/16:0),N-(hexadecanoyl)-1-deoxysphinganine,C34H69NO2   ,523.5328,Sphingolipids [SP],Other Sphingolipids [SP00],
LMSP01010001,Sphingosine,Sphing-4-enine,C18H37NO2   ,299.2824,Sphingolipids [SP],Sphingoid bases [SP01],Sphing-4-enines (Sphingosines) [SP0101]
LMSP01010002,3-ketosphingosine,3-keto-sphing-4-enine,C18H35NO2   ,297.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphing-4-enines (Sphingosines) [SP0101]
LMSP01020001,Sphinganine,Sphinganine,C18H39NO2   ,301.2981,Sphingolipids [SP],Sphingoid bases [SP01],Sphinganines [SP0102]
LMSP01020002,3-ketosphinganine,3-dehydrosphinganine,C18H37NO2   ,299.2824,Sphingolipids [SP],Sphingoid bases [SP01],Sphinganines [SP0102]
LMSP01030001,Phytosphingosine,4R-hydroxysphinganine,C18H39NO3   ,317.293,Sphingolipids [SP],Sphingoid bases [SP01],4-Hydroxysphinganines (Phytosphingosines) [SP0103]
LMSP01030002,Dehydrophytosphingosine,4R-hydroxysphing-8E-enine,C18H37NO3   ,315.2773,Sphingolipids [SP],Sphingoid bases [SP01],4-Hydroxysphinganines (Phytosphingosines) [SP0103]
LMSP01040001,C16 Sphinganine,hexadecasphinganine,C16H35NO2   ,273.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base homologs and variants [SP0104]
LMSP01040002,C17 Sphingosine,heptadecasphing-4-enine,C17H35NO2   ,285.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base homologs and variants [SP0104]
LMSP01040003,C17 Sphinganine,heptadecasphinganine,C17H37NO2   ,287.2824,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base homologs and variants [SP0104]
LMSP01040006,C14 sphingosine,tetradecasphing-4E-enine,C14H29NO2   ,243.2198,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base homologs and variants [SP0104]
LMSP01040008,C16 Sphingosine,Hexadecasphing-4E-enine,C16H33NO2   ,271.2511,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base homologs and variants [SP0104]
LMSP01050001,Sphingosine-1-phosphate,Sphing-4-enine-1-phosphate,C18H38NO5P   ,379.2488,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base 1-phosphates [SP0105]
LMSP01050002,Sphinganine-phosphate,Sphinganine-1-phosphate,C18H40NO5P   ,381.2644,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base 1-phosphates [SP0105]
LMSP01050003,Phytosphingosine 1-phosphate,"(2S,3S,4R)-2-amino-3,4-dihydroxyoctadecyl dihydrogen phosphate",C18H40NO6P   ,397.2593,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base 1-phosphates [SP0105]
LMSP01050004,C19 Sphingosine-1-phosphate,Nonadecaphing-4-enine-1-phosphate,C19H40NO5P   ,393.2644,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base 1-phosphates [SP0105]
LMSP01050005,C16 Sphingosine-1-phosphate,Hexadecaphing-4-enine-1-phosphate,C16H34NO5P   ,351.2175,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base 1-phosphates [SP0105]
LMSP01050006,C16 Sphinganine-1-phosphate,Hexadecaphinganine-1-phosphate,C16H36NO5P   ,353.2331,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base 1-phosphates [SP0105]
LMSP01050007,C17 Sphingosine-1-phosphate,heptadecasphing-4-enine-1-phosphate,C17H36NO5P   ,365.2331,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base 1-phosphates [SP0105]
LMSP01050008,C17 Sphinganine-1-phosphate,heptadecasphinganine-1-phosphate,C17H38NO5P   ,367.2488,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base 1-phosphates [SP0105]
LMSP01060001,Sphingosine-1-phosphocholine,Sphing-4-enine-1-phosphocholine,C23H49N2O5P   ,464.3379,Sphingolipids [SP],Sphingoid bases [SP01],Lysosphingomyelins and lysoglycosphingolipids [SP0106]
LMSP01060002,Sphinganine-1-phosphocholine,Sphinganine-1-phosphocholine,C23H51N2O5P   ,466.3536,Sphingolipids [SP],Sphingoid bases [SP01],Lysosphingomyelins and lysoglycosphingolipids [SP0106]
LMSP01060003,C17 sphingosine-1-phosphocholine,heptadecasphing-4-enine-1-phosphocholine,C22H47N2O5P   ,450.3223,Sphingolipids [SP],Sphingoid bases [SP01],Lysosphingomyelins and lysoglycosphingolipids [SP0106]
LMSP01070001,"N,N-dimethylsphingosine","N,N-dimethylsphing-4-enine",C20H41NO2   ,327.3137,Sphingolipids [SP],Sphingoid bases [SP01],N-methylated sphingoid bases [SP0107]
LMSP01080002,"4E,14Z-Sphingadiene","sphinga-4E,14Z-dienine",C18H35NO2   ,297.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080003,6-hydroxysphingosine,6-hydroxysphing-4E-enine,C18H37NO3   ,315.2773,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080004,"5-hydroxy,3E-sphingosine","2R-amino-3E-octadecene-1,5-diol",C18H37NO2   ,299.2824,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080005,"iso (4E,15-methyl-d16:1) sphingosine",15-methyl-hexadecasphing-4E-enine,C17H35NO2   ,285.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080006,"anteiso (4E,14-methyl-d16:1) sphingosine",14-methyl-hexadecasphing-4E-enine,C17H35NO2   ,285.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080007,"(4E,6E,d14:2) sphingosine","tetradecasphinga-4E,6E-dienine",C14H27NO2   ,241.2042,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080008,"(8Z,d18:1) sphingosine",Sphing-8Z-enine,C18H37NO2   ,299.2824,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080009,4-hydroxy-8cis-sphingenine,4R-hydroxy-sphing-8Z-enine,C18H37NO3   ,315.2773,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080010,"(4E,8E,d18:2) sphingosine","sphinga-4E,8E-dienine",C18H35NO2   ,297.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080011,"(4E,8Z,d18:2) sphingosine","sphinga-4E,8Z-dienine",C18H35NO2   ,297.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080012,"(4E,8E,9Me-d19:2)sphingosine","9-methyl-sphinga-4E,8E-dienine",C19H37NO2   ,311.2824,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080013,"(4E,8E,10E-d18:3)sphingosine","sphinga-4E,8E,10E-trienine",C18H33NO2   ,295.2511,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080014,"(9Me,4E,8E,10E-d19:3)sphingosine","9-methyl-sphinga-4E,8E,10E-trienine",C19H35NO2   ,309.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080015,Termitomycesphin A,-,C41H77NO10   ,743.5548,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080016,Aplidiasphingosine,"2S-amino-5,9,13,17-tetramethyl-8E,16-octadecadiene-1,3R,14-triol",C22H43NO3   ,369.3243,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080017,Plakoside A,-,C57H105NO9   ,947.7789,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080018,Calicogorgin A,-,C23H41NO3   ,379.3086,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080019,Hemsleyin imine A,-,C39H75NO3   ,605.5747,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080020,Myriocin,-,C21H39NO6   ,401.2777,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080021,Sulfamisterin,-,C19H36NNaO8S   ,461.2059,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080022,Fumonisin B1,-,C34H59NO15   ,721.3885,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080023,Fumonisin B2,-,C34H59NO14   ,705.3936,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080024,Fumonisin B3,-,C34H59NO14   ,705.3936,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080025,Fumonisin B4,-,C34H59NO13   ,689.3986,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080026,Fumonisin A1,-,C36H61NO16   ,763.399,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080027,Fumonisin C1,-,C33H57NO15   ,707.3728,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080028,Fumonisin C2,-,C33H57NO14   ,691.3779,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080029,Fumonisin C3,-,C33H57NO14   ,691.3779,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080030,Fumonisin C4,-,C33H57NO13   ,675.383,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080031,-,"2-amino-14,16-dimethyloctadecan-3-ol",C20H43NO   ,313.3345,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080032,Spisulosine,1-deoxy-sphinganine,C18H39NO   ,285.3032,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080033,Xestoaminol C,1-deoxy-tetradecasphinganine,C14H31NO   ,229.2406,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080034,Halaminol A,1-deoxy-tetradecasphing-13-enine,C14H29NO   ,227.2249,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080035,Obscuraminol A,"1-deoxy-sphinga-6Z,9Z,12Z,15Z-tetraenine",C18H31NO   ,277.2406,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080036,Crucigasterin 277,"1-deoxy-sphinga-5E,9Z,12Z,15Z-tetraenine",C18H31NO   ,277.2406,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080037,Calyxinin,"(2S,3S,26R,27S)-2,27-diamino-3,26,28-trihydroxyoctacosan-11-one",C28H58N2O4   ,486.4397,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080038,Oceanin,"(2R,3R,26R,27S)-2,27-diamino-3,26,28-trihydroxyoctacosan-11-one",C28H58N2O4   ,486.4397,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080039,Rhizochalinin D,-,C35H70N2O8   ,646.5132,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080040,Leucettamol A,"(2S,3R,5Z,8Z,11Z,14Z,17Z,20Z,28R,29S)-2,29-diaminotriaconta-5,8,11,14,17,20-hexaene-3,28-diol",C30H52N2O2   ,472.4029,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080041,Capnine,"(2R,3R)-2-amino-3-hydroxy-15-methylhexadecane-1-sulfonic acid",C17H37NO4S   ,351.2443,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080042,-,2-carboxy-2-amino-3-O-(13'-methyltetradecanoyl)-4-hydroxy-17-methyloctadec-5-ene-1-sulfonic acid,C35H67NO8S   ,661.4587,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080043,R-Dysidazirine,methyl 3-(pentadec-1E-enyl)-2H-azirine-2S-carboxylate,C19H33NO2   ,307.2511,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080044,S-Antazirine,"methyl 3-(13,13-dibromotrideca-1E,12-dienyl)-2H-azirine-2S-carboxylate",C17H25Br2NO2   ,433.0252,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080045,Penaresidin A,2S-((11S-hydroxy-12-methyltetradecyl)-4S-(hydroxymethyl)azetidin-3R-ol,C19H39NO3   ,329.293,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080046,Penaresidin B,2S-((11S-hydroxy-13-methyltetradecyl)-4S-(hydroxymethyl)azetidin-3R-ol,C19H39NO3   ,329.293,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080047,Penazetidine A,2S-(hydroxymethyl)-4S-(12-methyloctadecyl)azetidin-3R-ol,C23H47NO2   ,369.3607,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080048,Pramanicin,-,C19H31NO6   ,369.2151,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080049,Prosopinine,6R-(8-hydroxydecyl)-2R-(hydroxymethyl)-piperidin-3R-ol,C16H33NO3   ,287.246,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080050,Micropine,"6S-((deca-1E,3E,5E-trienyl)-2R-(hydroxymethyl)-piperidin-3R-ol",C16H27NO2   ,265.2042,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080051,Prosafrinine,11-(5S-hydroxy-6S-methylpiperidin-2R-yl)undecan-3-one,C17H33NO2   ,283.2511,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080052,Lepadin D,5S-(5S-hydroxyoctyl)-2S-methyldecahydroquinolin-3R-ol,C18H35NO2   ,297.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080053,Clavepictine B,"(9aS)-6S-(deca-1,3E-dienyl)-4S-methyloctahydro-1H-quinolizin-3R-ol",C20H35NO   ,305.2719,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080054,Oceanalin A,-,C41H72N2O9   ,736.5238,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080055,Safingol ( L-threo-sphinganine),"2S-aminooctadecane-1,3R-diol",C18H39NO2   ,301.2981,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080056,"N,N-dimethyl-Safingol","2S-dimethylaminooctadecane-1,3R-diol",C20H43NO2   ,329.3294,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080057,"N,N,N-trimethyl-sphingosine","N,N,N-trimethyl-sphing-4E-enine",C21H44NO2   ,342.3372,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080058,Enigmol,"2S-aminooctadecane-3S,5S-diol",C18H39NO2   ,301.2981,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080059,-,"2S-amino-octadeca-4E,6E-diene-1,3R-diol",C18H35NO2   ,297.2668,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080060,Scyphostatin A,-,C31H45NO5   ,511.3298,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080061,Sphingofungin A,"2S-guanidino-3R,4R,5S,14R-tetrahydroxyicos-6E-enoic acid",C21H41N3O6   ,431.2995,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080062,Sphingofungin B,"2S-amino-3R,4R,5S,14R-tetrahydroxyeicos-6E-enoic acid",C20H39NO6   ,389.2777,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080063,Sphingofungin C,"2S-amino-5S-acetoxy-3R,4R,14R-trihydroxyeicos-6E-enoic acid",C22H41NO7   ,431.2883,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080064,Sphingofungin D,"2S-acetamido-3R,4R,5S,14R-tetrahydroxyeicos-6E-enoic acid",C22H41NO7   ,431.2883,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080065,Sphingofungin E,"2S-amino-3R,4R,5S-trihydroxy-2-(hydroxymethyl)-14-oxo-eicos-6E-enoic acid",C21H39NO7   ,417.2727,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP01080066,Sphingofungin F,"2S-amino-3R,4R,5S-trihydroxy-2-methyl-14-oxo-eicos-6E-enoic acid",C21H39NO6   ,401.2777,Sphingolipids [SP],Sphingoid bases [SP01],Sphingoid base analogs [SP0108]
LMSP02010000,Ceramide,N-acyl-sphing-4-enine,-   ,-,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010001,Cer(d18:1/14:0),N-(tetradecanoyl)-sphing-4-enine,C32H63NO3   ,509.4808,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010002,Cer(d18:1/12:0),N-(dodecanoyl)-sphing-4-enine,C30H59NO3   ,481.4495,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010003,Cer(d18:1/18:1(9Z)),N-(9Z-octadecenoyl)-sphing-4-enine,C36H69NO3   ,563.5277,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010004,Cer(d18:1/16:0),N-(hexadecanoyl)-sphing-4-enine,C34H67NO3   ,537.5121,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010006,Cer(d18:1/18:0),N-(octadecanoyl)-sphing-4-enine,C36H71NO3   ,565.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010007,Cer(d18:1/20:0),N-(eicosanoyl)-sphing-4-enine,C38H75NO3   ,593.5747,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010008,Cer(d18:1/22:0),N-(docosanoyl)-sphing-4-enine,C40H79NO3   ,621.606,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010009,Cer(d18:1/24:1(15Z)),N-(15Z-tetracosenoyl)-sphing-4-enine,C42H81NO3   ,647.6216,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010010,Cer(d18:1/26:1(17Z)),N-(17Z-hexacosenoyl)-sphing-4-enine,C44H85NO3   ,675.6529,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010011,Cer(d18:1/26:0),N-(hexacosanoyl)-sphing-4-enine,C44H87NO3   ,677.6686,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010012,Cer(d18:1/24:0),N-(tetracosanoyl)-sphing-4-enine,C42H83NO3   ,649.6373,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010013,Cer(d18:1/25:0),N-(pentacosanoyl)-sphing-4-enine,C43H85NO3   ,663.6529,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010014,Cer(d18:1/2:0),N-(acetyl)-sphing-4-enine,C20H39NO3   ,341.293,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010015,Cer(d16:1/17:0),N-(heptadecanoyl)-hexdecasphing-4-enine,C33H65NO3   ,523.4964,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010016,Cer(d16:1/22:0),N-(docosanoyl)-hexadecasphing-4-enine,C38H75NO3   ,593.5747,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010017,Cer(d16:1/23:0),N-(tricosanoyl)-hexadecasphing-4-enine,C39H77NO3   ,607.5903,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010020,Cer(d18:1/17:0),N-(heptadecanoyl)-sphing-4-enine,C35H69NO3   ,551.5277,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010021,Cer(d18:1/23:0),N-(tricosanoyl)-sphing-4-enine,C41H81NO3   ,635.6216,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010022,Cer(d18:2/14:0),"N-(tetradecanoyl)-4E,14Z-sphingadienine",C32H61NO3   ,507.4651,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010023,Cer(d18:2/15:0),"N-(pentadecanoyl)-4E,14Z-sphingadienine",C33H63NO3   ,521.4808,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010024,Cer(d18:2/16:0),"N-(hexadecanoyl)-4E,14Z-sphingadienine",C34H65NO3   ,535.4964,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010025,Cer(d18:2/18:1),"N-(9Z-octadecenoyl)-4E,14Z-sphingadienine",C36H67NO3   ,561.5121,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010026,Cer(d18:2/20:0),"N-(eicosanoyl)-4E,14Z-sphingadienine",C38H73NO3   ,591.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010027,Cer(d18:2/20:1),"N-(11Z-eicosenoyl)-4E,14Z-sphingadienine",C38H71NO3   ,589.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010028,Cer(d18:2/21:0),"N-(heneicosanoyl)-4E,14Z-sphingadienine",C39H75NO3   ,605.5747,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010029,Cer(d18:2/22:0),"N-(docosanoyl)-4E,14Z-sphingadienine",C40H77NO3   ,619.5903,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010030,Cer(d18:2/23:0),"N-(tricosanoyl)-4E,14Z-sphingadienine",C41H79NO3   ,633.606,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010032,Cer(d18:1/19:0),N-(nonadecanoyl)-sphing-4-enine,C37H73NO3   ,579.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010033,Cer(d14:1/16:0),N-(hexadecanoyl)-tetradecasphing-4-enine,C30H59NO3   ,481.4495,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010034,Cer(d14:1/18:0),N-(octadecanoyl)-tetradecasphing-4-enine,C32H63NO3   ,509.4808,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010035,Cer(d14:1/18:1),N-(9Z-octadecenoyl)-tetradecasphing-4-enine,C32H61NO3   ,507.4651,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010036,Cer(d14:1/20:0),N-(eicosanoyl)-tetradecasphing-4-enine,C34H67NO3   ,537.5121,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010037,Cer(d14:1/20:1),N-(11Z-eicosenoyl)-tetradecasphing-4-enine,C34H65NO3   ,535.4964,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010038,Cer(d14:1/22:0),N-(docosanoyl)-tetradecasphing-4-enine,C36H71NO3   ,565.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010039,Cer(d14:1/22:1),N-(13Z-docosenoyl)-tetradecasphing-4-enine,C36H69NO3   ,563.5277,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010040,Cer(d14:1/24:0),N-(tetracosanoyl)-tetradecasphing-4-enine,C38H75NO3   ,593.5747,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010041,Cer(d14:1/24:1),N-(15Z-tetracosenoyl)-tetradecasphing-4-enine,C38H73NO3   ,591.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010042,Cer(d14:1/26:0),N-(hexacosanoyl)-tetradecasphing-4-enine,C40H79NO3   ,621.606,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010043,Cer(d15:1/20:0),N-(eicosanoyl)-pentadecasphing-4-enine,C35H69NO3   ,551.5277,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010044,Cer(d15:1/22:0),N-(docosanoyl)-pentadecasphing-4-enine,C37H73NO3   ,579.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010045,Cer(d15:1/24:0),N-(tetracosanoyl)-pentadecasphing-4-enine,C39H77NO3   ,607.5903,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010046,Cer(d16:1/18:0),N-(octadecanoyl)-hexadecasphing-4-enine,C34H67NO3   ,537.5121,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010047,Cer(d16:1/20:0),N-(eicosanoyl)-hexadecasphing-4-enine,C36H71NO3   ,565.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010048,Cer(d16:1/20:1),N-(11Z-eicosenoyl)-hexadecasphing-4-enine,C36H69NO3   ,563.5277,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010049,Cer(d16:1/22:1),N-(13Z-docosenoyl)-hexadecasphing-4-enine,C38H73NO3   ,591.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010050,Cer(d16:1/24:0),N-(tetracosanoyl)-hexadecasphing-4-enine,C40H79NO3   ,621.606,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010051,"Cer(d14:2(4E,6E)/16:0)","N-(hexadecanoyl)-4E,6E-tetradecasphingadienine",C30H57NO3   ,479.4338,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010052,"Cer(d14:2(4E,6E)/18:0)","N-(octadecanoyl)-4E,6E-tetradecasphingadienine",C32H61NO3   ,507.4651,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010053,"Cer(d14:2(4E,6E)/18:1(9Z))","N-(9Z-octadecenoyl)-4E,6E-tetradecasphingadienine",C32H59NO3   ,505.4495,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010054,"Cer(d14:2(4E,6E)/20:0)","N-(eicosanoyl)-4E,6E-tetradecasphingadienine",C34H65NO3   ,535.4964,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010055,"Cer(d14:2(4E,6E)/20:1(11Z))","N-(11Z-eicosenoyl)-4E,6E-tetradecasphingadienine",C34H63NO3   ,533.4808,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010056,"Cer(d14:2(4E,6E)/22:0)","N-(docosanoyl)-4E,6E-tetradecasphingadienine",C36H69NO3   ,563.5277,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010057,"Cer(d14:2(4E,6E)/22:1(13Z))","N-(13Z-docosenoyl)-4E,6E-tetradecasphingadienine",C36H67NO3   ,561.5121,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010058,"Cer(d14:2(4E,6E)/24:0)","N-(tetracosanoyl)-4E,6E-tetradecasphingadienine",C38H73NO3   ,591.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010059,"Cer(d14:2(4E,6E)/24:1(15Z))","N-(15Z-tetracosenoyl)-4E,6E-tetradecasphingadienine",C38H71NO3   ,589.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010060,"Cer(d15:2(4E,6E)/20:0)","N-(eicosanoyl)-4E,6E-pentadecasphingadienine",C35H67NO3   ,549.5121,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010061,"Cer(d15:2(4E,6E)/22:0)","N-(docosanoyl)-4E,6E-pentadecasphingadienine",C37H71NO3   ,577.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010062,"Cer(d16:2(4E,6E)/18:0)","N-(octadecanoyl)-4E,6E-hexadecasphingadienine",C34H65NO3   ,535.4964,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010063,"Cer(d16:2(4E,6E)/20:0)","N-(eicosanoyl)-4E,6E-hexadecasphingadienine",C36H69NO3   ,563.5277,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010064,"Cer(d16:2(4E,6E)/20:1(11Z))","N-(11Z-eicosenoyl)-4E,6E-hexadecasphingadienine",C36H67NO3   ,561.5121,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010065,"Cer(d16:2(4E,6E)/22:0)","N-(docosanoyl)-4E,6E-hexadecasphingadienine",C38H73NO3   ,591.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010066,"Cer(d16:2(4E,6E)/22:1(13Z))","N-(13Z-docosenoyl)-4E,6E-hexadecasphingadienine",C38H71NO3   ,589.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010067,"Cer(d16:2(4E,6E)/24:0)","N-(tetracosanoyl)-4E,6E-hexadecasphingadienine",C40H77NO3   ,619.5903,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010068,Cer(d14:1(4E)/20:0(2OH)),N-(2-hydroxy-eicosanoyl)-tetradecasphing-4-enine,C34H67NO4   ,553.507,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010069,Cer(d14:1(4E)/20:1(11Z)(2OH)),N-(2-hydroxy-11Z-eicosenoyl)-tetradecasphing-4-enine,C34H65NO4   ,551.4914,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010070,Cer(d14:1(4E)/22:0(2OH)),N-(2-hydroxy-docosanoyl)-tetradecasphing-4-enine,C36H71NO4   ,581.5383,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010071,Cer(d14:1(4E)/22:1(13Z)(2OH)),N-(2-hydroxy-13Z-docosenoyl)-tetradecasphing-4-enine,C36H69NO4   ,579.5227,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010072,Cer(d14:1(4E)/24:0(2OH)),N-(2-hydroxy-tetracosanoyl)-tetradecasphing-4-enine,C38H75NO4   ,609.5696,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010073,Cer(d14:1(4E)/26:0(2OH)),N-(2-hydroxy-hexacosanoyl)-tetradecasphing-4-enine,C40H79NO4   ,637.6009,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010074,"Cer(d14:2(4E,6E)/18:0(2OH))","N-(2-hydroxy-octadecanoyl)-4E,6E-tetradecasphingadienine",C32H61NO4   ,523.4601,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010075,"Cer(d14:2(4E,6E)/18:1(9Z)(2OH))","N-(2-hydroxy-9Z-octadecenoyl)-4E,6E-tetradecasphingadienine",C32H59NO4   ,521.4444,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010076,"Cer(d14:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-4E,6E-tetradecasphingadienine",C34H65NO4   ,551.4914,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010077,"Cer(d14:2(4E,6E)/20:1(11Z)(2OH))","N-(2-hydroxy-11Z-eicosenoyl)-4E,6E-tetradecasphingadienine",C34H63NO4   ,549.4757,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010078,"Cer(d14:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-4E,6E-tetradecasphingadienine",C36H69NO4   ,579.5227,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010079,"Cer(d14:2(4E,6E)/22:1(13Z)(2OH))","N-(2-hydroxy-13Z-docosenoyl)-4E,6E-tetradecasphingadienine",C36H67NO4   ,577.507,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010080,"Cer(d14:2(4E,6E)/24:0(2OH))","N-(2-hydroxy-tetracosanoyl)-4E,6E-tetradecasphingadienine",C38H73NO4   ,607.554,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010081,"Cer(d15:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-4E,6E-pentadecasphingadienine",C35H67NO4   ,565.507,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010082,"Cer(d15:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-4E,6E-pentadecasphingadienine",C37H71NO4   ,593.5383,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010083,Cer(d16:1(4E)/18:1(9Z)(2OH)),N-(2-hydroxy-9Z-octadecenoyl)-hexadecasphing-4-enine,C34H65NO4   ,551.4914,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010084,Cer(d16:1(4E)/20:0(2OH)),N-(2-hydroxy-eicosanoyl)-hexadecasphing-4-enine,C36H71NO4   ,581.5383,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010085,Cer(d16:1(4E)/22:0(2OH)),N-(2-hydroxy-docosanoyl)-hexadecasphing-4-enine,C38H75NO4   ,609.5696,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010086,Cer(d16:1(4E)/24:0(2OH)),N-(2-hydroxy-tetracosanoyl)-hexadecasphing-4-enine,C40H79NO4   ,637.6009,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010087,"Cer(d16:2(4E,6E)/18:0(2OH))","N-(2-hydroxy-octadecanoyl)-4E,6E-hexadecasphingadienine",C34H65NO4   ,551.4914,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010088,"Cer(d16:2(4E,6E)/18:1(9Z)(2OH))","N-(2-hydroxy-9Z-octadecenoyl)-4E,6E-hexadecasphingadienine",C34H63NO4   ,549.4757,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010089,"Cer(d16:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-4E,6E-hexadecasphingadienine",C36H69NO4   ,579.5227,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010090,"Cer(d16:2(4E,6E)/20:1(11Z)(2OH))","N-(2-hydroxy-11Z-eicosenoyl)-4E,6E-hexadecasphingadienine",C36H67NO4   ,577.507,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010091,"Cer(d16:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-4E,6E-hexadecasphingadienine",C38H73NO4   ,607.554,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010092,"Cer(d16:2(4E,6E)/22:1(13Z)(2OH))","N-(2-hydroxy-13Z-docosenoyl)-4E,6E-hexadecasphingadienine",C38H71NO4   ,605.5383,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010093,"Cer(d16:2(4E,6E)/24:0(2OH))","N-(2-hydroxy-tetracosanoyl)-4E,6E-hexadecasphingadienine",C40H77NO4   ,635.5853,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010094,Cer(d14:1(4E)/18:1(9Z)(2OH)),N-(2-hydroxy-9Z-octadecenoyl)-tetradecasphing-4-enine,C32H61NO4   ,523.4601,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02010095,  ,"N-(2R-hydroxy-15-methyl-3E-octadecenoyl)-4E,10E,12E-sphingatrienine",C37H67NO4   ,589.507,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02020000,Dihydroceramide,N-acyl-sphinganine,-   ,-,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020001,Cer(d18:0/16:0),N-(hexadecanoyl)-sphinganine,C34H69NO3   ,539.5277,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020008,Cer(d18:0/18:0),N-(octadecanoyl)-sphinganine,C36H73NO3   ,567.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020009,Cer(d18:0/20:0),N-(eicosanoyl)-sphinganine,C38H77NO3   ,595.5903,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020010,Cer(d18:0/22:0),N-(docosanoyl)-sphinganine,C40H81NO3   ,623.6216,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020011,Cer(d18:0/24:1(15Z)),N-(15Z-tetracosenoyl)-sphinganine,C42H83NO3   ,649.6373,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020012,Cer(d18:0/24:0),N-(tetracosanoyl)-sphinganine,C42H85NO3   ,651.6529,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020013,Cer(d18:0/26:1(17Z)),N-(17Z-hexacosenoyl)-sphinganine,C44H87NO3   ,677.6686,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020014,Cer(d18:0/26:0),N-(hexacosanoyl)-sphinganine,C44H89NO3   ,679.6842,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020015,Cer(d18:0/18:1(9Z)),N-(9Z-octadecenoyl)-sphinganine,C36H71NO3   ,565.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020016,Cer(d18:0/14:0),N-(tetradecanoyl)-sphinganine,C32H65NO3   ,511.4964,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020017,Cer(d18:0/h24:0),N-(24-hydroxytetracosanoyl)-sphinganine,C42H85NO4   ,667.6479,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020018,Cer(d18:0/h26:0),N-(26-hydroxyhexacosanoyl)-sphinganine,C44H89NO4   ,695.6792,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020019,Cer(d18:0/h17:0),N-(2R-hydroxyheptadecanoyl)-sphinganine,C35H71NO4   ,569.5383,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020020,Cer(d18:0/13:0),N-(tridecanoyl)-sphinganine,C31H63NO3   ,497.4808,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02020021,Cer(d18:0/15:0),N-(pentadecanoyl)-sphinganine,C33H67NO3   ,525.5121,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02020022,Cer(d18:0/17:0),N-(heptadecanoyl)-sphinganine,C35H71NO3   ,553.5434,Sphingolipids [SP],Ceramides [SP02],N-acylsphingosines (ceramides) [SP0201]
LMSP02020023,Cer(d20:0/16:0),N-(hexadecanoyl)-eicosasphinganine,C36H73NO3   ,567.559,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020024,Cer(d20:0/18:0),N-(octadecanoyl)-eicosasphinganine,C38H77NO3   ,595.5903,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020025,Cer(d20:0/20:0),N-(eicosanoyl)-eicosasphinganine,C40H81NO3   ,623.6216,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020026,Cer(d20:0/22:0),N-(docosanoyl)-eicosasphinganine,C42H85NO3   ,651.6529,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020027,Cer(d20:0/24:0),N-(tetracosanoyl)-eicosasphinganine,C44H89NO3   ,679.6842,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020028,Cer(d20:0/26:0),N-(hexacosanoyl)-eicosasphinganine,C46H93NO3   ,707.7155,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020029,Cer(d18:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-sphinganine,C34H69NO4   ,555.5227,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020030,Cer(d18:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-sphinganine,C36H73NO4   ,583.554,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020031,Cer(d18:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-sphinganine,C38H77NO4   ,611.5853,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020032,Cer(d18:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-sphinganine,C40H81NO4   ,639.6166,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020033,Cer(d18:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-sphinganine,C42H85NO4   ,667.6479,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020034,Cer(d18:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-sphinganine,C44H89NO4   ,695.6792,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020035,Cer(d20:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-eicosasphinganine,C36H73NO4   ,583.554,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020036,Cer(d20:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-eicosasphinganine,C38H77NO4   ,611.5853,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020037,Cer(d20:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-eicosasphinganine,C40H81NO4   ,639.6166,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020038,Cer(d20:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-eicosasphinganine,C42H85NO4   ,667.6479,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020039,Cer(d20:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-eicosasphinganine,C44H89NO4   ,695.6792,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02020040,Cer(d20:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-eicosasphinganine,C46H93NO4   ,723.7105,Sphingolipids [SP],Ceramides [SP02],N-acylsphinganines (dihydroceramides) [SP0202]
LMSP02030001,Cer(t18:0/16:0),N-(hexadecanoyl)-4R-hydroxysphinganine,C34H69NO4   ,555.5227,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030002,Cer(t18:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-4R-hydroxysphinganine,C42H85NO5   ,683.6428,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030003,Cer(t18:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-4R-hydroxysphinganine,C44H89NO5   ,711.6741,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030004,Cer(t18:0/24:0),N-(tetracosanoyl)-4R-hydroxysphinganine,C42H85NO4   ,667.6479,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030005,Cer(t18:0/26:0),N-(hexacosanoyl)-4R-hydroxysphinganine,C44H89NO4   ,695.6792,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030006,Cer(t18:0/18:0),N-(octadecanoyl)-4R-hydroxysphinganine,C36H73NO4   ,583.554,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030007,Cer(t18:0/20:0),N-(eicosanoyl)-4R-hydroxysphinganine,C38H77NO4   ,611.5853,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030008,Cer(t18:0/22:0),N-(docosanoyl)-4R-hydroxysphinganine,C40H81NO4   ,639.6166,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030009,Cer(t20:0/16:0),N-(hexadecanoyl)-4R-hydroxy-eicosasphinganine,C36H73NO4   ,583.554,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030010,Cer(t20:0/18:0),N-(octadecanoyl)-4R-hydroxy-eicosasphinganine,C38H77NO4   ,611.5853,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030011,Cer(t20:0/20:0),N-(eicosanoyl)-4R-hydroxy-eicosasphinganine,C40H81NO4   ,639.6166,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030012,Cer(t20:0/22:0),N-(docosanoyl)-4R-hydroxy-eicosasphinganine,C42H85NO4   ,667.6479,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030013,Cer(t20:0/24:0),N-(tetracosanoyl)-4R-hydroxy-eicosasphinganine,C44H89NO4   ,695.6792,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030014,Cer(t20:0/26:0),N-(hexacosanoyl)-4R-hydroxy-eicosasphinganine,C46H93NO4   ,723.7105,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030015,Cer(t18:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-4R-hydroxysphinganine,C34H69NO5   ,571.5176,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030016,Cer(t18:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-4R-hydroxysphinganine,C36H73NO5   ,599.5489,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030017,Cer(t18:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-4R-hydroxysphinganine,C38H77NO5   ,627.5802,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030018,Cer(t18:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-4R-hydroxysphinganine,C40H81NO5   ,655.6115,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030019,Cer(t20:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-4R-hydroxyeicosasphinganine,C36H73NO5   ,599.5489,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030020,Cer(t20:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-4R-hydroxyeicosasphinganine,C38H77NO5   ,627.5802,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030021,Cer(t20:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-4R-hydroxyeicosasphinganine,C40H81NO5   ,655.6115,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030022,Cer(t20:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-4R-hydroxyeicosasphinganine,C42H85NO5   ,683.6428,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030023,Cer(t20:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-4R-hydroxyeicosasphinganine,C44H89NO5   ,711.6741,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02030024,Cer(t20:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-4R-hydroxyeicosasphinganine,C46H93NO5   ,739.7054,Sphingolipids [SP],Ceramides [SP02],N-acyl-4-hydroxysphinganines (phytoceramides) [SP0203]
LMSP02040001,-,"N-(30-(9Z,12Z-octadecadienoyloxy)-triacontanoyl)-sphing-4-enine",C66H125NO5   ,1011.9558,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040002,1-O-myristoyl-Cer(d18:1/16:0),1-O-tetradecanoyl-N-(hexadecanoyl)-sphing-4-enine,C48H93NO4   ,747.7105,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040003,1-O-palmitoyl-Cer(d18:1/16:0),1-O-hexadecanoyl-N-(hexadecanoyl)-sphing-4-enine,C50H97NO4   ,775.7418,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040004,1-O-stearoyl-Cer(d18:1/16:0),1-O-octadecanoyl-N-(hexadecanoyl)-sphing-4-enine,C52H101NO4   ,803.7731,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040005,1-O-eicosanoyl-Cer(d18:1/16:0),1-O-eicosanoyl-N-(hexadecanoyl)-sphing-4-enine,C54H105NO4   ,831.8044,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040006,1-O-behenoyl-Cer(d18:1/16:0),1-O-docosanoyl-N-(hexadecanoyl)-sphing-4-enine,C56H109NO4   ,859.8357,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040007,1-O-lignoceroyl-Cer(d18:1/16:0),1-O-tetracosanoyl-N-(hexadecanoyl)-sphing-4-enine,C58H113NO4   ,887.867,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040008,1-O-cerotoyl-Cer(d18:1/16:0),1-O-hexacosanoyl-N-(hexadecanoyl)-sphing-4-enine,C60H117NO4   ,915.8983,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040009,1-O-carboceroyl-Cer(d18:1/16:0),1-O-heptacosanoyl-N-(hexadecanoyl)-sphing-4-enine,C59H115NO4   ,901.8826,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040010,1-O-tricosanoyl-Cer(d18:1/16:0),1-O-tricosanoyl-N-(hexadecanoyl)-sphing-4-enine,C57H111NO4   ,873.8513,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040011,1-O-palmitoyl-Cer(d18:1/18:0),1-O-hexadecanoyl-N-(octadecanoyl)-sphing-4-enine,C52H101NO4   ,803.7731,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040012,1-O-myristoyl-Cer(d18:1/18:0),1-O-tetradecanoyl-N-(octadecanoyl)-sphing-4-enine,C50H97NO4   ,775.7418,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040013,1-O-stearoyl-Cer(d18:1/18:0),1-O-octadecanoyl-N-(octadecanoyl)-sphing-4-enine,C54H105NO4   ,831.8044,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040014,1-O-eicosanoyl-Cer(d18:1/18:0),1-O-eicosanoyl-N-(octadecanoyl)-sphing-4-enine,C56H109NO4   ,859.8357,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040015,1-O-behenoyl-Cer(d18:1/18:0),1-O-docosanoyl-N-(octadecanoyl)-sphing-4-enine,C58H113NO4   ,887.867,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040016,1-O-lignoceroyl-Cer(d18:1/18:0),1-O-tetracosanoyl-N-(octadecanoyl)-sphing-4-enine,C60H117NO4   ,915.8983,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040017,1-O-cerotoyl-Cer(d18:1/18:0),1-O-hexacosanoyl-N-(octadecanoyl)-sphing-4-enine,C62H121NO4   ,943.9296,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040018,1-O-carboceroyl-Cer(d18:1/18:0),1-O-octacosanoyl-N-(octadecanoyl)-sphing-4-enine,C64H125NO4   ,971.9609,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02040019,1-O-tricosanoyl-Cer(d18:1/18:0),1-O-tricosanoyl-N-(octadecanoyl)-sphing-4-enine,C66H129NO4   ,999.9922,Sphingolipids [SP],Ceramides [SP02],Acylceramides [SP0204]
LMSP02050000,N-Acyl ceramide phosphate,N-(acyl)-sphing-4-enine-1-phosphate,-   ,-,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050001,CerP(d18:1/12:0),N-(dodecanoyl)-sphing-4-enine-1-phosphate,C30H60NO6P   ,561.4158,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050002,CerP(d18:1/16:0),N-(hexadecanoyl)-sphing-4-enine-1-phosphate,C34H68NO6P   ,617.4784,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050003,CerP(d18:0/16:0),N-(hexadecanoyl)-sphinganine-1-phosphate,C34H70NO6P   ,619.4941,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050004,CerP(d18:1/18:0),N-(octadecanoyl)-sphing-4-enine-1-phosphate,C36H72NO6P   ,645.5097,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050005,CerP(d18:1/20:0),N-(eicosanoyl)-sphing-4-enine-1-phosphate,C38H76NO6P   ,673.541,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050006,CerP(d18:1/22:0),N-(docosanoyl)-sphing-4-enine-1-phosphate,C40H80NO6P   ,701.5723,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050007,CerP(d18:1/24:1(15Z)),N-(15Z-tetracosenoyl)-sphing-4-enine-1-phosphate,C42H82NO6P   ,727.588,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050008,CerP(d18:1/24:0),N-(tetracosanoyl)-sphing-4-enine-1-phosphate,C42H84NO6P   ,729.6036,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050010,CerP(d18:1/26:0),N-(hexacosanoyl)-sphing-4-enine-1-phosphate,C44H88NO6P   ,757.6349,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050011,CerP(d18:1/26:1(17Z)),N-(17Z-hexacosenoyl)-sphing-4-enine-1-phosphate,C46H90NO6P   ,783.6506,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050012,CerP(d18:1/8:0),N-(octanoyl)-sphing-4-enine-1-phosphate,C26H52NO6P   ,505.3532,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050013,CerP(d18:1/14:0),N-(tetradecanoyl)-sphing-4-enine-1-phosphate,C32H64NO6P   ,589.4471,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP02050014,CerP(d18:1/2:0),N-(acetyl)-sphing-4-enine-1-phosphate,C20H40NO6P   ,421.2593,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP020500A0,Dihydroceramide phosphate,N-acyl-sphinganine-1-phosphate,-   ,-,Sphingolipids [SP],Ceramides [SP02],Ceramide 1-phosphates [SP0205]
LMSP03010000,Sphingomyelin,N-acyl-sphing-4-enine-1-phosphocholine,-   ,-,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010001,SM(d18:1/18:0),N-(octadecanoyl)-sphing-4-enine-1-phosphocholine,C41H83N2O6P   ,730.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010002,SM(d18:1/12:0),N-(dodecanoyl)-sphing-4-enine-1-phosphocholine,C35H71N2O6P   ,646.505,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010003,SM(d18:1/16:0),N-(hexadecanoyl)-sphing-4-enine-1-phosphocholine,C39H79N2O6P   ,702.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010004,SM(d18:0/16:0),N-(hexadecanoyl)-sphinganine-1-phosphocholine,C39H81N2O6P   ,704.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010005,SM(d18:1/20:0),N-(eicosanoyl)-sphing-4-enine-1-phosphocholine,C43H87N2O6P   ,758.6302,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010006,SM(d18:1/22:0),N-(docosanoyl)-sphing-4-enine-1-phosphocholine,C45H91N2O6P   ,786.6615,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010007,SM(d18:1/24:1(15Z)),N-(15Z-tetracosenoyl)-sphing-4-enine-1-phosphocholine,C47H93N2O6P   ,812.6771,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010008,SM(d18:1/24:0),N-(tetracosanoyl)-sphing-4-enine-1-phosphocholine,C47H95N2O6P   ,814.6928,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010009,SM(d18:1/26:1(17Z)),N-(17Z-hexacosenoyl)-sphing-4-enine-1-phosphocholine,C49H97N2O6P   ,840.7084,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010010,SM(d18:1/26:0),N-(hexacosanoyl)-sphing-4-enine-1-phosphocholine,C49H99N2O6P   ,842.7241,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010020,SM(d18:0/18:0),N-(octadecanoyl)-sphinganine-1-phosphocholine,C41H85N2O6P   ,732.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010021,SM(d18:0/20:0),N-(eicosanoyl)-sphinganine-1-phosphocholine,C43H89N2O6P   ,760.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010022,SM(d18:0/22:0),N-(docosanoyl)-sphinganine-1-phosphocholine,C45H93N2O6P   ,788.6771,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010023,SM(d18:0/24:1(15Z)),N-(15Z-tetracosenoyl)-sphinganine-1-phosphocholine,C47H95N2O6P   ,814.6928,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010024,SM(d18:0/24:0),N-(tetracosanoyl)-sphinganine-1-phosphocholine,C47H97N2O6P   ,816.7084,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010025,SM(d18:0/26:1(17Z)),N-(17Z-hexacosenoyl)-sphinganine-1-phosphocholine,C49H99N2O6P   ,842.7241,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010026,SM(d18:0/26:0),N-(hexacosanoyl)-sphinganine-1-phosphocholine,C49H101N2O6P   ,844.7397,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010027,SM(d18:1/25:0),N-(pentacosanoyl)-sphing-4-enine-1-phosphocholine,C48H97N2O6P   ,828.7084,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010028,SM(d18:1/14:0),N-(tetradecanoyl)-sphing-4-enine-1-phosphocholine,C37H75N2O6P   ,674.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010029,SM(d18:1/18:1(9Z)),N-(9Z-octadecenoyl)-sphing-4-enine-1-phosphocholine,C41H81N2O6P   ,728.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010030,SM(d18:0/14:0),N-(tetradecanoyl)-sphinganine-1-phosphocholine,C37H77N2O6P   ,676.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010031,SM(d18:0/18:1(9Z)),N-(9Z-octadecenoyl)-sphinganine-1-phosphocholine,C41H83N2O6P   ,730.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010033,SM(d18:0/13:0),N-(tridecanoyl)-sphinganine-1-phosphocholine,C36H75N2O6P   ,662.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010034,SM(d18:2/14:0),"N-(tetradecanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C37H73N2O6P   ,672.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010035,SM(d16:1/16:0),N-(hexadecanoyl)-hexadecasphing-4-enine-1-phosphocholine,C37H75N2O6P   ,674.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010036,SM(d18:2/15:0),"N-(heptadecanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C38H75N2O6P   ,686.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010037,SM(d16:1/17:0),N-(heptadecanoyl)-hexadecasphing-4-enine-1-phosphocholine,C38H77N2O6P   ,688.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010038,SM(d18:1/15:0),N-(pentadecanoyl)-sphing-4-enine-1-phosphocholine,C38H77N2O6P   ,688.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010040,SM(d16:1/18:1),N-(9Z-octadecenoyl)-hexadecasphing-4-enine-1-phosphocholine,C39H77N2O6P   ,700.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010041,SM(d18:1/16:1),N-(9Z-hexadecenoyl)-sphing-4-enine-1-phosphocholine,C39H77N2O6P   ,700.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010042,SM(d16:1/18:0),N-(octadecanoyl)-hexadecasphing-4-enine-1-phosphocholine,C39H79N2O6P   ,702.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010043,SM(d17:1/17:0),N-(heptadecanoyl)-heptadecasphing-4-enine-1-phosphocholine,C39H79N2O6P   ,702.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010044,SM(d18:1/17:0),N-(heptadecanoyl)-sphing-4-enine-1-phosphocholine,C40H81N2O6P   ,716.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010045,SM(d19:1/16:0),N-(hexadecanoyl)-nonadecasphing-4-enine-1-phosphocholine,C40H81N2O6P   ,716.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010046,SM(d18:0/17:0),N-(heptadecanoyl)-sphinganine-1-phosphocholine,C40H83N2O6P   ,718.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010047,SM(d18:2/18:1),"N-(9Z-octadecenoyl)-4E,14Z-sphingadienine-1-phosphocholine",C41H79N2O6P   ,726.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010048,SM(d16:1/20:1),N-(11Z-eicosenoyl)-hexadecasphing-4-enine-1-phosphocholine,C41H81N2O6P   ,728.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010049,SM(d18:0/18:2),"N-(9Z,12Z-octadecadienoyl)-sphinganine-1-phosphocholine",C41H81N2O6P   ,728.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010050,SM(d18:2/18:0),"N-(octadecanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C41H81N2O6P   ,728.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010051,SM(d19:1/17:1),N-(9Z-heptadecenoyl)-nonadecasphing-4-enine-1-phosphocholine,C41H81N2O6P   ,728.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010052,SM(d16:1/20:0),N-(eicosanoyl)-hexadecasphing-4-enine-1-phosphocholine,C41H83N2O6P   ,730.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010053,SM(d16:0/20:0),N-(eicosanoyl)-hexadecasphinganine-1-phosphocholine,C41H85N2O6P   ,732.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010054,SM(d19:0/17:0),N-(heptadecanoyl)-nonadecasphinganine-1-phosphocholine,C41H85N2O6P   ,732.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010055,SM(d18:1/19:0),N-(nonadecanoyl)-sphing-4-enine-1-phosphocholine,C42H85N2O6P   ,744.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010056,SM(d19:1/18:0),N-(octadecanoyl)-nonadecasphing-4-enine-1-phosphocholine,C42H85N2O6P   ,744.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010057,SM(d18:2/20:1),"N-(11Z-eicosenoyl)-4E,12Z-sphingadienine-1-phosphocholine",C43H83N2O6P   ,754.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010058,SM(d16:1/22:1),N-(13Z-docosenoyl)-hexadecasphing-4-enine-1-phosphocholine,C43H85N2O6P   ,756.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010059,SM(d18:1/20:1),N-(11Z-eicosenoyl)-sphing-4-enine-1-phosphocholine,C43H85N2O6P   ,756.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010060,SM(d18:2/20:0),"N-(eicosanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C43H85N2O6P   ,756.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010061,SM(d16:1/22:0),N-(docosanoyl)-hexadecasphing-4-enine-1-phosphocholine,C43H87N2O6P   ,758.6302,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010063,SM(d16:0/22:0),N-(docosanoyl)-hexadecasphinganine-1-phosphocholine,C43H89N2O6P   ,760.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010064,SM(d18:2/21:0),"N-(heneicosanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C44H87N2O6P   ,770.6302,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010065,SM(d16:1/23:0),N-(tricosanoyl)-hexadecasphing-4-enine-1-phosphocholine,C44H89N2O6P   ,772.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010066,SM(d17:1/22:0),N-(docosanoyl)-heptadecasphing-4-enine-1-phosphocholine,C44H89N2O6P   ,772.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010067,SM(d18:1/21:0),N-(heneicosanoyl)-sphing-4-enine-1-phosphocholine,C44H89N2O6P   ,772.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010068,SM(d19:1/20:0),N-(eicosanoyl)-nonadecasphing-4-enine-1-phosphocholine,C44H89N2O6P   ,772.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010069,SM(d20:1/19:0),N-(nonadecanoyl)-eicosasphing-4-enine-1-phosphocholine,C44H89N2O6P   ,772.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010070,SM(d18:2/22:1),"N-(13Z-docosenoyl)-4E,14Z-sphingadienine-1-phosphocholine",C45H87N2O6P   ,782.6302,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010071,SM(d16:1/24:1),N-(15Z-tetracosenoyl)-hexadecasphing-4-enine-1-phosphocholine,C45H89N2O6P   ,784.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010072,SM(d18:1/22:1),N-(13Z-docosenoyl)-sphing-4-enine-1-phosphocholine,C45H89N2O6P   ,784.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010073,SM(d16:1/24:0),N-(tetracosanoyl)-hexadecasphing-4-enine-1-phosphocholine,C45H91N2O6P   ,786.6615,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010074,SM(d17:1/24:1),N-(15Z-tetracosenoyl)-heptadecasphing-4-enine-1-phosphocholine,C46H91N2O6P   ,798.6615,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010075,SM(d18:2/23:0),"N-(tricosanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C46H91N2O6P   ,798.6615,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010076,SM(d16:1/25:0),N-(pentacosanoyl)-hexadecasphing-4-enine-1-phosphocholine,C46H93N2O6P   ,800.6771,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010077,SM(d17:1/24:0),N-(tetracosanoyl)-heptadecasphing-4-enine-1-phosphocholine,C46H93N2O6P   ,800.6771,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010078,SM(d18:1/23:0),N-(tricosanoyl)-sphing-4-enine-1-phosphocholine,C46H93N2O6P   ,800.6771,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010079,SM(d18:0/12:0),N-(dodecanoyl)-sphinganine-1-phosphocholine,C35H73N2O6P   ,648.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010080,SM(d18:2/24:1),"N-(15Z-tetracosenoyl)-4E,14Z-sphingadienine-1-phosphocholine",C47H91N2O6P   ,810.6615,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010081,SM(d18:2/24:0),"N-(tetracosanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C47H93N2O6P   ,812.6771,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010082,SM(d17:1/26:1),N-(17Z-hexacosenoyl)-heptadecasphing-4-enine-1-phosphocholine,C48H95N2O6P   ,826.6928,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010083,SM(d18:2/25:0),"N-(pentacosanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C48H95N2O6P   ,826.6928,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010084,SM(d19:1/24:1),N-(15Z-tetracosenoyl)-nonadecasphing-4-enine-1-phosphocholine,C48H95N2O6P   ,826.6928,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010085,SM(d19:0/24:1),N-(15Z-tetracosenoyl)-nonadecasphinganine-1-phosphocholine,C48H97N2O6P   ,828.7084,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010086,SM(d19:1/24:0),N-(tetracosanoyl)-nonadecasphing-4-enine-1-phosphocholine,C48H97N2O6P   ,828.7084,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010087,SM(d20:1/23:0),N-(tricosanoyl)-eicosasphing-4-enine-1-phosphocholine,C48H97N2O6P   ,828.7084,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010088,SM(d20:0/24:1),N-(15Z-tetracosenoyl)-eicosasphinganine-1-phosphocholine,C49H99N2O6P   ,842.7241,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010089,SM(d17:0/27:0),N-(heptacosanoyl)-heptadecasphinganine-1-phosphocholine,C49H101N2O6P   ,844.7397,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010090,SM(d18:2/16:0),"N-(hexadecanoyl)-4E,14Z-sphingadienine-1-phosphocholine",C39H77N2O6P   ,700.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010091,SM(d18:0/15:0),N-(pentadecanoyl)-sphinganine-1-phosphocholine,C38H79N2O6P   ,690.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03010092,SM(d18:2/22:0),"N-(docosanoyl)-4E,12Z-sphingadienine-1-phosphocholine",C45H89N2O6P   ,784.6458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP030100A0,Dihydrosphingomyelin,N-acyl-sphinganine-1-phosphocholine,-   ,-,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphocholines (sphingomyelins) [SP0301]
LMSP03020000,N-Acyl ceramide phosphoethanolamine,N-(acyl)-sphing-4-enine-1-phosphoethanolamine,-   ,-,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020001,PE-Cer(d14:1(4E)/18:0),N-(octadecanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C34H69N2O6P   ,632.4893,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020002,PE-Cer(d14:1(4E)/16:0),N-(hexadecanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C32H65N2O6P   ,604.458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020003,PE-Cer(d14:1(4E)/18:1(9Z)),N-(9Z-octadecenoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C34H67N2O6P   ,630.4737,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020004,PE-Cer(d14:1(4E)/19:0),N-(nonadecanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C35H71N2O6P   ,646.505,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020005,PE-Cer(d14:1(4E)/20:0),N-(eicosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C36H73N2O6P   ,660.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020006,PE-Cer(d14:1(4E)/20:1(11Z)),N-(11Z-eicosenoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C36H71N2O6P   ,658.505,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020007,PE-Cer(d14:1(4E)/21:0),N-(heneicosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C37H75N2O6P   ,674.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020008,PE-Cer(d14:1(4E)/22:0),N-(docosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C38H77N2O6P   ,688.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020009,PE-Cer(d14:1(4E)/22:1(13Z)),N-(13Z-docosenoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C38H75N2O6P   ,686.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020010,PE-Cer(d14:1(4E)/23:0),N-(tricosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C39H79N2O6P   ,702.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020011,PE-Cer(d14:1(4E)/24:0),N-(tetracosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C40H81N2O6P   ,716.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020012,PE-Cer(d14:1(4E)/24:1(15Z)),N-(15Z-tetracosenoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C40H79N2O6P   ,714.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020013,PE-Cer(d14:1(4E)/25:0),N-(pentacosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C41H83N2O6P   ,730.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020014,PE-Cer(d14:1(4E)/26:0),N-(hexacosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C42H85N2O6P   ,744.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020015,PE-Cer(d15:1(4E)/18:0),N-(octadecanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine,C35H71N2O6P   ,646.505,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020016,PE-Cer(d15:1(4E)/20:0),N-(eicosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine,C37H75N2O6P   ,674.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020017,PE-Cer(d15:1(4E)/22:0),N-(docosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine,C39H79N2O6P   ,702.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020018,PE-Cer(d15:1(4E)/24:0),N-(tetracosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine,C41H83N2O6P   ,730.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020019,PE-Cer(d16:1(4E)/16:0),N-(hexadecanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C34H69N2O6P   ,632.4893,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020020,PE-Cer(d16:1(4E)/18:0),N-(octadecanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C36H73N2O6P   ,660.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020021,PE-Cer(d16:1(4E)/19:0),N-(nonadecanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C37H75N2O6P   ,674.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020022,PE-Cer(d16:1(4E)/20:0),N-(eicosanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C38H77N2O6P   ,688.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020023,PE-Cer(d16:1(4E)/21:0),N-(heneicosanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C39H79N2O6P   ,702.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020024,PE-Cer(d16:1(4E)/22:0),N-(docosanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C40H81N2O6P   ,716.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020025,PE-Cer(d16:1(4E)/23:0),N-(tricosanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C41H83N2O6P   ,730.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020026,PE-Cer(d16:1(4E)/24:0),N-(tetracosanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C42H85N2O6P   ,744.6145,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020027,PE-Cer(d16:1(4E)/22:1(13Z)),N-(13Z-docosenoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C40H79N2O6P   ,714.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020028,PE-Cer(d16:1(4E)/24:1(15Z)),N-(15Z-tetracosenoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C42H83N2O6P   ,742.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020029,"PE-Cer(d14:2(4E,6E)/16:0)","N-(hexadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C32H63N2O6P   ,602.4424,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020030,"PE-Cer(d14:2(4E,6E)/18:0)","N-(octadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C34H67N2O6P   ,630.4737,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020031,"PE-Cer(d14:2(4E,6E)/18:1(9Z))","N-(9Z-octadecenoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C34H65N2O6P   ,628.458,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020032,"PE-Cer(d14:2(4E,6E)/20:0)","N-(eicosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C36H71N2O6P   ,658.505,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020033,"PE-Cer(d14:2(4E,6E)/20:1(11Z))","N-(11Z-eicosenoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C36H69N2O6P   ,656.4893,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020034,"PE-Cer(d14:2(4E,6E)/22:0)","N-(docosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C38H75N2O6P   ,686.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020035,"PE-Cer(d14:2(4E,6E)/22:1(13Z))","N-(13Z-docosenoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C38H73N2O6P   ,684.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020036,"PE-Cer(d14:2(4E,6E)/24:0)","N-(tetracosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C40H79N2O6P   ,714.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020037,"PE-Cer(d14:2(4E,6E)/24:1(15Z))","N-(15Z-tetracosenoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C40H77N2O6P   ,712.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020038,"PE-Cer(d14:2(4E,6E)/26:0)","N-(hexacosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C42H83N2O6P   ,742.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020039,"PE-Cer(d14:2(4E,6E)/19:0)","N-(nonadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C35H69N2O6P   ,644.4893,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020040,"PE-Cer(d14:2(4E,6E)/21:0)","N-(heneicosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C37H73N2O6P   ,672.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020041,"PE-Cer(d14:2(4E,6E)/23:0)","N-(tricosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C39H77N2O6P   ,700.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020042,"PE-Cer(d14:2(4E,6E)/25:0)","N-(pentacosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C41H81N2O6P   ,728.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020043,"PE-Cer(d15:2(4E,6E)/18:0)","N-(octadecanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine",C35H69N2O6P   ,644.4893,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020044,"PE-Cer(d15:2(4E,6E)/20:0)","N-(eicosanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine",C37H73N2O6P   ,672.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020045,"PE-Cer(d15:2(4E,6E)/22:0)","N-(docosanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine",C39H77N2O6P   ,700.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020046,"PE-Cer(d15:2(4E,6E)/24:0)","N-(tetracosanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine",C41H81N2O6P   ,728.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020047,"PE-Cer(d16:2(4E,6E)/16:0)","N-(hexadecanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C34H67N2O6P   ,630.4737,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020048,"PE-Cer(d16:2(4E,6E)/18:0)","N-(octadecanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C36H71N2O6P   ,658.505,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020049,"PE-Cer(d16:2(4E,6E)/18:1(9Z))","N-(9Z-octadecenoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C36H69N2O6P   ,656.4893,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020050,"PE-Cer(d16:2(4E,6E)/20:0)","N-(eicosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C38H75N2O6P   ,686.5363,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020051,"PE-Cer(d16:2(4E,6E)/20:1(11Z))","N-(11Z-eicosenoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C38H73N2O6P   ,684.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020052,"PE-Cer(d16:2(4E,6E)/22:0)","N-(docosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C40H79N2O6P   ,714.5676,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020053,"PE-Cer(d16:2(4E,6E)/22:1(13Z))","N-(13Z-docosenoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C40H77N2O6P   ,712.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020054,"PE-Cer(d16:2(4E,6E)/24:0)","N-(tetracosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C42H83N2O6P   ,742.5989,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020055,"PE-Cer(d16:2(4E,6E)/24:1(15Z))","N-(15Z-tetracosenoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C42H81N2O6P   ,740.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020056,"PE-Cer(d16:2(4E,6E)/19:0)","N-(nonadecanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C37H73N2O6P   ,672.5206,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020057,"PE-Cer(d16:2(4E,6E)/21:0)","N-(heneicosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C39H77N2O6P   ,700.5519,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020058,"PE-Cer(d16:2(4E,6E)/23:0)","N-(tricosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C41H81N2O6P   ,728.5832,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020059,PE-Cer(d14:1(4E)/18:0(2OH)),N-(2-hydroxy-octadecanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C34H69N2O7P   ,648.4842,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020060,PE-Cer(d14:1(4E)/20:0(2OH)),N-(2-hydroxy-eicosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C36H73N2O7P   ,676.5155,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020061,PE-Cer(d14:1(4E)/20:1(11Z)(2OH)),N-(2-hydroxy-11Z-eicosenoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C36H71N2O7P   ,674.4999,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020062,PE-Cer(d14:1(4E)/22:0(2OH)),N-(2-hydroxy-docosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C38H77N2O7P   ,704.5468,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020063,PE-Cer(d14:1(4E)/22:1(13Z)(2OH)),N-(2-hydroxy-13Z-docosenoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C38H75N2O7P   ,702.5312,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020064,PE-Cer(d14:1(4E)/24:0(2OH)),N-(2-hydroxy-tetracosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C40H81N2O7P   ,732.5781,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020065,PE-Cer(d14:1(4E)/24:1(15Z)(2OH)),N-(2-hydroxy-15Z-tetracosenoyl)-tetradecasphing-4-enine-1-phosphoethanolamine,C40H79N2O7P   ,730.5625,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020066,"PE-Cer(d14:2(4E,6E)/16:0(2OH))","N-(2-hydroxy-hexadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C32H63N2O7P   ,618.4373,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020067,"PE-Cer(d14:2(4E,6E)/18:0(2OH))","N-(2-hydroxy-octadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C34H67N2O7P   ,646.4686,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020068,"PE-Cer(d14:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C36H71N2O7P   ,674.4999,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020069,"PE-Cer(d14:2(4E,6E)/20:1(11Z)(2OH))","N-(2-hydroxy-11Z-eicosenoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C36H69N2O7P   ,672.4842,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020070,"PE-Cer(d14:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C38H75N2O7P   ,702.5312,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020071,"PE-Cer(d14:2(4E,6E)/22:1(13Z)(2OH))","N-(2-hydroxy-13Z-docosenoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C38H73N2O7P   ,700.5155,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020072,"PE-Cer(d14:2(4E,6E)/24:0(2OH))","N-(2-hydroxy-tetracosanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C40H79N2O7P   ,730.5625,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020073,"PE-Cer(d14:2(4E,6E)/24:1(15Z)(2OH))","N-(2-hydroxy-15Z-tetracosenoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine",C40H77N2O7P   ,728.5468,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020074,PE-Cer(d15:1(4E)/20:0(2OH)),N-(2-hydroxy-eicosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine,C37H75N2O7P   ,690.5312,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020075,PE-Cer(d15:1(4E)/22:0(2OH)),N-(2-hydroxy-docosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine,C39H79N2O7P   ,718.5625,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020076,"PE-Cer(d15:2(4E,6E)/18:0(2OH))","N-(2-hydroxy-octadecanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine",C35H69N2O7P   ,660.4842,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020077,"PE-Cer(d15:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine",C37H73N2O7P   ,688.5155,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020078,"PE-Cer(d15:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine",C39H77N2O7P   ,716.5468,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020079,"PE-Cer(d15:2(4E,6E)/24:0(2OH))","N-(2-hydroxy-tetracosanoyl)-4E,6E-pentadecasphingadienine-1-phosphoethanolamine",C41H81N2O7P   ,744.5781,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020080,PE-Cer(d16:1(4E)/18:0(2OH)),N-(2-hydroxy-octadecanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C36H73N2O7P   ,676.5155,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020081,PE-Cer(d16:1(4E)/18:1(9Z)(2OH)),N-(2-hydroxy-9Z-octadecenoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C36H71N2O7P   ,674.4999,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020082,PE-Cer(d16:1(4E)/20:0(2OH)),N-(2-hydroxy-eicosanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C38H77N2O7P   ,704.5468,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020083,PE-Cer(d16:1(4E)/20:1(11Z)(2OH)),N-(2-hydroxy-11Z-eicosenoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C38H75N2O7P   ,702.5312,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020084,PE-Cer(d16:1(4E)/22:0(2OH)),N-(2-hydroxy-docosanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C40H81N2O7P   ,732.5781,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020085,PE-Cer(d16:1(4E)/22:1(13Z)(2OH)),N-(2-hydroxy-13Z-docosenoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C40H79N2O7P   ,730.5625,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020086,PE-Cer(d16:1(4E)/24:0(2OH)),N-(2-hydroxy-tetracosanoyl)-hexadecasphing-4-enine-1-phosphoethanolamine,C42H85N2O7P   ,760.6094,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020087,"PE-Cer(d16:2(4E,6E)/16:0(2OH))","N-(2-hydroxy-hexadecanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C34H67N2O7P   ,646.4686,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020088,"PE-Cer(d16:2(4E,6E)/18:0(2OH))","N-(2-hydroxy-octadecanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C36H71N2O7P   ,674.4999,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020089,"PE-Cer(d16:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C38H75N2O7P   ,702.5312,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020090,"PE-Cer(d16:2(4E,6E)/20:1(11Z)(2OH))","N-(2-hydroxy-11Z-eicosenoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C38H73N2O7P   ,700.5155,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020091,"PE-Cer(d16:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C40H79N2O7P   ,730.5625,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020092,"PE-Cer(d16:2(4E,6E)/22:1(13Z)(2OH))","N-(2-hydroxy-13Z-docosenoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C40H77N2O7P   ,728.5468,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020093,"PE-Cer(d16:2(4E,6E)/24:0(2OH))","N-(2-hydroxy-tetracosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C42H83N2O7P   ,758.5938,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03020094,"PE-Cer(d16:2(4E,6E)/24:1(15Z)(2OH))","N-(2-hydroxy-15Z-tetracosenoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine",C42H81N2O7P   ,756.5781,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoethanolamines [SP0302]
LMSP03030001,PI-Cer(d18:1/22:0),N-(docosanoyl)-sphing-4-enine-1-phospho-(1'-myo-inositol),C46H90NO11P   ,863.6252,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030003,M(IP)2C(t18:0/26:0(2OH)),N-(2-hydroxy-hexacosanoyl)-4R-hydroxysphinganine-1-O-[inositol-1-phosphoryl-6-mannosyl-alpha1-2-inositol-1-phosphate],C62H121NO26P2   ,1357.7652,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030004,MIPC(t18:0/26:0(2OH)),N-(2-hydroxy-hexacosanoyl)-4R-hydroxysphinganine-1-O-[mannosyl-alpha1-2-inositol-1-phosphate],C56H110NO18P   ,1115.7461,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030005,GlcN-alpha1-4-GlcUA-alpha1-2-PI-Cer(t18:1/24:0(2OH)),N-(2-hydroxy-tetracosanoyl)-4R-hydroxysphing-8E-enine-1-O-[2-amino-D-glucopyranosyl(alpha1-4)-D-glucopyranosyl(alpha1-2)-myo-inositol-1-phosphate],C60H113N2O23P   ,1260.7472,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030006,PI-Cer(d18:0/16:0),N-(hexadecanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C40H80NO11P   ,781.5469,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030007,PI-Cer(d18:0/18:0),N-(octadecanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C42H84NO11P   ,809.5782,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030008,PI-Cer(d18:0/20:0),N-(eicosanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C44H88NO11P   ,837.6095,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030009,PI-Cer(d18:0/22:0),N-(docosanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C46H92NO11P   ,865.6408,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030010,PI-Cer(d18:0/24:0),N-(tetracosanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C48H96NO11P   ,893.6721,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030011,PI-Cer(d18:0/26:0),N-(hexacosanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C50H100NO11P   ,921.7034,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030012,PI-Cer(t18:0/16:0),N-(hexadecanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C40H80NO12P   ,797.5418,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030013,PI-Cer(t18:0/18:0),N-(octadecanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C42H84NO12P   ,825.5731,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030014,PI-Cer(t18:0/20:0),N-(eicosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C44H88NO12P   ,853.6044,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030015,PI-Cer(t18:0/22:0),N-(docosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C46H92NO12P   ,881.6357,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030016,PI-Cer(t18:0/24:0),N-(tetracosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C48H96NO12P   ,909.667,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030017,PI-Cer(t18:0/26:0),N-(hexacosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C50H100NO12P   ,937.6983,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030018,PI-Cer(t20:0/16:0),N-(hexadecanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C42H84NO12P   ,825.5731,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030019,PI-Cer(t20:0/18:0),N-(octadecanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C44H88NO12P   ,853.6044,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030020,PI-Cer(t20:0/20:0),N-(eicosanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C46H92NO12P   ,881.6357,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030021,PI-Cer(t20:0/22:0),N-(docosanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C48H96NO12P   ,909.667,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030022,PI-Cer(t20:0/24:0),N-(tetracosanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C50H100NO12P   ,937.6983,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030023,PI-Cer(t20:0/26:0),N-(hexacosanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C52H104NO12P   ,965.7296,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030024,PI-Cer(d20:0/16:0),N-(hexadecanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C42H84NO11P   ,809.5782,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030025,PI-Cer(d20:0/18:0),N-(octadecanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C44H88NO11P   ,837.6095,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030026,PI-Cer(d20:0/20:0),N-(eicosanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C46H92NO11P   ,865.6408,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030027,PI-Cer(d20:0/22:0),N-(docosanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C48H96NO11P   ,893.6721,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030028,PI-Cer(d20:0/24:0),N-(tetracosanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C50H100NO11P   ,921.7034,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030029,PI-Cer(d20:0/26:0),N-(hexacosanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C52H104NO11P   ,949.7347,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030030,PI-Cer(d18:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C40H80NO12P   ,797.5418,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030031,PI-Cer(d18:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C42H84NO12P   ,825.5731,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030032,PI-Cer(d18:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C44H88NO12P   ,853.6044,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030033,PI-Cer(d18:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C46H92NO12P   ,881.6357,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030034,PI-Cer(d18:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C48H96NO12P   ,909.667,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030035,PI-Cer(d18:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-sphinganine-1-phospho-(1'-myo-inositol),C50H100NO12P   ,937.6983,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030036,PI-Cer(t18:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C40H80NO13P   ,813.5367,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030037,PI-Cer(t18:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C42H84NO13P   ,841.568,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030038,PI-Cer(t18:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C44H88NO13P   ,869.5993,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030039,PI-Cer(t18:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C46H92NO13P   ,897.6306,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030040,PI-Cer(t18:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C48H96NO13P   ,925.6619,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030041,PI-Cer(t18:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-myo-inositol),C50H100NO13P   ,953.6932,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030042,PI-Cer(t20:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C42H84NO13P   ,841.568,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030043,PI-Cer(t20:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C44H88NO13P   ,869.5993,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030044,PI-Cer(t20:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C46H92NO13P   ,897.6306,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030045,PI-Cer(t20:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C48H96NO13P   ,925.6619,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030046,PI-Cer(t20:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C50H100NO13P   ,953.6932,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030047,PI-Cer(t20:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-4R-hydroxyeicosasphinganine-1-phospho-(1'-myo-inositol),C52H104NO13P   ,981.7245,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030048,PI-Cer(d20:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C42H84NO12P   ,825.5731,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030049,PI-Cer(d20:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C44H88NO12P   ,853.6044,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030050,PI-Cer(d20:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C46H92NO12P   ,881.6357,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030051,PI-Cer(d20:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C48H96NO12P   ,909.667,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030052,PI-Cer(d20:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C50H100NO12P   ,937.6983,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030053,PI-Cer(d20:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-eicosasphinganine-1-phospho-(1'-myo-inositol),C52H104NO12P   ,965.7296,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030054,MIPC(d18:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C46H90NO17P   ,959.5946,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030055,MIPC(d18:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C48H94NO17P   ,987.6259,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030056,MIPC(d18:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C50H98NO17P   ,1015.6572,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030057,MIPC(d18:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C52H102NO17P   ,1043.6885,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030058,MIPC(d18:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C54H106NO17P   ,1071.7198,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030059,MIPC(d18:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C56H110NO17P   ,1099.7511,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030060,MIPC(d18:0/16:0),N-(hexadecanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C46H90NO16P   ,943.5997,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030061,MIPC(d18:0/18:0),N-(octadecanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C48H94NO16P   ,971.631,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030062,MIPC(d18:0/20:0),N-(eicosanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C50H98NO16P   ,999.6623,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030063,MIPC(d18:0/22:0),N-(docosanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C52H102NO16P   ,1027.6936,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030064,MIPC(d18:0/24:0),N-(tetracosanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C54H106NO16P   ,1055.7249,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030065,MIPC(d18:0/26:0),N-(hexacosanoyl)-sphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C56H110NO16P   ,1083.7562,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030066,MIPC(t18:0/16:0),N-(hexadecanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C46H90NO17P   ,959.5946,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030067,MIPC(t18:0/18:0),N-(octadecanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C48H94NO17P   ,987.6259,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030068,MIPC(t18:0/20:0),N-(eicosanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C50H98NO17P   ,1015.6572,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030069,MIPC(t18:0/22:0),N-(docosanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C52H102NO17P   ,1043.6885,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030070,MIPC(t18:0/24:0),N-(tetracosanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C54H106NO17P   ,1071.7198,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030071,MIPC(t18:0/26:0),N-(hexacosanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C56H110NO17P   ,1099.7511,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030072,MIPC(t18:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C46H90NO18P   ,975.5896,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030073,MIPC(t18:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C48H94NO18P   ,1003.6209,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030074,MIPC(t18:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C50H98NO18P   ,1031.6522,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030075,MIPC(t18:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C52H102NO18P   ,1059.6835,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030076,MIPC(t18:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-4R-hydroxysphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C54H106NO18P   ,1087.7148,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030078,MIPC(d20:0/16:0),N-(hexadecanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C48H94NO16P   ,971.631,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030079,MIPC(d20:0/18:0),N-(octadecanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C50H98NO16P   ,999.6623,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030080,MIPC(d20:0/20:0),N-(eicosanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C52H102NO16P   ,1027.6936,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030081,MIPC(d20:0/22:0),N-(docosanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C54H106NO16P   ,1055.7249,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030082,MIPC(d20:0/24:0),N-(tetracosanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C56H110NO16P   ,1083.7562,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030083,MIPC(d20:0/26:0),N-(hexacosanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C58H114NO16P   ,1111.7875,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030084,MIPC(d20:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C48H94NO17P   ,987.6259,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030085,MIPC(d20:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C50H98NO17P   ,1015.6572,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030086,MIPC(d20:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C52H102NO17P   ,1043.6885,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030087,MIPC(d20:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C54H106NO17P   ,1071.7198,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030088,MIPC(d20:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C56H110NO17P   ,1099.7511,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030089,MIPC(d20:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-eicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C58H114NO17P   ,1127.7824,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030090,MIPC(t20:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C48H94NO18P   ,1003.6209,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030091,MIPC(t20:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C50H98NO18P   ,1031.6522,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030092,MIPC(t20:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C52H102NO18P   ,1059.6835,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030093,MIPC(t20:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C54H106NO18P   ,1087.7148,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030094,MIPC(t20:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C56H110NO18P   ,1115.7461,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030095,MIPC(t20:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C58H114NO18P   ,1143.7774,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030096,MIPC(t20:0/16:0),N-(hexadecanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C48H94NO17P   ,987.6259,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030097,MIPC(t20:0/18:0),N-(octadecanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C50H98NO17P   ,1015.6572,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030098,MIPC(t20:0/20:0),N-(eicosanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C52H102NO17P   ,1043.6885,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030099,MIPC(t20:0/22:0),N-(docosanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C54H106NO17P   ,1071.7198,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030100,MIPC(t20:0/24:0),N-(tetracosanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C56H110NO17P   ,1099.7511,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030101,MIPC(t20:0/26:0),N-(hexacosanoyl)-4R-hydroxyeicosasphinganine-1-O-[D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate] ,C58H114NO17P   ,1127.7824,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030102,M(IP)2C(t18:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate]  ,C52H101NO26P2   ,1217.6087,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030103,M(IP)2C(t18:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate]  ,C54H105NO26P2   ,1245.64,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030104,M(IP)2C(t18:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C56H109NO26P2   ,1273.6713,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030105,M(IP)2C(t18:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C58H113NO26P2   ,1301.7026,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030106,M(IP)2C(t18:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C60H117NO26P2   ,1329.7339,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030108,M(IP)2C(t18:0/16:0),N-(hexadecanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C52H101NO25P2   ,1201.6138,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030109,M(IP)2C(t18:0/18:0),N-(octadecanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C54H105NO25P2   ,1229.6451,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030110,M(IP)2C(t18:0/20:0),N-(eicosanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C56H109NO25P2   ,1257.6764,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030111,M(IP)2C(t18:0/22:0),N-(docosanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C58H113NO25P2   ,1285.7077,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030112,M(IP)2C(t18:0/24:0),N-(tetracosanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C60H117NO25P2   ,1313.739,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030113,M(IP)2C(t18:0/26:0),N-hexacosanoyl)-4R-hydroxysphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C62H121NO25P2   ,1341.7703,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030114,M(IP)2C(d18:0/16:0),N-hexadecanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C52H101NO24P2   ,1185.6189,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030115,M(IP)2C(d18:0/18:0),N-(octadecanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C54H105NO24P2   ,1213.6502,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030116,M(IP)2C(d18:0/20:0),N-(eicosanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C56H109NO24P2   ,1241.6815,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030117,M(IP)2C(d18:0/22:0),N-(docosanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C58H113NO24P2   ,1269.7128,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030118,M(IP)2C(d18:0/24:0),N-(tetracosanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C60H117NO24P2   ,1297.7441,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030119,M(IP)2C(d18:0/26:0),N-(hexacosanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C62H121NO24P2   ,1325.7754,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030120,M(IP)2C(d18:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C52H101NO25P2   ,1201.6138,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030121,M(IP)2C(d18:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C54H105NO25P2   ,1229.6451,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030122,M(IP)2C(d18:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C56H109NO25P2   ,1257.6764,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030123,M(IP)2C(d18:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C58H113NO25P2   ,1285.7077,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030124,M(IP)2C(d18:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C60H117NO25P2   ,1313.739,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030125,M(IP)2C(d18:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-sphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C62H121NO25P2   ,1341.7703,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030126,M(IP)2C(d20:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C54H105NO25P2   ,1229.6451,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030127,M(IP)2C(d20:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C56H109NO25P2   ,1257.6764,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030128,M(IP)2C(d20:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C58H113NO25P2   ,1285.7077,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030129,M(IP)2C(d20:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C60H117NO25P2   ,1313.739,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030130,M(IP)2C(d20:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C62H121NO25P2   ,1341.7703,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030131,M(IP)2C(d20:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C64H125NO25P2   ,1369.8016,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030132,M(IP)2C(d20:0/16:0),N-(hexadecanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C54H105NO24P2   ,1213.6502,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030133,M(IP)2C(d20:0/18:0),N-(octadecanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C56H109NO24P2   ,1241.6815,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030134,M(IP)2C(d20:0/20:0),N-(eicosanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C58H113NO24P2   ,1269.7128,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030135,M(IP)2C(d20:0/22:0),N-(docosanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C60H117NO24P2   ,1297.7441,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030136,M(IP)2C(d20:0/24:0),N-(tetracosanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C62H121NO24P2   ,1325.7754,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030137,M(IP)2C(d20:0/26:0),N-(hexacosanoyl)-eicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C64H125NO24P2   ,1353.8067,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030138,M(IP)2C(t20:0/16:0(2OH)),N-(2-hydroxyhexadecanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C54H105NO26P2   ,1245.64,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030139,M(IP)2C(t20:0/18:0(2OH)),N-(2-hydroxyoctadecanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C56H109NO26P2   ,1273.6713,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030140,M(IP)2C(t20:0/20:0(2OH)),N-(2-hydroxyeicosanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C58H113NO26P2   ,1301.7026,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030141,M(IP)2C(t20:0/22:0(2OH)),N-(2-hydroxydocosanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C60H117NO26P2   ,1329.7339,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030142,M(IP)2C(t20:0/24:0(2OH)),N-(2-hydroxytetracosanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C62H121NO26P2   ,1357.7652,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030143,M(IP)2C(t20:0/26:0(2OH)),N-(2-hydroxyhexacosanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C64H125NO26P2   ,1385.7965,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030144,M(IP)2C(t20:0/16:0),N-(hexadecanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C54H105NO25P2   ,1229.6451,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030145,M(IP)2C(t20:0/18:0),N-(octadecanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C56H109NO25P2   ,1257.6764,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030146,M(IP)2C(t20:0/20:0),N-(eicosanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C58H113NO25P2   ,1285.7077,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030147,M(IP)2C(t20:0/22:0),N-(docosanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C60H117NO25P2   ,1313.739,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030148,M(IP)2C(t20:0/24:0),N-(tetracosanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C62H121NO25P2   ,1341.7703,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP03030149,M(IP)2C(t20:0/26:0),N-(hexacosanoyl)-4R-hydroxyeicosasphinganine-1-O-[myo-inositol-1-phosphoryl-6-D-mannopyranosyl-alpha1-2-myo-inositol-1-phosphate],C64H125NO25P2   ,1369.8016,Sphingolipids [SP],Phosphosphingolipids [SP03],Ceramide phosphoinositols [SP0303]
LMSP04000000,Ceramide ciliatine,N-(acyl)-sphing-4-enine-1-(2-aminoethylphosphonate),-   ,-,Sphingolipids [SP],Phosphonosphingolipids [SP04],
LMSP04000001,-,N-(tetradecanoyl)-sphing-4-enine-1-(2-aminoethylphosphonate),C34H69N2O5P   ,616.4944,Sphingolipids [SP],Phosphonosphingolipids [SP04],
LMSP04000002,N-palmitoyl-D-sphingosyl-1-(2-aminoethyl)phosphonate,N-(hexadecanoyl)-sphing-4-enine-1-(2-aminoethylphosphonate),C36H73N2O5P   ,644.5257,Sphingolipids [SP],Phosphonosphingolipids [SP04],
LMSP05000001,Syriacin,"N-(34S-methyl-5Z,9Z,12Z,15Z,18Z,21Z-hexatriacontahexaenoyl)-1-sulfo-beta-D-fucosyl-(16R-methyl-sphing-4-enine)",C62H109NO10S   ,1059.7772,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Other Neutral glycosphingolipids [SP0500]
LMSP05010031,Glucosyl sphingosine,1-beta-glucosyl-sphing-4-enine,C24H47NO7   ,461.3353,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP05010032,FMC-5(d18:1/18:0),"N-(octadecanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine ",C52H91NO13   ,937.649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP05010033,FMC-5(d18:1/20:0),"N-(eicosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine ",C54H95NO13   ,965.6803,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP05010034,FMC-5(d18:1/22:0),"N-(docosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine ",C56H99NO13   ,993.7116,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP05010035,FMC-5(d18:1/24:0),"N-(tetracosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine ",C58H103NO13   ,1021.7429,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP05010036,FMC-5(d18:1/24:1),"N-(15Z-tetracosenoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine ",C58H101NO13   ,1019.7273,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP05010037,FMC-6(d18:1/24:0(2-OH)),"N-(2-hydroxy-tetracosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine",C58H103NO14   ,1037.7379,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP05010038,FMC-6(d18:1/22:0(2-OH)),"N-(2-hydroxy-docosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine",C56H99NO14   ,1009.7066,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP05010039,Phalluside-1,"N-(2R-hydroxy-hexadecanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E,10E-trienine",C41H75NO9   ,725.5442,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA00,GlcCer,Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA01,GlcCer(d18:1/12:0),N-(dodecanoyl)-1-beta-glucosyl-sphing-4-enine,C36H69NO8   ,643.5023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA03,GlcCer(d18:1/16:0),N-(hexadecanoyl)-1-beta-glucosyl-sphing-4-enine,C40H77NO8   ,699.5649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA04,GlcCer(d18:0/16:0),N-(hexadecanoyl)-1-beta-glucosyl-sphinganine,C40H79NO8   ,701.5806,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA05,GlcCer(d18:1/18:0),N-(octadecanoyl)-1-beta-glucosyl-sphing-4-enine,C42H81NO8   ,727.5962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA06,GlcCer(d18:1/20:0),N-(eicosanoyl)-1-beta-glucosyl-sphing-4-enine,C44H85NO8   ,755.6275,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA07,GlcCer(d18:1/22:0),N-(docosanoyl)-1-beta-glucosyl-sphing-4-enine,C46H89NO8   ,783.6588,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA08,GlcCer(d18:1/24:1(15Z)),N-(15Z-tetracosenoyl)-1-beta-glucosyl-sphing-4-enine,C48H91NO8   ,809.6745,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA09,GlcCer(d18:1/24:0),N-(tetracosanoyl)-1-beta-glucosyl-sphing-4-enine,C48H93NO8   ,811.6901,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA10,GlcCer(d18:1/26:1(17Z)),N-(17Z-hexacosenoyl)-1-beta-glucosyl-sphing-4-enine,C50H95NO8   ,837.7058,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA11,GlcCer(d18:1/26:0),N-(hexacosanoyl)-1-beta-glucosyl-sphing-4-enine,C50H97NO8   ,839.7214,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA19,GlcCer(d18:0/18:0),N-(octadecanoyl)-1-beta-glucosyl-sphinganine,C42H83NO8   ,729.6119,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA20,GlcCer(d18:0/20:0),N-(eicosanoyl)-1-beta-glucosyl-sphinganine,C44H87NO8   ,757.6432,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA21,GlcCer(d18:0/22:0),N-(docosanoyl)-1-beta-glucosyl-sphinganine,C46H91NO8   ,785.6745,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA22,GlcCer(d18:0/24:1(15Z)),N-(15Z-tetracosenoyl)-1-beta-glucosyl-sphinganine,C48H93NO8   ,811.6901,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA23,GlcCer(d18:0/24:0),N-(tetracosanoyl)-1-beta-glucosyl-sphinganine,C48H95NO8   ,813.7058,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA24,GlcCer(d18:0/26:1(17Z)),N-(17Z-hexacosenoyl)-1-beta-glucosyl-sphinganine,C50H97NO8   ,839.7214,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA25,GlcCer(d18:0/26:0),N-(hexacosanoyl)-1-beta-glucosyl-sphinganine,C50H99NO8   ,841.7371,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA26,GlcCer(d18:1/14:0),N-(tetradecanoyl)-1-beta-glucosyl-sphing-4-enine,C38H73NO8   ,671.5336,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA27,GlcCer(d18:1/18:1(9Z)),N-(9Z-octadecenoyl)-1-beta-glucosyl-sphing-4-enine,C42H79NO8   ,725.5806,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA28,GlcCer(d18:0/14:0),N-(tetradecanoyl)-1-beta-glucosyl-sphinganine,C38H75NO8   ,673.5493,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA29,GlcCer(d18:0/18:1(9Z)),N-(9Z-octadecenoyl)-1-beta-glucosyl-sphinganine,C42H81NO8   ,727.5962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA30,GlcCer(d16:1/22:0),N-(docosanoyl)-1-beta-glucosyl-hexadecasphing-4-enine,C44H85NO8   ,755.6275,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA31,GlcCer(d16:1/23:0),N-(tricosanoyl)-1-beta-glucosyl-hexadecasphing-4-enine,C45H87NO8   ,769.6432,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA32,GlcCer(d18:1/23:0),N-(tricosanoyl)-1-beta-glucosyl-sphing-4-enine,C47H91NO8   ,797.6745,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA33,GlcCer(d18:2/16:0),"N-(hexadecanoyl)-1beta-glucosyl-4E,14Z-sphingadienine",C40H75NO8   ,697.5493,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA34,GlcCer(d18:2/20:0),"N-(eicosanoyl)-1beta-glucosyl-4E,14Z-sphingadienine",C44H83NO8   ,753.6119,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA35,GlcCer(d18:2/20:1),"N-(11Z-eicosenoyl)-1beta-glucosyl-4E,14Z-sphingadienine",C44H81NO8   ,751.5962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA36,GlcCer(d18:2/21:0),"N-(heneicosanoyl)-1beta-glucosyl-4E,14Z-sphingadienine",C45H85NO8   ,767.6275,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA37,GlcCer(d18:2/22:0),"N-(docosanoyl)-1beta-glucosyl-4E,14Z-sphingadienine",C46H87NO8   ,781.6432,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA38,GlcCer(d18:2/23:0),"N-(tricosanoyl)-1beta-glucosyl-4E,14Z-sphingadienine",C47H89NO8   ,795.6588,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA39,GlcCer(d14:1/16:0),N-(hexadecanoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C36H69NO8   ,643.5023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA40,GlcCer(d14:1/18:0),N-(octadecanoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C38H73NO8   ,671.5336,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA41,GlcCer(d14:1/18:1),N-(9Z-octadecenoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C38H71NO8   ,669.518,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA42,GlcCer(d14:1/20:0),N-(eicosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C40H77NO8   ,699.5649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA43,GlcCer(d14:1/22:0),N-(docosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C42H81NO8   ,727.5962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA44,GlcCer(d14:1/24:0),N-(tetracosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C44H85NO8   ,755.6275,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA45,GlcCer(d14:1/24:1),N-(15Z-tetracosenoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C44H83NO8   ,753.6119,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA46,GlcCer(d15:1/18:0),N-(octadecanoyl)-1-beta-glucosyl-pentadecasphing-4-enine,C39H75NO8   ,685.5493,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA47,GlcCer(d15:1/20:0),N-(eicosanoyl)-1-beta-glucosyl-pentadecasphing-4-enine,C41H79NO8   ,713.5806,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA48,GlcCer(d15:1/22:0),N-(docosanoyl)-1-beta-glucosyl-pentadecasphing-4-enine,C43H83NO8   ,741.6119,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA49,GlcCer(d16:1/18:0),N-(octadecanoyl)-1-beta-glucosyl-hexadecasphing-4-enine,C40H77NO8   ,699.5649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA50,GlcCer(d16:1/20:0),N-(eicosanoyl)-1-beta-glucosyl-hexadecasphing-4-enine,C42H81NO8   ,727.5962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA51,GlcCer(d16:1/24:0),N-(tetracosanoyl)-1-beta-glucosyl-hexadecasphing-4-enine,C46H89NO8   ,783.6588,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA52,"GlcCer(d14:2(4E,6E)/16:0)","N-(hexadecanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C36H67NO8   ,641.4867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA53,"GlcCer(d14:2(4E,6E)/18:0)","N-(octadecanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C38H71NO8   ,669.518,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA54,"GlcCer(d14:2(4E,6E)/18:1(9Z))","N-(9Z-octadecenoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C38H69NO8   ,667.5023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA55,"GlcCer(d14:2(4E,6E)/20:0)","N-(eicosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C40H75NO8   ,697.5493,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA56,"GlcCer(d14:2(4E,6E)/22:0)","N-(docosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C42H79NO8   ,725.5806,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA57,"GlcCer(d14:2(4E,6E)/24:0)","N-(tetracosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C44H83NO8   ,753.6119,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA58,"GlcCer(d15:2(4E,6E)/18:0)","N-(octadecanoyl)-1-beta-glucosyl-4E,6E-pentadecasphingadienine",C39H73NO8   ,683.5336,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA59,"GlcCer(d15:2(4E,6E)/20:0)","N-(eicosanoyl)-1-beta-glucosyl-4E,6E-pentadecasphingadienine",C41H77NO8   ,711.5649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA60,"GlcCer(d15:2(4E,6E)/22:0)","N-(docosanoyl)-1-beta-glucosyl-4E,6E-pentadecasphingadienine",C43H81NO8   ,739.5962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA61,"GlcCer(d16:2(4E,6E)/18:0)","N-(octadecanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine",C40H75NO8   ,697.5493,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA62,"GlcCer(d16:2(4E,6E)/20:0)","N-(eicosanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine",C42H79NO8   ,725.5806,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA63,"GlcCer(d16:2(4E,6E)/22:0)","N-(docosanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine",C44H83NO8   ,753.6119,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA64,"GlcCer(d16:2(4E,6E)/24:0)","N-(tetracosanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine",C46H87NO8   ,781.6432,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA65,GlcCer(d14:1(4E)/20:0(2OH)),N-(2-hydroxy-eicosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C40H77NO9   ,715.5598,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA66,GlcCer(d14:1(4E)/22:0(2OH)),N-(2-hydroxy-docosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C42H81NO9   ,743.5911,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA67,GlcCer(d14:1(4E)/22:1(13Z)(2OH)),N-(2-hydroxy-13Z-docosenoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C42H79NO9   ,741.5755,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA68,GlcCer(d14:1(4E)/24:0(2OH)),N-(2-hydroxy-tetracosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C44H85NO9   ,771.6224,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA69,GlcCer(d14:1(4E)/24:1(15Z)(2OH)),N-(2-hydroxy-15Z-tetracosenoyl)-1-beta-glucosyl-tetradecasphing-4-enine,C44H83NO9   ,769.6068,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA70,"GlcCer(d14:2(4E,6E)/18:0(2OH))","N-(2-hydroxy-octadecanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C38H71NO9   ,685.5129,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA71,"GlcCer(d14:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C40H75NO9   ,713.5442,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA72,"GlcCer(d14:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C42H79NO9   ,741.5755,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA73,"GlcCer(d14:2(4E,6E)/24:0(2OH))","N-(2-hydroxy-tetracosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine",C44H83NO9   ,769.6068,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA74,"GlcCer(d15:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-1-beta-glucosyl-4E,6E-pentadecasphingadienine",C41H77NO9   ,727.5598,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA75,"GlcCer(d15:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-1-beta-glucosyl-4E,6E-pentadecasphingadienine",C43H81NO9   ,755.5911,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA76,GlcCer(d16:1(4E)/20:0(2OH)),N-(2-hydroxy-eicosanoyl)-1-beta-glucosyl-hexadecasphing-4-enine,C42H81NO9   ,743.5911,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA77,GlcCer(d16:1(4E)/22:0(2OH)),N-(2-hydroxy-docosanoyl)-1-beta-glucosyl-hexadecasphing-4-enine,C44H85NO9   ,771.6224,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA78,"GlcCer(d16:2(4E,6E)/18:0(2OH))","N-(2-hydroxy-octadecanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine",C40H75NO9   ,713.5442,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA79,"GlcCer(d16:2(4E,6E)/20:0(2OH))","N-(2-hydroxy-eicosanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine",C42H79NO9   ,741.5755,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA80,"GlcCer(d16:2(4E,6E)/22:0(2OH))","N-(2-hydroxy-docosanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine",C44H83NO9   ,769.6068,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AA81,"GlcCer(d16:2(4E,6E)/24:0(2OH))","N-(2-hydroxy-tetracosanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine",C46H87NO9   ,797.6381,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB00,LacCer,Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB02,LacCer(d18:1/12:0),N-(dodecanoyl)-1-b-lactosyl-sphing-4-enine,C42H79NO13   ,805.5551,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB03,LacCer(d18:1/16:0),N-(hexadecanoyl)-1-b-lactosyl-sphing-4-enine,C46H87NO13   ,861.6177,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB04,LacCer(d18:1/18:0),N-(octadecanoyl)-1-b-lactosyl-sphing-4-enine,C48H91NO13   ,889.649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB05,LacCer(d18:1/20:0),N-(eicosanoyl)-1-b-lactosyl-sphing-4-enine,C50H95NO13   ,917.6803,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB06,LacCer(d18:1/22:0),N-(docosanoyl)-1-b-lactosyl-sphing-4-enine,C52H99NO13   ,945.7116,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB07,LacCer(d18:1/24:0),N-(tetracosanoyl)-1-b-lactosyl-sphing-4-enine,C54H103NO13   ,973.7429,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB08,LacCer(d18:1/26:0),N-(hexacosanoyl)-1-b-lactosyl-sphing-4-enine,C56H107NO13   ,1001.7742,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB09,LacCer(d18:1/24:1(15Z)),N-(15Z-tetracosenoyl)-1-b-lactosyl-sphing-4-enine,C54H101NO13   ,971.7273,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB10,LacCer(d18:1/26:1(17Z)),N-(17Z-hexacosenoyl)-1-b-lactosyl-sphing-4-enine,C56H105NO13   ,999.7586,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB11,LacCer(d18:1/18:1(9Z)),N-(9Z-octadecenoyl)-1-beta-lactosyl-sphing-4-enine,C48H89NO13   ,887.6334,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB12,LacCer(d18:1/14:0),N-(tetradecanoyl)-1-b-lactosyl-sphing-4-enine,C44H83NO13   ,833.5864,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB13,LacCer(d18:0/14:0),N-(tetradecanoyl)-1-beta-lactosyl-sphinganine,C44H85NO13   ,835.6021,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB14,LacCer(d18:0/16:0),N-(hexadecanoyl)-1-beta-lactosyl-sphinganine,C46H89NO13   ,863.6334,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB15,LacCer(d18:0/18:0),N-(octadecanoyl)-1-beta-lactosyl-sphinganine,C48H93NO13   ,891.6647,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB16,LacCer(d18:0/20:0),N-(eicosanoyl)-1-beta-lactosyl-sphinganine,C50H97NO13   ,919.696,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB17,LacCer(d18:0/22:0),N-(docosanoyl)-1-beta-lactosyl-sphinganine,C52H101NO13   ,947.7273,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB18,LacCer(d18:0/24:0),N-(tetracosanoyl)-1-beta-lactosyl-sphinganine,C54H105NO13   ,975.7586,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB19,LacCer(d18:0/26:0),N-(hexacosanoyl)-1-beta-lactosyl-sphinganine,C56H109NO13   ,1003.7899,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB20,LacCer(d18:0/26:1),N-(17Z-hexacosenoyl)-1-beta-lactosyl-sphinganine,C56H107NO13   ,1001.7742,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB21,LacCer(d18:0/24:1),N-(15Z-tetracosenoyl)-1-beta-lactosyl-sphinganine,C54H103NO13   ,973.7429,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB22,LacCer(d18:0/18:1),N-(9Z-octadecenoyl)-1-beta-lactosyl-sphinganine,C48H91NO13   ,889.649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB23,LacCer(d14:0/18:0),N-(octadecanoyl)-1-beta-lactosyl-tetradecasphinganine,C44H85NO13   ,835.6021,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AB24,LacCer(d14:1/16:0),N-(hexadecanoyl)-1-beta-lactosyl-tetradecasphing-4-enine,C42H79NO13   ,805.5551,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC00,-,Galbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC01,GalCer(d18:1/16:0),Galbeta-Cer(d18:1/16:0),C40H77NO8   ,699.5649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC02,GalCer(d18:1/18:0),Galbeta-Cer(d18:1/18:0),C42H81NO8   ,727.5962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC03,GalCer(d18:1/20:0),Galbeta-Cer(d18:1/20:0),C44H85NO8   ,755.6275,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC04,GalCer(d18:1/22:0),Galbeta-Cer(d18:1/22:0),C46H89NO8   ,783.6588,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC05,GalCer(d18:1/24:0),Galbeta-Cer(d18:1/24:0),C48H93NO8   ,811.6901,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC06,GalCer(d18:1/26:0),Galbeta-Cer(d18:1/26:0),C50H97NO8   ,839.7214,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC07,GalCer(d18:1/24:1(15Z)),Galbeta-Cer(d18:1/24:1(15Z)),C48H91NO8   ,809.6745,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC08,GalCer(d18:1/26:1(17Z)),Galbeta-Cer(d18:1/26:1(17Z)),C50H95NO8   ,837.7058,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC09,GalCer(d16:1/22:0),N-(docosanoyl)-1-beta-galactosyl-hexadecasphing-4-enine,C44H85NO8   ,755.6275,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC10,GalCer(d16:1/23:0),N-(tricosanoyl)-1-beta-galactosyl-hexadecasphing-4-enine,C45H87NO8   ,769.6432,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC11,GalCer(d18:0/16:0),N-(hexadecanoyl)-1-beta-galactosyl-sphinganine,C40H79NO8   ,701.5806,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC12,GalCer(d18:0/20:0),N-(eicosanoyl)-1-beta-galactosyl-sphinganine,C44H87NO8   ,757.6432,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC13,GalCer(d18:0/22:0),N-(docosanoyl)-1-beta-galactosyl-sphinganine,C46H91NO8   ,785.6745,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC14,GalCer(d18:0/24:0),N-(tetracosanoyl)-1-beta-galactosyl-sphinganine,C48H95NO8   ,813.7058,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC15,GalCer(d18:0/26:0),N-(hexacosanoyl)-1-beta-galactosyl-sphinganine,C50H99NO8   ,841.7371,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC16,GalCer(d18:0/26:1),N-(17Z-hexacosenoyl)-1-beta-galactosyl-sphinganine,C50H97NO8   ,839.7214,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC17,GalCer(d18:1/23:0),N-(tricosanoyl)-1-beta-galactosyl-sphing-4-enine,C47H91NO8   ,797.6745,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC18,GalCer(d18:2/16:0),"N-(hexadecanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine",C40H75NO8   ,697.5493,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC19,GalCer(d18:2/20:0),"N-(eicosanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine",C44H83NO8   ,753.6119,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC20,GalCer(d18:2/20:1),"N-(11Z-eicosenoyl)-1-beta-galactosyl-4E,14Z-sphingadienine",C44H81NO8   ,751.5962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC21,GalCer(d18:2/21:0),"N-(heneicosanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine",C45H85NO8   ,767.6275,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC22,GalCer(d18:2/22:0),"N-(docosanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine",C46H87NO8   ,781.6432,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AC23,GalCer(d18:2/23:0),"N-(tricosanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine",C47H89NO8   ,795.6588,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD00,-,Manbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD01,-,Manbeta1-4Glcbeta-Cer(d18:1/16:0),C46H87NO13   ,861.6177,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD02,-,Manbeta1-4Glcbeta-Cer(d18:1/18:0),C48H91NO13   ,889.649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD03,-,Manbeta1-4Glcbeta-Cer(d18:1/20:0),C50H95NO13   ,917.6803,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD04,-,Manbeta1-4Glcbeta-Cer(d18:1/22:0),C52H99NO13   ,945.7116,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD05,-,Manbeta1-4Glcbeta-Cer(d18:1/24:0),C54H103NO13   ,973.7429,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD06,-,Manbeta1-4Glcbeta-Cer(d18:1/26:0),C56H107NO13   ,1001.7742,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD07,-,Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C54H101NO13   ,971.7273,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0501AD08,-,Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C56H105NO13   ,999.7586,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Simple Glc series [SP0501]
LMSP0502AA00,Gb3,Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AA01,-,Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C52H97NO18   ,1023.6706,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AA02,-,Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C54H101NO18   ,1051.7019,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AA03,-,Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C56H105NO18   ,1079.7332,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AA04,-,Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C58H109NO18   ,1107.7645,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AA05,-,Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C60H113NO18   ,1135.7958,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AA06,-,Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C62H117NO18   ,1163.8271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AA07,-,Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C60H111NO18   ,1133.7801,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AA08,-,Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C62H115NO18   ,1161.8114,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB00,Globoside I/Cytolipin K,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB01,-,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB02,-,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB03,-,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB04,-,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB05,-,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB06,-,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB07,-,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AB08,-,GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC00,Forssman antigen,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC01,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC02,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC03,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC04,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC05,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC06,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC07,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AC08,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD00,Para-Forssman x3b,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD01,-,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD02,-,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD03,-,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD04,-,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD05,-,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD06,-,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD07,-,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AD08,-,GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE00,SSEA-3 antigen,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE01,-,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE02,-,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE03,-,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE04,-,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE05,-,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE06,-,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE07,-,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AE08,-,Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF00,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF01,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF02,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF03,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF04,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF05,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF06,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF07,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AF08,-,Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG00,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG01,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O38   ,1753.935,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG02,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O38   ,1781.9663,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG03,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O38   ,1809.9976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG04,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O38   ,1838.0289,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG05,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O38   ,1866.0602,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG06,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O38   ,1894.0915,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG07,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O38   ,1864.0445,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AG08,-,Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O38   ,1892.0758,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH00,globo-Lex-9,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O42   ,1899.9929,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O42   ,1928.0242,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O42   ,1956.0555,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O42   ,1984.0868,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O42   ,2012.1181,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O42   ,2040.1494,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O42   ,2010.1024,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AH08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O42   ,2038.1337,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI00,type IV H,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI01,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O32   ,1534.8607,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI02,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O32   ,1562.892,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI03,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O32   ,1590.9233,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI04,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O32   ,1618.9546,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI05,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O32   ,1646.9859,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI06,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O32   ,1675.0172,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI07,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O32   ,1644.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AI08,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O32   ,1673.0015,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ00,type IV A antigen,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AJ08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK00,type IV B antigen,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C78H140N2O37   ,1696.9135,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C80H144N2O37   ,1724.9448,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C82H148N2O37   ,1752.9761,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C84H152N2O37   ,1781.0074,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C86H156N2O37   ,1809.0387,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C88H160N2O37   ,1837.07,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C86H154N2O37   ,1807.0231,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AK08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C88H158N2O37   ,1835.0544,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL00,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL01,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C58H107NO23   ,1185.7234,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL02,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C60H111NO23   ,1213.7547,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL03,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C62H115NO23   ,1241.786,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL04,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C64H119NO23   ,1269.8173,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL05,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C66H123NO23   ,1297.8486,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL06,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C68H127NO23   ,1325.8799,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL07,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C66H121NO23   ,1295.8329,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AL08,-,Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C68H125NO23   ,1323.8642,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM00,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM01,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C64H117NO28   ,1347.7762,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM02,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C66H121NO28   ,1375.8075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM03,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C68H125NO28   ,1403.8388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM04,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C70H129NO28   ,1431.8701,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM05,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C72H133NO28   ,1459.9014,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM06,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C74H137NO28   ,1487.9327,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM07,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C72H131NO28   ,1457.8858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AM08,-,Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C74H135NO28   ,1485.9171,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN00,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN01,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C70H127NO33   ,1509.829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN02,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C72H131NO33   ,1537.8603,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN03,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C74H135NO33   ,1565.8916,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN04,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C76H139NO33   ,1593.9229,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN05,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C78H143NO33   ,1621.9542,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN06,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C80H147NO33   ,1649.9855,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN07,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C78H141NO33   ,1619.9386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AN08,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C80H145NO33   ,1647.9699,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO00,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO01,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C58H107NO23   ,1185.7234,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO02,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C60H111NO23   ,1213.7547,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO03,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C62H115NO23   ,1241.786,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO04,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C64H119NO23   ,1269.8173,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO05,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C66H123NO23   ,1297.8486,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO06,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C68H127NO23   ,1325.8799,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO07,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C66H121NO23   ,1295.8329,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AO08,-,Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C68H125NO23   ,1323.8642,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP00,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP01,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP02,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP03,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP04,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP05,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP06,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP07,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AP08,-,GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ00,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ01,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O33   ,1550.8556,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ02,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O33   ,1578.8869,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ03,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O33   ,1606.9182,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ04,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O33   ,1634.9495,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ05,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O33   ,1662.9808,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ06,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O33   ,1691.0121,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ07,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O33   ,1660.9651,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AQ08,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O33   ,1688.9964,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR00,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR01,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C78H140N2O38   ,1712.9084,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR02,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C80H144N2O38   ,1740.9397,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR03,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C82H148N2O38   ,1768.971,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR04,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C84H152N2O38   ,1797.0023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR05,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C86H156N2O38   ,1825.0336,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR06,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C88H160N2O38   ,1853.0649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR07,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C86H154N2O38   ,1823.018,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AR08,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C88H158N2O38   ,1851.0493,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS00,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS01,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS02,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS03,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS04,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS05,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS06,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS07,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AS08,-,GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT00,Branched Forssman,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT01,-,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H146N4O38   ,1794.9615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT02,-,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H150N4O38   ,1822.9928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT03,-,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H154N4O38   ,1851.0241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT04,-,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H158N4O38   ,1879.0554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT05,-,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H162N4O38   ,1907.0867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT06,-,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H166N4O38   ,1935.118,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT07,-,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H160N4O38   ,1905.0711,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AT08,-,GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H164N4O38   ,1933.1024,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU00,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU01,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C64H117NO27   ,1331.7813,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU02,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C66H121NO27   ,1359.8126,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU03,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C68H125NO27   ,1387.8439,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU04,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C70H129NO27   ,1415.8752,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU05,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C72H133NO27   ,1443.9065,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU06,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C74H137NO27   ,1471.9378,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU07,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C72H131NO27   ,1441.8909,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AU08,-,Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C74H135NO27   ,1469.9222,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV00,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV01,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H156N4O42   ,1941.0194,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV02,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H160N4O42   ,1969.0507,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV03,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H164N4O42   ,1997.082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV04,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H168N4O42   ,2025.1133,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV05,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H172N4O42   ,2053.1446,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV06,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H176N4O42   ,2081.1759,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV07,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H170N4O42   ,2051.129,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AV08,-,GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H174N4O42   ,2079.1603,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW00,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW01,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C76H137NO38   ,1671.8819,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW02,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C78H141NO38   ,1699.9132,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW03,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C80H145NO38   ,1727.9445,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW04,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C82H149NO38   ,1755.9758,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW05,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C84H153NO38   ,1784.0071,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW06,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C86H157NO38   ,1812.0384,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW07,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C84H151NO38   ,1781.9914,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AW08,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C86H155NO38   ,1810.0227,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX00,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX01,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C84H150N2O43   ,1874.9612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX02,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C86H154N2O43   ,1902.9925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX03,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C88H158N2O43   ,1931.0238,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX04,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C90H162N2O43   ,1959.0551,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX05,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C92H166N2O43   ,1987.0864,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX06,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C94H170N2O43   ,2015.1177,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX07,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C92H164N2O43   ,1985.0708,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AX08,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C94H168N2O43   ,2013.1021,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY00,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY01,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H147NO43   ,1833.9347,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY02,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H151NO43   ,1861.966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY03,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H155NO43   ,1889.9973,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY04,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H159NO43   ,1918.0286,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY05,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H163NO43   ,1946.0599,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY06,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H167NO43   ,1974.0912,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY07,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H161NO43   ,1944.0442,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AY08,-,Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H165NO43   ,1972.0755,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ00,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ01,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C90H160N2O48   ,2037.0141,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ02,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C92H164N2O48   ,2065.0454,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ03,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C94H168N2O48   ,2093.0767,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ04,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C96H172N2O48   ,2121.108,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ05,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C98H176N2O48   ,2149.1393,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ06,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C100H180N2O48   ,2177.1706,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ07,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C98H174N2O48   ,2147.1236,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502AZ08,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C100H178N2O48   ,2175.1549,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA00,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA01,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA02,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA03,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA04,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA05,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA06,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA07,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BA08,-,Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB00,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB01,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C76H136N4O33   ,1632.9087,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB02,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C78H140N4O33   ,1660.94,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB03,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C80H144N4O33   ,1688.9713,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB04,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C82H148N4O33   ,1717.0026,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB05,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C84H152N4O33   ,1745.0339,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB06,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C86H156N4O33   ,1773.0652,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB07,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C84H150N4O33   ,1743.0182,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BB08,-,GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C86H154N4O33   ,1771.0495,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC00,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC01,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC02,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC03,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC04,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC05,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC06,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC07,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BC08,-,GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD00,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD01,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD02,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD03,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD04,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD05,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD06,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD07,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BD08,-,GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE00,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE01,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE02,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE03,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE04,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE05,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE06,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE07,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BE08,-,GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF00,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF01,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O33   ,1550.8556,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF02,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O33   ,1578.8869,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF03,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O33   ,1606.9182,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF04,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O33   ,1634.9495,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF05,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O33   ,1662.9808,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF06,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O33   ,1691.0121,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF07,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O33   ,1660.9651,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BF08,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O33   ,1688.9964,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG00,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG01,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG02,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG03,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG04,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG05,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG06,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG07,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BG08,-,Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH00,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH01,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH02,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH03,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH04,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH05,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH06,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH07,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BH08,-,Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI00,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI01,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI02,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI03,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI04,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI05,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI06,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI07,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BI08,-,Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ00,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ01,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ02,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ03,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ04,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ05,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ06,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ07,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BJ08,-,Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK00,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK01,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK02,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK03,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK04,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK05,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK06,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK07,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BK08,-,Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL00,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL01,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL02,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL03,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL04,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL05,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL06,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL07,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BL08,-,GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM00,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM01,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O32   ,1534.8607,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM02,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O32   ,1562.892,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM03,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O32   ,1590.9233,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM04,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O32   ,1618.9546,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM05,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O32   ,1646.9859,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM06,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O32   ,1675.0172,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM07,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O32   ,1644.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BM08,-,Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O32   ,1673.0015,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN00,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN01,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN02,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN03,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN04,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN05,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN06,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN07,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0502BN08,-,GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
LMSP0503AA00,"asialo-GM2, GA2, Tay-Sachs globoside",GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AA01,-,GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C54H100N2O18   ,1064.6971,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AA02,-,GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C56H104N2O18   ,1092.7284,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AA03,-,GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C58H108N2O18   ,1120.7597,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AA04,-,GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C60H112N2O18   ,1148.791,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AA05,-,GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C62H116N2O18   ,1176.8223,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AA06,-,GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C64H120N2O18   ,1204.8536,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AA07,-,GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C62H114N2O18   ,1174.8067,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AA08,-,GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C64H118N2O18   ,1202.838,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB00,asialo-GM1,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB01,-,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB02,-,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB03,-,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB04,-,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB05,-,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB06,-,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB07,-,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AB08,-,Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC00,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC01,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC02,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC03,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC04,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC05,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC06,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC07,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AC08,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD00,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD01,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD02,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD03,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD04,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD05,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD06,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD07,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AD08,-,Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE00,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE01,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE02,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE03,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE04,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE05,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE06,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE07,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AE08,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF00,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AF08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG00,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG01,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG02,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG03,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG04,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG05,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG06,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG07,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AG08,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH00,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AH08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI00,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI01,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O27   ,1372.8079,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI02,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O27   ,1400.8392,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI03,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O27   ,1428.8705,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI04,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O27   ,1456.9018,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI05,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O27   ,1484.9331,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI06,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O27   ,1512.9644,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI07,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O27   ,1482.9174,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AI08,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O27   ,1510.9487,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ00,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ01,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ02,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ03,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ04,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ05,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ06,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ07,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AJ08,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK00,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O32   ,1534.8607,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O32   ,1562.892,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O32   ,1590.9233,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O32   ,1618.9546,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O32   ,1646.9859,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O32   ,1675.0172,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O32   ,1644.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AK08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O32   ,1673.0015,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL00,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL01,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL02,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL03,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL04,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL05,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL06,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL07,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AL08,-,GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM00,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM01,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM02,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM03,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM04,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM05,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM06,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM07,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AM08,-,GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN00,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN01,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C62H113N3O23   ,1267.7765,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN02,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C64H117N3O23   ,1295.8078,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN03,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C66H121N3O23   ,1323.8391,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN04,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C68H125N3O23   ,1351.8704,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN05,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C70H129N3O23   ,1379.9017,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN06,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C72H133N3O23   ,1407.933,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN07,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C70H127N3O23   ,1377.886,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AN08,-,GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C72H131N3O23   ,1405.9173,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO00,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO01,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO02,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO03,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO04,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO05,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO06,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO07,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AO08,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP00,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP01,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP02,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP03,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP04,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP05,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP06,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP07,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0503AP08,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
LMSP0504AA00,"Amino CTH, Lc3Cer",GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AA01,-,GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C54H100N2O18   ,1064.6971,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AA02,-,GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C56H104N2O18   ,1092.7284,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AA03,-,GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C58H108N2O18   ,1120.7597,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AA04,-,GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C60H112N2O18   ,1148.791,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AA05,-,GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C62H116N2O18   ,1176.8223,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AA06,-,GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C64H120N2O18   ,1204.8536,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AA07,-,GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C62H114N2O18   ,1174.8067,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AA08,-,GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C64H118N2O18   ,1202.838,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB00,"LM1, iso-LM1",Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB01,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB02,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB03,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB04,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB05,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB06,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB07,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AB08,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC00,Lewis a,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC01,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O27   ,1372.8079,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC02,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O27   ,1400.8392,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC03,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O27   ,1428.8705,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC04,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O27   ,1456.9018,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC05,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O27   ,1484.9331,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC06,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O27   ,1512.9644,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC07,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O27   ,1482.9174,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AC08,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O27   ,1510.9487,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD00,type I H antigen,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD01,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O27   ,1372.8079,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD02,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O27   ,1400.8392,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD03,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O27   ,1428.8705,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD04,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O27   ,1456.9018,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD05,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O27   ,1484.9331,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD06,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O27   ,1512.9644,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD07,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O27   ,1482.9174,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AD08,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O27   ,1510.9487,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE00,type I B antigen,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O32   ,1534.8607,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O32   ,1562.892,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O32   ,1590.9233,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O32   ,1618.9546,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O32   ,1646.9859,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O32   ,1675.0172,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O32   ,1644.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AE08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O32   ,1673.0015,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF00,type I A antigen,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AF08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG00,Bleb,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C78H140N2O36   ,1680.9186,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C80H144N2O36   ,1708.9499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C82H148N2O36   ,1736.9812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C84H152N2O36   ,1765.0125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C86H156N2O36   ,1793.0438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C88H160N2O36   ,1821.0751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C86H154N2O36   ,1791.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AG08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C88H158N2O36   ,1819.0594,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH00,Aleb,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O36   ,1721.9451,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O36   ,1749.9764,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O36   ,1778.0077,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O36   ,1806.039,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O36   ,1834.0703,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O36   ,1862.1016,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O36   ,1832.0547,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AH08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O36   ,1860.086,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI00,Leb,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI01,-,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O31   ,1518.8658,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI02,-,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O31   ,1546.8971,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI03,-,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O31   ,1574.9284,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI04,-,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O31   ,1602.9597,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI05,-,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O31   ,1630.991,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI06,-,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O31   ,1659.0223,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI07,-,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O31   ,1628.9753,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AI08,-,Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O31   ,1657.0066,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ00,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ01,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ02,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ03,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ04,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ05,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ06,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ07,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AJ08,-,GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK00,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK01,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK02,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK03,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK04,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK05,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK06,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK07,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AK08,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL00,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL01,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL02,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL03,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL04,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL05,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL06,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL07,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AL08,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM00,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM01,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM02,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM03,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM04,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM05,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM06,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM07,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AM08,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN00,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN01,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN02,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN03,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN04,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN05,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN06,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN07,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AN08,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO00,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO01,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H146N4O38   ,1794.9615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO02,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H150N4O38   ,1822.9928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO03,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H154N4O38   ,1851.0241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO04,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H158N4O38   ,1879.0554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO05,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H162N4O38   ,1907.0867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO06,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H166N4O38   ,1935.118,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO07,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H160N4O38   ,1905.0711,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AO08,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H164N4O38   ,1933.1024,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H156N4O42   ,1941.0194,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H160N4O42   ,1969.0507,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H164N4O42   ,1997.082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H168N4O42   ,2025.1133,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H172N4O42   ,2053.1446,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H176N4O42   ,2081.1759,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H170N4O42   ,2051.129,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AP08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H174N4O42   ,2079.1603,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ00,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ01,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ02,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ03,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ04,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ05,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ06,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ07,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AQ08,-,Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR00,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR01,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR02,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR03,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR04,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR05,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR06,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR07,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AR08,-,GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS00,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS01,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O36   ,1721.9451,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS02,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O36   ,1749.9764,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS03,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O36   ,1778.0077,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS04,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O36   ,1806.039,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS05,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O36   ,1834.0703,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS06,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O36   ,1862.1016,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS07,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O36   ,1832.0547,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AS08,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O36   ,1860.086,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT00,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O41   ,1883.998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O41   ,1912.0293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O41   ,1940.0606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O41   ,1968.0919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O41   ,1996.1232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O41   ,2024.1545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O41   ,1994.1075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AT08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O41   ,2022.1388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU00,Ley-A-9,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU01,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C92H163N3O45   ,2030.0559,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU02,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C94H167N3O45   ,2058.0872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU03,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C96H171N3O45   ,2086.1185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU04,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C98H175N3O45   ,2114.1498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU05,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C100H179N3O45   ,2142.1811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU06,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C102H183N3O45   ,2170.2124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU07,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C100H177N3O45   ,2140.1654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AU08,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C102H181N3O45   ,2168.1967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV00,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AV08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW00,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW01,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O41   ,1883.998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW02,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O41   ,1912.0293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW03,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O41   ,1940.0606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW04,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O41   ,1968.0919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW05,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O41   ,1996.1232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW06,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O41   ,2024.1545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW07,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O41   ,1994.1075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AW08,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O41   ,2022.1388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX00,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX01,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H156N4O42   ,1941.0194,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX02,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H160N4O42   ,1969.0507,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX03,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H164N4O42   ,1997.082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX04,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H168N4O42   ,2025.1133,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX05,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H172N4O42   ,2053.1446,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX06,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H176N4O42   ,2081.1759,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX07,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H170N4O42   ,2051.129,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AX08,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H174N4O42   ,2079.1603,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY00,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY01,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O47   ,2103.0723,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY02,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O47   ,2131.1036,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY03,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O47   ,2159.1349,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY04,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O47   ,2187.1662,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY05,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O47   ,2215.1975,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY06,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O47   ,2243.2288,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY07,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O47   ,2213.1818,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AY08,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O47   ,2241.2131,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ00,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ01,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C100H176N4O51   ,2249.1302,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ02,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C102H180N4O51   ,2277.1615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ03,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C104H184N4O51   ,2305.1928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ04,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C106H188N4O51   ,2333.2241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ05,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C108H192N4O51   ,2361.2554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ06,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C110H196N4O51   ,2389.2867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ07,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C108H190N4O51   ,2359.2397,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504AZ08,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C110H194N4O51   ,2387.271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA00,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA01,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O47   ,2103.0723,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA02,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O47   ,2131.1036,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA03,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O47   ,2159.1349,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA04,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O47   ,2187.1662,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA05,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O47   ,2215.1975,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA06,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O47   ,2243.2288,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA07,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O47   ,2213.1818,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BA08,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O47   ,2241.2131,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB00,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB01,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C100H176N4O51   ,2249.1302,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB02,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C102H180N4O51   ,2277.1615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB03,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C104H184N4O51   ,2305.1928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB04,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C106H188N4O51   ,2333.2241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB05,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C108H192N4O51   ,2361.2554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB06,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C110H196N4O51   ,2389.2867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB07,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C108H190N4O51   ,2359.2397,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BB08,-,Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C110H194N4O51   ,2387.271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC00,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O41   ,1883.998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O41   ,1912.0293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O41   ,1940.0606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O41   ,1968.0919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O41   ,1996.1232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O41   ,2024.1545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O41   ,1994.1075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BC08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O41   ,2022.1388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD00,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BD08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C96H169N5O47   ,2144.0988,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C98H173N5O47   ,2172.1301,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C100H177N5O47   ,2200.1614,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C102H181N5O47   ,2228.1927,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C104H185N5O47   ,2256.224,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C106H189N5O47   ,2284.2553,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C104H183N5O47   ,2254.2084,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BF08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C106H187N5O47   ,2282.2397,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O52   ,2306.1516,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O52   ,2334.1829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O52   ,2362.2142,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O52   ,2390.2455,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O52   ,2418.2768,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O52   ,2446.3081,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O52   ,2416.2612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BG08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O52   ,2444.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH00,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH01,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C90H159N5O43   ,1998.0409,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH02,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C92H163N5O43   ,2026.0722,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH03,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C94H167N5O43   ,2054.1035,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH04,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C96H171N5O43   ,2082.1348,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH05,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C98H175N5O43   ,2110.1661,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH06,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C100H179N5O43   ,2138.1974,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH07,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C98H173N5O43   ,2108.1504,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BH08,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C100H177N5O43   ,2136.1817,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI00,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI01,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C96H169N5O48   ,2160.0937,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI02,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C98H173N5O48   ,2188.125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI03,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C100H177N5O48   ,2216.1563,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI04,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C102H181N5O48   ,2244.1876,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI05,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C104H185N5O48   ,2272.2189,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI06,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C106H189N5O48   ,2300.2502,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI07,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C104H183N5O48   ,2270.2033,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BI08,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C106H187N5O48   ,2298.2346,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ00,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ01,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O52   ,2306.1516,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ02,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O52   ,2334.1829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ03,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O52   ,2362.2142,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ04,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O52   ,2390.2455,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ05,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O52   ,2418.2768,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ06,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O52   ,2446.3081,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ07,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O52   ,2416.2612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BJ08,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O52   ,2444.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK00,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK01,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C104H182N6O53   ,2363.1731,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK02,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C106H186N6O53   ,2391.2044,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK03,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C108H190N6O53   ,2419.2357,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK04,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C110H194N6O53   ,2447.267,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK05,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C112H198N6O53   ,2475.2983,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK06,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C114H202N6O53   ,2503.3296,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK07,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C112H196N6O53   ,2473.2826,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BK08,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C114H200N6O53   ,2501.3139,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL00,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL01,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C110H192N6O57   ,2509.231,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL02,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C112H196N6O57   ,2537.2623,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL03,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C114H200N6O57   ,2565.2936,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL04,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C116H204N6O57   ,2593.3249,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL05,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C118H208N6O57   ,2621.3562,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL06,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C120H212N6O57   ,2649.3875,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL07,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C118H206N6O57   ,2619.3406,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BL08,-,GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C120H210N6O57   ,2647.3719,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O56   ,2452.2095,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O56   ,2480.2408,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O56   ,2508.2721,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O56   ,2536.3034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O56   ,2564.3347,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O56   ,2592.366,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O56   ,2562.3191,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BM08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O56   ,2590.3504,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C110H192N6O57   ,2509.231,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C112H196N6O57   ,2537.2623,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C114H200N6O57   ,2565.2936,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C116H204N6O57   ,2593.3249,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C118H208N6O57   ,2621.3562,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C120H212N6O57   ,2649.3875,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C118H206N6O57   ,2619.3406,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BN08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C120H210N6O57   ,2647.3719,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C116H202N6O61   ,2655.2889,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C118H206N6O61   ,2683.3202,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C120H210N6O61   ,2711.3515,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C122H214N6O61   ,2739.3828,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C124H218N6O61   ,2767.4141,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C126H222N6O61   ,2795.4454,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C124H216N6O61   ,2765.3985,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BO08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C126H220N6O61   ,2793.4298,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O56   ,2452.2095,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O56   ,2480.2408,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O56   ,2508.2721,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O56   ,2536.3034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O56   ,2564.3347,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O56   ,2592.366,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O56   ,2562.3191,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BP08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O56   ,2590.3504,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C116H202N6O61   ,2655.2889,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C118H206N6O61   ,2683.3202,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C120H210N6O61   ,2711.3515,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C122H214N6O61   ,2739.3828,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C124H218N6O61   ,2767.4141,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C126H222N6O61   ,2795.4454,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C124H216N6O61   ,2765.3985,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BQ08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C126H220N6O61   ,2793.4298,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR00,VI3(Galb 1-4GlcNAcb )-Lc4Cer,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BR08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT00,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT01,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O41   ,1883.998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT02,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O41   ,1912.0293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT03,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O41   ,1940.0606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT04,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O41   ,1968.0919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT05,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O41   ,1996.1232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT06,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O41   ,2024.1545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT07,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O41   ,1994.1075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BT08,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O41   ,2022.1388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU00,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU01,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU02,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU03,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU04,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU05,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU06,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU07,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0504BU08,-,Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
LMSP0505AA00,"paragloboside, nLc4Cer",Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AA01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AA02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AA03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AA04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AA05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AA06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AA07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AA08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB00,"X-hapten, SSEA-1, Lex-5",Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O27   ,1372.8079,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O27   ,1400.8392,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O27   ,1428.8705,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O27   ,1456.9018,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O27   ,1484.9331,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O27   ,1512.9644,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O27   ,1482.9174,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AB08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O27   ,1510.9487,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AC08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD00,"H1 glycolipid, type II antigen",Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O27   ,1372.8079,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O27   ,1400.8392,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O27   ,1428.8705,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O27   ,1456.9018,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O27   ,1484.9331,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O27   ,1512.9644,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O27   ,1482.9174,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AD08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O27   ,1510.9487,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE00,type II B antigen,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O32   ,1534.8607,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O32   ,1562.892,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O32   ,1590.9233,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O32   ,1618.9546,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O32   ,1646.9859,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O32   ,1675.0172,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O32   ,1644.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AE08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O32   ,1673.0015,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF00,type II A antigen,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF01,-,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF02,-,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF03,-,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF04,-,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF05,-,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF06,-,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF07,-,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AF08,-,GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG00,Ley-6,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG01,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O31   ,1518.8658,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG02,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O31   ,1546.8971,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG03,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O31   ,1574.9284,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG04,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O31   ,1602.9597,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG05,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O31   ,1630.991,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG06,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O31   ,1659.0223,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG07,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O31   ,1628.9753,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AG08,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O31   ,1657.0066,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH00,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH01,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH02,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH03,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH04,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH05,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH06,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH07,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AH08,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI00,type III H antigen,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI01,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O41   ,1883.998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI02,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O41   ,1912.0293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI03,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O41   ,1940.0606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI04,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O41   ,1968.0919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI05,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O41   ,1996.1232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI06,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O41   ,2024.1545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI07,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O41   ,1994.1075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AI08,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O41   ,2022.1388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ00,type III A antigen,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O46   ,2087.0773,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O46   ,2115.1086,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O46   ,2143.1399,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O46   ,2171.1712,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O46   ,2199.2025,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O46   ,2227.2338,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O46   ,2197.1869,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AJ08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O46   ,2225.2182,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK00,nLc5Cer,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK01,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK02,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK03,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK04,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK05,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK06,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK07,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AK08,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL00,"nLc6Cer, i antigen",Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AL08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM00,type II H antigen,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AM08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN00,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN01,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H146N4O38   ,1794.9615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN02,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H150N4O38   ,1822.9928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN03,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H154N4O38   ,1851.0241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN04,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H158N4O38   ,1879.0554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN05,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H162N4O38   ,1907.0867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN06,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H166N4O38   ,1935.118,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN07,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H160N4O38   ,1905.0711,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AN08,-,Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H164N4O38   ,1933.1024,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO00,type II B antigen,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O42   ,1899.9929,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O42   ,1928.0242,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O42   ,1956.0555,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O42   ,1984.0868,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O42   ,2012.1181,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O42   ,2040.1494,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O42   ,2010.1024,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AO08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O42   ,2038.1337,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP00,I antigen,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP01,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H156N4O43   ,1957.0143,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP02,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H160N4O43   ,1985.0456,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP03,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H164N4O43   ,2013.0769,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP04,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H168N4O43   ,2041.1082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP05,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H172N4O43   ,2069.1395,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP06,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H176N4O43   ,2097.1708,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP07,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H170N4O43   ,2067.1239,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AP08,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H174N4O43   ,2095.1552,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ00,type II A antigen,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H156N4O42   ,1941.0194,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H160N4O42   ,1969.0507,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H164N4O42   ,1997.082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H168N4O42   ,2025.1133,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H172N4O42   ,2053.1446,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H176N4O42   ,2081.1759,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H170N4O42   ,2051.129,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AQ08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H174N4O42   ,2079.1603,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR00,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C100H176N4O51   ,2249.1302,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C102H180N4O51   ,2277.1615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C104H184N4O51   ,2305.1928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C106H188N4O51   ,2333.2241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C108H192N4O51   ,2361.2554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C110H196N4O51   ,2389.2867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C108H190N4O51   ,2359.2397,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AR08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C110H194N4O51   ,2387.271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS00,Lex-7,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AS08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT00,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C112H196N4O61   ,2573.2358,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C114H200N4O61   ,2601.2671,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C116H204N4O61   ,2629.2984,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C118H208N4O61   ,2657.3297,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C120H212N4O61   ,2685.361,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C122H216N4O61   ,2713.3923,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C120H210N4O61   ,2683.3454,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AT08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C122H214N4O61   ,2711.3767,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU00,dimeric Lex,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O41   ,1883.998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O41   ,1912.0293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O41   ,1940.0606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O41   ,1968.0919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O41   ,1996.1232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O41   ,2024.1545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O41   ,1994.1075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AU08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O41   ,2022.1388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV00,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AV08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW00,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW01,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O47   ,2103.0723,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW02,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O47   ,2131.1036,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW03,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O47   ,2159.1349,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW04,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O47   ,2187.1662,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW05,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O47   ,2215.1975,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW06,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O47   ,2243.2288,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW07,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O47   ,2213.1818,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AW08,-,Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O47   ,2241.2131,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX00,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX01,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C100H176N4O51   ,2249.1302,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX02,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C102H180N4O51   ,2277.1615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX03,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C104H184N4O51   ,2305.1928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX04,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C106H188N4O51   ,2333.2241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX05,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C108H192N4O51   ,2361.2554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX06,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C110H196N4O51   ,2389.2867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX07,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C108H190N4O51   ,2359.2397,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AX08,-,Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C110H194N4O51   ,2387.271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O56   ,2452.2095,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O56   ,2480.2408,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O56   ,2508.2721,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O56   ,2536.3034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O56   ,2564.3347,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O56   ,2592.366,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O56   ,2562.3191,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AY08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O56   ,2590.3504,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ00,Ley-8,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ01,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O41   ,1883.998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ02,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O41   ,1912.0293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ03,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O41   ,1940.0606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ04,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O41   ,1968.0919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ05,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O41   ,1996.1232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ06,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O41   ,2024.1545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ07,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O41   ,1994.1075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505AZ08,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O41   ,2022.1388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA00,trimeric LeY-9,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA01,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C92H163N3O45   ,2030.0559,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA02,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C94H167N3O45   ,2058.0872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA03,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C96H171N3O45   ,2086.1185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA04,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C98H175N3O45   ,2114.1498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA05,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C100H179N3O45   ,2142.1811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA06,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C102H183N3O45   ,2170.2124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA07,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C100H177N3O45   ,2140.1654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BA08,-,Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C102H181N3O45   ,2168.1967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB00,trimeric Lex,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C106H186N4O55   ,2395.1881,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C108H190N4O55   ,2423.2194,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C110H194N4O55   ,2451.2507,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C112H198N4O55   ,2479.282,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C114H202N4O55   ,2507.3133,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C116H206N4O55   ,2535.3446,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C114H200N4O55   ,2505.2976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BB08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C116H204N4O55   ,2533.3289,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC00,dimeric Lex,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C100H176N4O51   ,2249.1302,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C102H180N4O51   ,2277.1615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C104H184N4O51   ,2305.1928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C106H188N4O51   ,2333.2241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C108H192N4O51   ,2361.2554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C110H196N4O51   ,2389.2867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C108H190N4O51   ,2359.2397,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BC08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C110H194N4O51   ,2387.271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD00,Lex-9,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O47   ,2103.0723,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O47   ,2131.1036,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O47   ,2159.1349,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O47   ,2187.1662,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O47   ,2215.1975,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O47   ,2243.2288,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O47   ,2213.1818,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BD08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O47   ,2241.2131,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE00,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H156N4O43   ,1957.0143,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H160N4O43   ,1985.0456,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H164N4O43   ,2013.0769,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H168N4O43   ,2041.1082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H172N4O43   ,2069.1395,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H176N4O43   ,2097.1708,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H170N4O43   ,2067.1239,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BE08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H174N4O43   ,2095.1552,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF00,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF01,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H146N4O38   ,1794.9615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF02,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H150N4O38   ,1822.9928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF03,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H154N4O38   ,1851.0241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF04,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H158N4O38   ,1879.0554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF05,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H162N4O38   ,1907.0867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF06,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H166N4O38   ,1935.118,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF07,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H160N4O38   ,1905.0711,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BF08,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H164N4O38   ,1933.1024,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG00,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG01,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG02,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG03,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG04,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG05,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG06,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG07,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BG08,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH00,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH01,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H156N4O42   ,1941.0194,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH02,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H160N4O42   ,1969.0507,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH03,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H164N4O42   ,1997.082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH04,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H168N4O42   ,2025.1133,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH05,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H172N4O42   ,2053.1446,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH06,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H176N4O42   ,2081.1759,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH07,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H170N4O42   ,2051.129,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BH08,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H174N4O42   ,2079.1603,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI00,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O47   ,2103.0723,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O47   ,2131.1036,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O47   ,2159.1349,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O47   ,2187.1662,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O47   ,2215.1975,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O47   ,2243.2288,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O47   ,2213.1818,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BI08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O47   ,2241.2131,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ00,galgactosyl-paraglobside,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ01,-,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ02,-,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ03,-,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ04,-,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ05,-,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ06,-,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ07,-,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BJ08,-,Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK00,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK01,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK02,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK03,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK04,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK05,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK06,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK07,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BK08,-,Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O38   ,1753.935,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O38   ,1781.9663,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O38   ,1809.9976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O38   ,1838.0289,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O38   ,1866.0602,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O38   ,1894.0915,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O38   ,1864.0445,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BL08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O38   ,1892.0758,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O36   ,1721.9451,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O36   ,1749.9764,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O36   ,1778.0077,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O36   ,1806.039,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O36   ,1834.0703,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O36   ,1862.1016,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O36   ,1832.0547,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BM08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O36   ,1860.086,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN00,P antigen,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN01,-,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN02,-,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN03,-,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN04,-,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN05,-,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN06,-,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN07,-,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BN08,-,GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO00,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO01,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O48   ,2119.0672,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO02,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O48   ,2147.0985,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO03,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O48   ,2175.1298,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO04,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O48   ,2203.1611,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO05,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O48   ,2231.1924,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO06,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O48   ,2259.2237,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO07,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O48   ,2229.1767,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BO08,-,Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O48   ,2257.208,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP00,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP01,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O53   ,2322.1465,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP02,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O53   ,2350.1778,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP03,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O53   ,2378.2091,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP04,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O53   ,2406.2404,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP05,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O53   ,2434.2717,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP06,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O53   ,2462.303,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP07,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O53   ,2432.2561,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BP08,-,GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O53   ,2460.2874,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ00,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O58   ,2484.1994,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O58   ,2512.2307,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O58   ,2540.262,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O58   ,2568.2933,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O58   ,2596.3246,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O58   ,2624.3559,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O58   ,2594.3089,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BQ08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O58   ,2622.3402,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C114H199N5O63   ,2646.2522,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C116H203N5O63   ,2674.2835,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C118H207N5O63   ,2702.3148,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C120H211N5O63   ,2730.3461,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C122H215N5O63   ,2758.3774,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C124H219N5O63   ,2786.4087,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C122H213N5O63   ,2756.3617,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BR08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C124H217N5O63   ,2784.393,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C122H212N6O68   ,2849.3316,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C124H216N6O68   ,2877.3629,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C126H220N6O68   ,2905.3942,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C128H224N6O68   ,2933.4255,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C130H228N6O68   ,2961.4568,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C132H232N6O68   ,2989.4881,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C130H226N6O68   ,2959.4411,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BS08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C132H230N6O68   ,2987.4724,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C128H222N6O73   ,3011.3844,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C130H226N6O73   ,3039.4157,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C132H230N6O73   ,3067.447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C134H234N6O73   ,3095.4783,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C136H238N6O73   ,3123.5096,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C138H242N6O73   ,3151.5409,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C136H236N6O73   ,3121.4939,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BT08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C138H240N6O73   ,3149.5252,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C134H232N6O78   ,3173.4372,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C136H236N6O78   ,3201.4685,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C138H240N6O78   ,3229.4998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C140H244N6O78   ,3257.5311,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C142H248N6O78   ,3285.5624,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C144H252N6O78   ,3313.5937,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C142H246N6O78   ,3283.5468,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BU08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C144H250N6O78   ,3311.5781,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O48   ,2119.0672,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O48   ,2147.0985,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O48   ,2175.1298,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O48   ,2203.1611,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O48   ,2231.1924,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O48   ,2259.2237,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O48   ,2229.1767,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BV08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O48   ,2257.208,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O53   ,2322.1465,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O53   ,2350.1778,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O53   ,2378.2091,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O53   ,2406.2404,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O53   ,2434.2717,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O53   ,2462.303,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O53   ,2432.2561,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BW08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O53   ,2460.2874,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O58   ,2484.1994,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O58   ,2512.2307,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O58   ,2540.262,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O58   ,2568.2933,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O58   ,2596.3246,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O58   ,2624.3559,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O58   ,2594.3089,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BX08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O58   ,2622.3402,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C114H199N5O63   ,2646.2522,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C116H203N5O63   ,2674.2835,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C118H207N5O63   ,2702.3148,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C120H211N5O63   ,2730.3461,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C122H215N5O63   ,2758.3774,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C124H219N5O63   ,2786.4087,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C122H213N5O63   ,2756.3617,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BY08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C124H217N5O63   ,2784.393,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C122H212N6O68   ,2849.3316,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C124H216N6O68   ,2877.3629,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C126H220N6O68   ,2905.3942,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C128H224N6O68   ,2933.4255,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C130H228N6O68   ,2961.4568,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C132H232N6O68   ,2989.4881,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C130H226N6O68   ,2959.4411,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505BZ08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C132H230N6O68   ,2987.4724,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C128H222N6O73   ,3011.3844,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C130H226N6O73   ,3039.4157,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C132H230N6O73   ,3067.447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C134H234N6O73   ,3095.4783,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C136H238N6O73   ,3123.5096,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C138H242N6O73   ,3151.5409,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C136H236N6O73   ,3121.4939,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CA08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C138H240N6O73   ,3149.5252,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB00,"II3GalNAcb , IV3Gala -nLc4Cer",Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CB08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC00,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC01,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O52   ,2306.1516,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC02,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O52   ,2334.1829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC03,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O52   ,2362.2142,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC04,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O52   ,2390.2455,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC05,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O52   ,2418.2768,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC06,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O52   ,2446.3081,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC07,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O52   ,2416.2612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CC08,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O52   ,2444.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD00,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O57   ,2468.2045,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O57   ,2496.2358,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O57   ,2524.2671,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O57   ,2552.2984,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O57   ,2580.3297,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O57   ,2608.361,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O57   ,2578.314,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CD08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O57   ,2606.3453,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE00,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE01,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE02,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE03,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE04,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE05,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE06,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE07,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CE08,-,GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF00,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF01,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF02,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF03,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF04,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF05,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF06,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF07,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CF08,-,Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG00,ClcNAc-Lex-5,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG01,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG02,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG03,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG04,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG05,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG06,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG07,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CG08,-,GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH00,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C100H176N4O51   ,2249.1302,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C102H180N4O51   ,2277.1615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C104H184N4O51   ,2305.1928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C106H188N4O51   ,2333.2241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C108H192N4O51   ,2361.2554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C110H196N4O51   ,2389.2867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C108H190N4O51   ,2359.2397,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CH08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C110H194N4O51   ,2387.271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI00,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI01,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI02,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI03,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI04,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI05,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI06,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI07,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CI08,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ00,Lea -X,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ01,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C86H153N3O41   ,1883.998,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ02,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C88H157N3O41   ,1912.0293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ03,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C90H161N3O41   ,1940.0606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ04,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C92H165N3O41   ,1968.0919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ05,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C94H169N3O41   ,1996.1232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ06,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C96H173N3O41   ,2024.1545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ07,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C94H167N3O41   ,1994.1075,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CJ08,-,Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C96H171N3O41   ,2022.1388,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK00,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK01,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK02,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK03,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK04,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK05,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK06,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK07,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CK08,-,Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL00,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL01,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O47   ,2103.0723,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL02,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O47   ,2131.1036,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL03,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O47   ,2159.1349,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL04,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O47   ,2187.1662,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL05,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O47   ,2215.1975,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL06,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O47   ,2243.2288,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL07,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O47   ,2213.1818,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CL08,-,Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O47   ,2241.2131,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN00,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN01,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O36   ,1721.9451,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN02,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O36   ,1749.9764,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN03,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O36   ,1778.0077,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN04,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O36   ,1806.039,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN05,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O36   ,1834.0703,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN06,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O36   ,1862.1016,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN07,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O36   ,1832.0547,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CN08,-,Fucalpha1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O36   ,1860.086,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C100H176N4O53   ,2281.12,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C102H180N4O53   ,2309.1513,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C104H184N4O53   ,2337.1826,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C106H188N4O53   ,2365.2139,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C108H192N4O53   ,2393.2452,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C110H196N4O53   ,2421.2765,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C108H190N4O53   ,2391.2295,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CO08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C110H194N4O53   ,2419.2608,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP00,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O47   ,2103.0723,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O47   ,2131.1036,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O47   ,2159.1349,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O47   ,2187.1662,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O47   ,2215.1975,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O47   ,2243.2288,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O47   ,2213.1818,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CP08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O47   ,2241.2131,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ00,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O56   ,2452.2095,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O56   ,2480.2408,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O56   ,2508.2721,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O56   ,2536.3034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O56   ,2564.3347,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O56   ,2592.366,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O56   ,2562.3191,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CQ08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O56   ,2590.3504,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C116H202N6O61   ,2655.2889,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C118H206N6O61   ,2683.3202,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C120H210N6O61   ,2711.3515,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C122H214N6O61   ,2739.3828,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C124H218N6O61   ,2767.4141,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C126H222N6O61   ,2795.4454,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C124H216N6O61   ,2765.3985,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CR08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C126H220N6O61   ,2793.4298,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS00,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H166N4O47   ,2103.0723,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H170N4O47   ,2131.1036,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H174N4O47   ,2159.1349,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H178N4O47   ,2187.1662,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H182N4O47   ,2215.1975,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H186N4O47   ,2243.2288,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H180N4O47   ,2213.1818,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CS08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H184N4O47   ,2241.2131,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT00,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O52   ,2306.1516,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O52   ,2334.1829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O52   ,2362.2142,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O52   ,2390.2455,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O52   ,2418.2768,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O52   ,2446.3081,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O52   ,2416.2612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CT08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O52   ,2444.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU00,type II A antigen,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU01,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU02,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU03,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU04,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU05,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU06,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU07,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CU08,-,GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV00,Gala 1-3Lex,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV01,-,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O32   ,1534.8607,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV02,-,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O32   ,1562.892,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV03,-,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O32   ,1590.9233,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV04,-,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O32   ,1618.9546,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV05,-,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O32   ,1646.9859,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV06,-,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O32   ,1675.0172,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV07,-,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O32   ,1644.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CV08,-,Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O32   ,1673.0015,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CW00,-,GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CX00,-,GalNAcbeta1-4(Galalpha1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY00,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C78H140N2O36   ,1680.9186,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C80H144N2O36   ,1708.9499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C82H148N2O36   ,1736.9812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C84H152N2O36   ,1765.0125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C86H156N2O36   ,1793.0438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C88H160N2O36   ,1821.0751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C86H154N2O36   ,1791.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CY08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C88H158N2O36   ,1819.0594,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ00,Isoglobotriglycosylceramide,Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ01,-,Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C52H97NO18   ,1023.6706,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ02,-,Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C54H101NO18   ,1051.7019,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ03,-,Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C56H105NO18   ,1079.7332,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ04,-,Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C58H109NO18   ,1107.7645,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ05,-,Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C60H113NO18   ,1135.7958,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ06,-,Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C62H117NO18   ,1163.8271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ07,-,Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C60H111NO18   ,1133.7801,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505CZ08,-,Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C62H115NO18   ,1161.8114,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA00,Cytolipin R,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA01,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA02,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA03,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA04,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA05,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA06,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA07,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DA08,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB00,iGb5,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB01,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB02,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB03,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB04,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB05,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB06,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB07,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DB08,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC00,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC01,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC02,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC03,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC04,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC05,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC06,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC07,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DC08,-,GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD00,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD01,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD02,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD03,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD04,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD05,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD06,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD07,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DD08,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE00,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE01,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O27   ,1372.8079,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE02,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O27   ,1400.8392,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE03,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O27   ,1428.8705,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE04,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O27   ,1456.9018,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE05,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O27   ,1484.9331,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE06,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O27   ,1512.9644,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE07,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O27   ,1482.9174,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DE08,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O27   ,1510.9487,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF00,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O32   ,1534.8607,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O32   ,1562.892,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O32   ,1590.9233,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O32   ,1618.9546,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O32   ,1646.9859,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O32   ,1675.0172,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O32   ,1644.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DF08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O32   ,1673.0015,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DG00,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DH00,-,Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI00,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C58H107NO22   ,1169.7285,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C60H111NO22   ,1197.7598,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C62H115NO22   ,1225.7911,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C64H119NO22   ,1253.8224,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C66H123NO22   ,1281.8537,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C68H127NO22   ,1309.885,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C66H121NO22   ,1279.838,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DI08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C68H125NO22   ,1307.8693,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ00,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ01,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O33   ,1550.8556,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ02,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O33   ,1578.8869,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ03,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O33   ,1606.9182,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ04,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O33   ,1634.9495,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ05,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O33   ,1662.9808,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ06,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O33   ,1691.0121,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ07,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O33   ,1660.9651,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DJ08,-,Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O33   ,1688.9964,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK00,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK01,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C72H130N2O32   ,1534.8607,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK02,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C74H134N2O32   ,1562.892,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK03,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C76H138N2O32   ,1590.9233,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK04,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C78H142N2O32   ,1618.9546,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK05,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C80H146N2O32   ,1646.9859,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK06,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C82H150N2O32   ,1675.0172,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK07,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C80H144N2O32   ,1644.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DK08,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C82H148N2O32   ,1673.0015,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL00,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C78H140N2O37   ,1696.9135,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C80H144N2O37   ,1724.9448,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C82H148N2O37   ,1752.9761,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C84H152N2O37   ,1781.0074,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C86H156N2O37   ,1809.0387,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C88H160N2O37   ,1837.07,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C86H154N2O37   ,1807.0231,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DL08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C88H158N2O37   ,1835.0544,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM00,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM01,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C58H107NO23   ,1185.7234,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM02,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C60H111NO23   ,1213.7547,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM03,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C62H115NO23   ,1241.786,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM04,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C64H119NO23   ,1269.8173,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM05,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C66H123NO23   ,1297.8486,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM06,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C68H127NO23   ,1325.8799,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM07,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C66H121NO23   ,1295.8329,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DM08,-,Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C68H125NO23   ,1323.8642,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN00,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN01,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN02,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN03,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN04,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN05,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN06,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN07,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DN08,-,GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO00,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO01,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO02,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO03,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO04,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO05,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO06,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO07,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DO08,-,Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP00,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP01,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP02,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP03,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP04,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP05,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP06,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP07,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DP08,-,GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ00,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ01,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ02,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ03,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ04,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ05,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ06,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ07,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DQ08,-,Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR00,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR01,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O32   ,1575.8872,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR02,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O32   ,1603.9185,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR03,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O32   ,1631.9498,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR04,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O32   ,1659.9811,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR05,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O32   ,1688.0124,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR06,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O32   ,1716.0437,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR07,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O32   ,1685.9968,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DR08,-,Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O32   ,1714.0281,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS00,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H143N3O37   ,1737.9401,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H147N3O37   ,1765.9714,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H151N3O37   ,1794.0027,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H155N3O37   ,1822.034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H159N3O37   ,1850.0653,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H163N3O37   ,1878.0966,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H157N3O37   ,1848.0496,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DS08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H161N3O37   ,1876.0809,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX00,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX01,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O56   ,2452.2095,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX02,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O56   ,2480.2408,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX03,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O56   ,2508.2721,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX04,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O56   ,2536.3034,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX05,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O56   ,2564.3347,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX06,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O56   ,2592.366,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX07,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O56   ,2562.3191,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DX08,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O56   ,2590.3504,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY00,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY01,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C110H192N6O57   ,2509.231,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY02,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C112H196N6O57   ,2537.2623,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY03,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C114H200N6O57   ,2565.2936,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY04,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C116H204N6O57   ,2593.3249,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY05,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C118H208N6O57   ,2621.3562,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY06,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C120H212N6O57   ,2649.3875,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY07,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C118H206N6O57   ,2619.3406,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DY08,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C120H210N6O57   ,2647.3719,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ00,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ01,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C110H192N6O57   ,2509.231,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ02,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C112H196N6O57   ,2537.2623,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ03,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C114H200N6O57   ,2565.2936,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ04,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C116H204N6O57   ,2593.3249,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ05,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C118H208N6O57   ,2621.3562,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ06,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C120H212N6O57   ,2649.3875,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ07,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C118H206N6O57   ,2619.3406,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505DZ08,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C120H210N6O57   ,2647.3719,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA00,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA01,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C106H186N4O57   ,2427.1779,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA02,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C108H190N4O57   ,2455.2092,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA03,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C110H194N4O57   ,2483.2405,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA04,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C112H198N4O57   ,2511.2718,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA05,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C114H202N4O57   ,2539.3031,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA06,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C116H206N4O57   ,2567.3344,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA07,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C114H200N4O57   ,2537.2875,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EA08,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C116H204N4O57   ,2565.3188,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB00,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB01,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C106H186N4O56   ,2411.183,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB02,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C108H190N4O56   ,2439.2143,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB03,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C110H194N4O56   ,2467.2456,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB04,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C112H198N4O56   ,2495.2769,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB05,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C114H202N4O56   ,2523.3082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB06,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C116H206N4O56   ,2551.3395,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB07,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C114H200N4O56   ,2521.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EB08,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C116H204N4O56   ,2549.3238,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC00,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C106H186N4O56   ,2411.183,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C108H190N4O56   ,2439.2143,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C110H194N4O56   ,2467.2456,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C112H198N4O56   ,2495.2769,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C114H202N4O56   ,2523.3082,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C116H206N4O56   ,2551.3395,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C114H200N4O56   ,2521.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EC08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C116H204N4O56   ,2549.3238,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED00,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED01,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C106H186N4O57   ,2427.1779,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED02,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C108H190N4O57   ,2455.2092,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED03,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C110H194N4O57   ,2483.2405,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED04,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C112H198N4O57   ,2511.2718,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED05,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C114H202N4O57   ,2539.3031,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED06,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C116H206N4O57   ,2567.3344,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED07,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C114H200N4O57   ,2537.2875,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505ED08,-,Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C116H204N4O57   ,2565.3188,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE00,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE01,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O52   ,2306.1516,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE02,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O52   ,2334.1829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE03,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O52   ,2362.2142,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE04,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O52   ,2390.2455,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE05,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O52   ,2418.2768,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE06,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O52   ,2446.3081,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE07,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O52   ,2416.2612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EE08,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O52   ,2444.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF00,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF01,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O52   ,2306.1516,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF02,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O52   ,2334.1829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF03,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O52   ,2362.2142,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF04,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O52   ,2390.2455,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF05,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O52   ,2418.2768,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF06,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O52   ,2446.3081,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF07,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O52   ,2416.2612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EF08,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O52   ,2444.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG00,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O52   ,2306.1516,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O52   ,2334.1829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O52   ,2362.2142,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O52   ,2390.2455,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O52   ,2418.2768,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O52   ,2446.3081,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O52   ,2416.2612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EG08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O52   ,2444.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH00,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH01,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C104H182N6O53   ,2363.1731,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH02,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C106H186N6O53   ,2391.2044,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH03,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C108H190N6O53   ,2419.2357,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH04,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C110H194N6O53   ,2447.267,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH05,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C112H198N6O53   ,2475.2983,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH06,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C114H202N6O53   ,2503.3296,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH07,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C112H196N6O53   ,2473.2826,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EH08,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C114H200N6O53   ,2501.3139,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI00,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI01,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O52   ,2306.1516,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI02,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O52   ,2334.1829,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI03,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O52   ,2362.2142,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI04,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O52   ,2390.2455,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI05,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O52   ,2418.2768,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI06,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O52   ,2446.3081,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI07,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O52   ,2416.2612,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EI08,-,Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O52   ,2444.2925,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ00,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ01,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ02,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ03,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ04,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ05,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ06,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ07,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EJ08,-,Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EK00,IV 4Galb-nLcOse4,Galbeta1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL00,IV 3-nLcOse4,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL01,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL02,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL03,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL04,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL05,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL06,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL07,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EL08,-,GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM00,VI 3GalNAca-IV 6kladoLcOse8,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM01,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C96H169N5O48   ,2160.0937,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM02,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C98H173N5O48   ,2188.125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM03,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C100H177N5O48   ,2216.1563,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM04,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C102H181N5O48   ,2244.1876,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM05,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C104H185N5O48   ,2272.2189,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM06,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C106H189N5O48   ,2300.2502,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM07,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C104H183N5O48   ,2270.2033,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EM08,-,GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C106H187N5O48   ,2298.2346,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN00,nLcOse10,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C102H179N5O53   ,2322.1465,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C104H183N5O53   ,2350.1778,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C106H187N5O53   ,2378.2091,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C108H191N5O53   ,2406.2404,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C110H195N5O53   ,2434.2717,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C112H199N5O53   ,2462.303,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C110H193N5O53   ,2432.2561,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EN08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C112H197N5O53   ,2460.2874,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO00,H4,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO01,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C108H189N5O57   ,2468.2045,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO02,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C110H193N5O57   ,2496.2358,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO03,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C112H197N5O57   ,2524.2671,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO04,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C114H201N5O57   ,2552.2984,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO05,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C116H205N5O57   ,2580.3297,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO06,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C118H209N5O57   ,2608.361,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO07,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C116H203N5O57   ,2578.314,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EO08,-,Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C118H207N5O57   ,2606.3453,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP00,B-IV antigen,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP01,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C126H219N5O71   ,2938.368,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP02,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C128H223N5O71   ,2966.3993,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP03,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C130H227N5O71   ,2994.4306,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP04,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C132H231N5O71   ,3022.4619,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP05,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C134H235N5O71   ,3050.4932,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP06,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C136H239N5O71   ,3078.5245,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP07,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C134H233N5O71   ,3048.4776,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0505EP08,-,Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C136H237N5O71   ,3076.5089,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
LMSP0506AA00,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AA01,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C58H107NO21   ,1153.7336,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AA02,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C60H111NO21   ,1181.7649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AA03,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C62H115NO21   ,1209.7962,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AA04,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C64H119NO21   ,1237.8275,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AA05,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C66H123NO21   ,1265.8588,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AA06,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C68H127NO21   ,1293.8901,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AA07,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C66H121NO21   ,1263.8431,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AA08,-,Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C68H125NO21   ,1291.8744,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD00,Forssman-like iGb4,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD01,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD02,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD03,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD04,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD05,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD06,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD07,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AD08,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH00,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH01,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C90H159N5O43   ,1998.0409,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH02,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C92H163N5O43   ,2026.0722,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH03,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C94H167N5O43   ,2054.1035,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH04,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C96H171N5O43   ,2082.1348,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH05,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C98H175N5O43   ,2110.1661,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH06,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C100H179N5O43   ,2138.1974,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH07,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C98H173N5O43   ,2108.1504,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AH08,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C100H177N5O43   ,2136.1817,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI00,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI01,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H146N4O38   ,1794.9615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI02,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H150N4O38   ,1822.9928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI03,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H154N4O38   ,1851.0241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI04,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H158N4O38   ,1879.0554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI05,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H162N4O38   ,1907.0867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI06,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H166N4O38   ,1935.118,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI07,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H160N4O38   ,1905.0711,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AI08,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H164N4O38   ,1933.1024,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ00,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ01,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H146N4O38   ,1794.9615,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ02,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H150N4O38   ,1822.9928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ03,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H154N4O38   ,1851.0241,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ04,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H158N4O38   ,1879.0554,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ05,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H162N4O38   ,1907.0867,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ06,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H166N4O38   ,1935.118,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ07,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H160N4O38   ,1905.0711,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AJ08,-,GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H164N4O38   ,1933.1024,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK00,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK01,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK02,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK03,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK04,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK05,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK06,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK07,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AK08,-,GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL00,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL01,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C76H136N4O33   ,1632.9087,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL02,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C78H140N4O33   ,1660.94,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL03,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C80H144N4O33   ,1688.9713,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL04,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C82H148N4O33   ,1717.0026,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL05,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C84H152N4O33   ,1745.0339,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL06,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C86H156N4O33   ,1773.0652,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL07,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C84H150N4O33   ,1743.0182,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AL08,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C86H154N4O33   ,1771.0495,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM00,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM01,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C74H133N3O33   ,1591.8821,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM02,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C76H137N3O33   ,1619.9134,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM03,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C78H141N3O33   ,1647.9447,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM04,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C80H145N3O33   ,1675.976,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM05,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C82H149N3O33   ,1704.0073,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM06,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C84H153N3O33   ,1732.0386,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM07,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C82H147N3O33   ,1701.9917,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AM08,-,Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C84H151N3O33   ,1730.023,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN00,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN01,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C66H120N2O28   ,1388.8028,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN02,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C68H124N2O28   ,1416.8341,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN03,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C70H128N2O28   ,1444.8654,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN04,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C72H132N2O28   ,1472.8967,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN05,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C74H136N2O28   ,1500.928,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN06,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C76H140N2O28   ,1528.9593,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN07,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H134N2O28   ,1498.9123,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AN08,-,Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C76H138N2O28   ,1526.9436,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO00,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO01,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H123N3O28   ,1429.8293,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO02,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H127N3O28   ,1457.8606,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO03,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H131N3O28   ,1485.8919,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO04,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H135N3O28   ,1513.9232,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO05,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H139N3O28   ,1541.9545,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO06,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H143N3O28   ,1569.9858,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO07,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H137N3O28   ,1539.9389,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AO08,-,GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H141N3O28   ,1567.9702,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP00,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP01,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C60H110N2O23   ,1226.7499,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP02,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C62H114N2O23   ,1254.7812,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP03,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C64H118N2O23   ,1282.8125,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP04,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C66H122N2O23   ,1310.8438,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP05,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C68H126N2O23   ,1338.8751,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP06,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C70H130N2O23   ,1366.9064,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP07,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C68H124N2O23   ,1336.8595,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0506AP08,-,Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C70H128N2O23   ,1364.8908,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-3Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
LMSP0507AA00,-,Manalpha1-3Manbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0507AA01,-,Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/16:0),C52H97NO18   ,1023.6706,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0507AA02,-,Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/18:0),C54H101NO18   ,1051.7019,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0507AA03,-,Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/20:0),C56H105NO18   ,1079.7332,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0507AA04,-,Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/22:0),C58H109NO18   ,1107.7645,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0507AA05,-,Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:0),C60H113NO18   ,1135.7958,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0507AA06,-,Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:0),C62H117NO18   ,1163.8271,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0507AA07,-,Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C60H111NO18   ,1133.7801,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0507AA08,-,Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C62H115NO18   ,1161.8114,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GlcNAcbeta1-2Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507]
LMSP0508AA00,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AA01,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/16:0),C54H100N2O18   ,1064.6971,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AA02,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/18:0),C56H104N2O18   ,1092.7284,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AA03,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/20:0),C58H108N2O18   ,1120.7597,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AA04,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/22:0),C60H112N2O18   ,1148.791,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AA05,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:0),C62H116N2O18   ,1176.8223,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AA06,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:0),C64H120N2O18   ,1204.8536,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AA07,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C62H114N2O18   ,1174.8067,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AA08,-,GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C64H118N2O18   ,1202.838,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AB00,CPS,GalNAcb1-4(Fuca1-3)GlcNAcb1-3Manb1-4Glcb-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0508AC00,CHS,GalNAcb1-4(GlcNAca1-2Fuca1-3)GlcNAcb1-3Manb1-4Glcb-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],GalNAcbeta1-4GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series) [SP0508]
LMSP0509AA00,-,Galalpha1-4Galbeta-Cer,-   ,-,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0509AA01,-,Galalpha1-4Galbeta-Cer(d18:1/16:0),C46H87NO13   ,861.6177,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0509AA02,-,Galalpha1-4Galbeta-Cer(d18:1/18:0),C48H91NO13   ,889.649,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0509AA03,-,Galalpha1-4Galbeta-Cer(d18:1/20:0),C50H95NO13   ,917.6803,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0509AA04,-,Galalpha1-4Galbeta-Cer(d18:1/22:0),C52H99NO13   ,945.7116,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0509AA05,-,Galalpha1-4Galbeta-Cer(d18:1/24:0),C54H103NO13   ,973.7429,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0509AA06,-,Galalpha1-4Galbeta-Cer(d18:1/26:0),C56H107NO13   ,1001.7742,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0509AA07,-,Galalpha1-4Galbeta-Cer(d18:1/24:1(15Z)),C54H101NO13   ,971.7273,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0509AA08,-,Galalpha1-4Galbeta-Cer(d18:1/26:1(17Z)),C56H105NO13   ,999.7586,Sphingolipids [SP],Neutral glycosphingolipids [SP05],Gal- (Gala series) [SP0509]
LMSP0601AA00,GM4,NeuAcalpha2-3Galbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AA01,-,NeuAcalpha2-3Galbeta-Cer(d18:1/16:0),C51H94N2O16   ,990.6603,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AA02,-,NeuAcalpha2-3Galbeta-Cer(d18:1/18:0),C53H98N2O16   ,1018.6916,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AA03,-,NeuAcalpha2-3Galbeta-Cer(d18:1/20:0),C55H102N2O16   ,1046.7229,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AA04,-,NeuAcalpha2-3Galbeta-Cer(d18:1/22:0),C57H106N2O16   ,1074.7542,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AA05,-,NeuAcalpha2-3Galbeta-Cer(d18:1/24:0),C59H110N2O16   ,1102.7855,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AA06,-,NeuAcalpha2-3Galbeta-Cer(d18:1/26:0),C61H114N2O16   ,1130.8168,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AA07,-,NeuAcalpha2-3Galbeta-Cer(d18:1/24:1(15Z)),C59H108N2O16   ,1100.7699,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AA08,-,NeuAcalpha2-3Galbeta-Cer(d18:1/26:1(17Z)),C61H112N2O16   ,1128.8012,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB00,SSEA-4 antigen,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AB08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC00,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC01,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H154N4O44   ,1970.9936,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC02,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H158N4O44   ,1999.0249,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC03,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H162N4O44   ,2027.0562,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC04,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H166N4O44   ,2055.0875,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC05,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H170N4O44   ,2083.1188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC06,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H174N4O44   ,2111.1501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC07,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H168N4O44   ,2081.1032,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AC08,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H172N4O44   ,2109.1345,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD00,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD01,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H154N4O44   ,1970.9936,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD02,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H158N4O44   ,1999.0249,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD03,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H162N4O44   ,2027.0562,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD04,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H166N4O44   ,2055.0875,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD05,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H170N4O44   ,2083.1188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD06,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H174N4O44   ,2111.1501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD07,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H168N4O44   ,2081.1032,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AD08,-,NeuAcalpha2-6(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H172N4O44   ,2109.1345,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE00,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H154N4O44   ,1970.9936,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H158N4O44   ,1999.0249,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H162N4O44   ,2027.0562,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H166N4O44   ,2055.0875,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H170N4O44   ,2083.1188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H174N4O44   ,2111.1501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H168N4O44   ,2081.1032,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AE08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H172N4O44   ,2109.1345,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF00,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF01,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O37   ,1695.8931,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF02,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O37   ,1723.9244,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF03,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O37   ,1751.9557,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF04,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O37   ,1779.987,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF05,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O37   ,1808.0183,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF06,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O37   ,1836.0496,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF07,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O37   ,1806.0027,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AF08,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O37   ,1834.034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG00,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG01,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H154N4O46   ,2002.9834,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG02,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H158N4O46   ,2031.0147,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG03,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H162N4O46   ,2059.046,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG04,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H166N4O46   ,2087.0773,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG05,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H170N4O46   ,2115.1086,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG06,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H174N4O46   ,2143.1399,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG07,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H168N4O46   ,2113.093,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AG08,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H172N4O46   ,2141.1243,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH00,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH01,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH02,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH03,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH04,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH05,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH06,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH07,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AH08,-,NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI00,SSEA-4 positional isomer,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI01,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI02,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI03,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI04,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI05,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI06,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI07,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AI08,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ00,GM3,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ01,-,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C57H104N2O21   ,1152.7132,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ02,-,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C59H108N2O21   ,1180.7445,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ03,-,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C61H112N2O21   ,1208.7758,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ04,-,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C63H116N2O21   ,1236.8071,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ05,-,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C65H120N2O21   ,1264.8384,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ06,-,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C67H124N2O21   ,1292.8697,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ07,-,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C65H118N2O21   ,1262.8227,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AJ08,-,NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C67H122N2O21   ,1290.854,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK00,GD3,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C68H121N3O29   ,1443.8086,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C70H125N3O29   ,1471.8399,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C72H129N3O29   ,1499.8712,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C74H133N3O29   ,1527.9025,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C76H137N3O29   ,1555.9338,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C78H141N3O29   ,1583.9651,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C76H135N3O29   ,1553.9181,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AK08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C78H139N3O29   ,1581.9494,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL00,GT3,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL01,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H138N4O37   ,1734.904,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL02,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H142N4O37   ,1762.9353,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL03,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H146N4O37   ,1790.9666,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL04,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H150N4O37   ,1818.9979,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL05,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H154N4O37   ,1847.0292,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL06,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H158N4O37   ,1875.0605,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL07,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H152N4O37   ,1845.0136,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AL08,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H156N4O37   ,1873.0449,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM00,GM2,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C65H117N3O26   ,1355.7925,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C67H121N3O26   ,1383.8238,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C69H125N3O26   ,1411.8551,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C71H129N3O26   ,1439.8864,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C73H133N3O26   ,1467.9177,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C75H137N3O26   ,1495.949,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C73H131N3O26   ,1465.9021,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AM08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C75H135N3O26   ,1493.9334,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN00,GD2,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN01,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C76H134N4O34   ,1646.888,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN02,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C78H138N4O34   ,1674.9193,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN03,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C80H142N4O34   ,1702.9506,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN04,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C82H146N4O34   ,1730.9819,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN05,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C84H150N4O34   ,1759.0132,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN06,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C86H154N4O34   ,1787.0445,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN07,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C84H148N4O34   ,1756.9975,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AN08,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C86H152N4O34   ,1785.0288,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO00,GT2,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO01,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C87H151N5O42   ,1937.9834,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO02,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C89H155N5O42   ,1966.0147,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO03,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C91H159N5O42   ,1994.046,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO04,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C93H163N5O42   ,2022.0773,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO05,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C95H167N5O42   ,2050.1086,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO06,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C97H171N5O42   ,2078.1399,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO07,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C95H165N5O42   ,2048.0929,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AO08,-,GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C97H169N5O42   ,2076.1242,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP00,GM1,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP01,GM1(12:0),Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/12:0),C67H119N3O31   ,1461.7828,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP02,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP03,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP04,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP05,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP06,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP07,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP08,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP09,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/14:0),C69H123N3O31   ,1489.8141,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AP10,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ00,GD1b,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ01,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ02,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ03,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ04,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ05,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ06,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ07,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AQ08,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR00,GT1c,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR01,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O47   ,2100.0362,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR02,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O47   ,2128.0675,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR03,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O47   ,2156.0988,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR04,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O47   ,2184.1301,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR05,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O47   ,2212.1614,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR06,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O47   ,2240.1927,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR07,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O47   ,2210.1458,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AR08,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O47   ,2238.1771,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS00,GD1a,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AS08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT00,GT1b,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O47   ,2100.0362,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O47   ,2128.0675,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O47   ,2156.0988,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O47   ,2184.1301,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O47   ,2212.1614,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O47   ,2240.1927,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O47   ,2210.1458,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AT08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O47   ,2238.1771,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU00,GQ1c,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C104H178N6O55   ,2391.1316,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C106H182N6O55   ,2419.1629,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C108H186N6O55   ,2447.1942,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C110H190N6O55   ,2475.2255,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C112H194N6O55   ,2503.2568,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C114H198N6O55   ,2531.2881,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C112H192N6O55   ,2501.2412,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AU08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C114H196N6O55   ,2529.2725,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV00,GQ1b,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C104H178N6O55   ,2391.1316,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C106H182N6O55   ,2419.1629,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C108H186N6O55   ,2447.1942,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C110H190N6O55   ,2475.2255,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C112H194N6O55   ,2503.2568,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C114H198N6O55   ,2531.2881,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C112H192N6O55   ,2501.2412,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AV08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C114H196N6O55   ,2529.2725,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW00,GT1a,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O47   ,2100.0362,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O47   ,2128.0675,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O47   ,2156.0988,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O47   ,2184.1301,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O47   ,2212.1614,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O47   ,2240.1927,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O47   ,2210.1458,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AW08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O47   ,2238.1771,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX00,GP1c,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C115H195N7O63   ,2682.227,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C117H199N7O63   ,2710.2583,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C119H203N7O63   ,2738.2896,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C121H207N7O63   ,2766.3209,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C123H211N7O63   ,2794.3522,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C125H215N7O63   ,2822.3835,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C123H209N7O63   ,2792.3366,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AX08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C125H213N7O63   ,2820.3679,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY00,"cis GM1, GM1b",NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AY08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ00,GalNAc-GM1b,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601AZ08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA00,"GD1a , GD1e",NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA01,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA02,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA03,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA04,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA05,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA06,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA07,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BA08,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB00,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB01,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB02,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB03,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB04,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB05,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB06,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB07,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BB08,-,Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC00,GalNAc-GM1,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC01,-,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC02,-,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC03,-,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC04,-,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC05,-,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC06,-,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC07,-,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BC08,-,GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD00,Fuc-GM1,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD01,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O35   ,1663.9033,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD02,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O35   ,1691.9346,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD03,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O35   ,1719.9659,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD04,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O35   ,1747.9972,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD05,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O35   ,1776.0285,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD06,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O35   ,1804.0598,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD07,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O35   ,1774.0128,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BD08,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O35   ,1802.0441,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE00,GD1aa,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE01,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE02,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE03,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE04,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE05,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE06,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE07,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BE08,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF00,GT1aa,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF01,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O47   ,2100.0362,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF02,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O47   ,2128.0675,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF03,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O47   ,2156.0988,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF04,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O47   ,2184.1301,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF05,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O47   ,2212.1614,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF06,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O47   ,2240.1927,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF07,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O47   ,2210.1458,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BF08,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O47   ,2238.1771,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG00,GalNAc-GD1a,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C90H157N5O44   ,2012.0202,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C92H161N5O44   ,2040.0515,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C94H165N5O44   ,2068.0828,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C96H169N5O44   ,2096.1141,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C98H173N5O44   ,2124.1454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C100H177N5O44   ,2152.1767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C98H171N5O44   ,2122.1297,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BG08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C100H175N5O44   ,2150.161,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH00,Gal-GD1b,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH01,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H154N4O44   ,1970.9936,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH02,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H158N4O44   ,1999.0249,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH03,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H162N4O44   ,2027.0562,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH04,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H166N4O44   ,2055.0875,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH05,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H170N4O44   ,2083.1188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH06,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H174N4O44   ,2111.1501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH07,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H168N4O44   ,2081.1032,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BH08,-,Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H172N4O44   ,2109.1345,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI00,Fuc-GD1b,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI01,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H154N4O43   ,1954.9987,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI02,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H158N4O43   ,1983.03,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI03,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H162N4O43   ,2011.0613,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI04,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H166N4O43   ,2039.0926,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI05,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H170N4O43   ,2067.1239,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI06,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H174N4O43   ,2095.1552,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI07,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H168N4O43   ,2065.1082,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BI08,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H172N4O43   ,2093.1395,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ00,GQ1ba,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ01,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C104H178N6O55   ,2391.1316,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ02,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C106H182N6O55   ,2419.1629,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ03,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C108H186N6O55   ,2447.1942,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ04,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C110H190N6O55   ,2475.2255,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ05,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C112H194N6O55   ,2503.2568,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ06,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C114H198N6O55   ,2531.2881,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ07,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C112H192N6O55   ,2501.2412,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BJ08,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C114H196N6O55   ,2529.2725,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK00,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK01,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C81H140N4O38   ,1776.9146,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK02,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C83H144N4O38   ,1804.9459,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK03,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C85H148N4O38   ,1832.9772,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK04,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C87H152N4O38   ,1861.0085,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK05,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C89H156N4O38   ,1889.0398,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK06,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C91H160N4O38   ,1917.0711,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK07,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C89H154N4O38   ,1887.0241,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BK08,-,9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C91H158N4O38   ,1915.0554,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL00,9-0-acetyl GTb1,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C95H163N5O48   ,2142.0468,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C97H167N5O48   ,2170.0781,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C99H171N5O48   ,2198.1094,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C101H175N5O48   ,2226.1407,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C103H179N5O48   ,2254.172,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C105H183N5O48   ,2282.2033,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C103H177N5O48   ,2252.1563,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BL08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C105H181N5O48   ,2280.1876,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM00,GM1alpha,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM01,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM02,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM03,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM04,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM05,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM06,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM07,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BM08,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN00,GD1c,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BN08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO00,GQ1aa,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C104H178N6O55   ,2391.1316,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C106H182N6O55   ,2419.1629,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C108H186N6O55   ,2447.1942,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C110H190N6O55   ,2475.2255,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C112H194N6O55   ,2503.2568,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C114H198N6O55   ,2531.2881,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C112H192N6O55   ,2501.2412,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BO08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C114H196N6O55   ,2529.2725,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP00,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP01,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O42   ,1898.9725,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP02,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O42   ,1927.0038,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP03,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O42   ,1955.0351,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP04,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O42   ,1983.0664,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP05,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O42   ,2011.0977,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP06,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O42   ,2039.129,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP07,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O42   ,2009.082,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BP08,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O42   ,2037.1133,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ00,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ01,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C96H167N5O51   ,2206.0628,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ02,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C98H171N5O51   ,2234.0941,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ03,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C100H175N5O51   ,2262.1254,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ04,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C102H179N5O51   ,2290.1567,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ05,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C104H183N5O51   ,2318.188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ06,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C106H187N5O51   ,2346.2193,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ07,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C104H181N5O51   ,2316.1724,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BQ08,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C106H185N5O51   ,2344.2037,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR00,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR01,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O45   ,2029.0355,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR02,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O45   ,2057.0668,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR03,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O45   ,2085.0981,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR04,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O45   ,2113.1294,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR05,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O45   ,2141.1607,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR06,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O45   ,2169.192,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR07,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O45   ,2139.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BR08,-,Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O45   ,2167.1763,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS00,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS01,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS02,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS03,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS04,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS05,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS06,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS07,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BS08,-,GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT00,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT01,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O40   ,1866.9826,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT02,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O40   ,1895.0139,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT03,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O40   ,1923.0452,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT04,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O40   ,1951.0765,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT05,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O40   ,1979.1078,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT06,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O40   ,2007.1391,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT07,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O40   ,1977.0922,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BT08,-,Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O40   ,2005.1235,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU00,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU01,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU02,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU03,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU04,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU05,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU06,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU07,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BU08,-,Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV00,GD1a (NeuAc/NeuGc),NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O40   ,1824.9357,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O40   ,1852.967,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O40   ,1880.9983,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O40   ,1909.0296,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O40   ,1937.0609,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O40   ,1965.0922,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O40   ,1935.0452,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BV08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O40   ,1963.0765,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW00,GT1b,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O48   ,2116.0311,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O48   ,2144.0624,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O48   ,2172.0937,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O48   ,2200.125,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O48   ,2228.1563,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O48   ,2256.1876,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O48   ,2226.1407,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BW08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O48   ,2254.172,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX00,GalNAc-GD1a(Neu5Ac/Neu5Gc),GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C90H157N5O45   ,2028.0151,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C92H161N5O45   ,2056.0464,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C94H165N5O45   ,2084.0777,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C96H169N5O45   ,2112.109,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C98H173N5O45   ,2140.1403,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C100H177N5O45   ,2168.1716,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C98H171N5O45   ,2138.1246,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BX08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C100H175N5O45   ,2166.1559,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY00,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY01,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O32   ,1533.8403,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY02,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O32   ,1561.8716,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY03,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O32   ,1589.9029,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY04,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O32   ,1617.9342,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY05,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O32   ,1645.9655,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY06,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O32   ,1673.9968,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY07,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O32   ,1643.9498,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BY08,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O32   ,1671.9811,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ00,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ01,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O37   ,1736.9197,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ02,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O37   ,1764.951,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ03,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O37   ,1792.9823,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ04,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O37   ,1821.0136,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ05,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O37   ,1849.0449,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ06,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O37   ,1877.0762,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ07,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O37   ,1847.0292,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601BZ08,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O37   ,1875.0605,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA00,GalNAc-GD1a(Neu5Gc/Neu5Ac),GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA01,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C90H157N5O45   ,2028.0151,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA02,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C92H161N5O45   ,2056.0464,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA03,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C94H165N5O45   ,2084.0777,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA04,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C96H169N5O45   ,2112.109,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA05,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C98H173N5O45   ,2140.1403,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA06,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C100H177N5O45   ,2168.1716,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA07,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C98H171N5O45   ,2138.1246,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CA08,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C100H175N5O45   ,2166.1559,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB00,"(KDN, Neu5Ac)GD1a",KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB01,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H141N3O39   ,1767.9142,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB02,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H145N3O39   ,1795.9455,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB03,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H149N3O39   ,1823.9768,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB04,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H153N3O39   ,1852.0081,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB05,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H157N3O39   ,1880.0394,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB06,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H161N3O39   ,1908.0707,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB07,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H155N3O39   ,1878.0238,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CB08,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H159N3O39   ,1906.0551,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC00,"(Neu5Ac, KDN)GD1a",NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H141N3O39   ,1767.9142,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H145N3O39   ,1795.9455,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H149N3O39   ,1823.9768,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H153N3O39   ,1852.0081,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H157N3O39   ,1880.0394,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H161N3O39   ,1908.0707,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H155N3O39   ,1878.0238,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CC08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H159N3O39   ,1906.0551,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD00,"(KDN,Neu5Ac)GD1a 2",KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD01,-,KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C80H141N3O39   ,1767.9142,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD02,-,KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C82H145N3O39   ,1795.9455,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD03,-,KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C84H149N3O39   ,1823.9768,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD04,-,KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C86H153N3O39   ,1852.0081,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD05,-,KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C88H157N3O39   ,1880.0394,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD06,-,KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C90H161N3O39   ,1908.0707,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD07,-,KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C88H155N3O39   ,1878.0238,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CD08,-,KDNalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C90H159N3O39   ,1906.0551,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF00,GT1ba,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF01,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O48   ,2116.0311,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF02,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O48   ,2144.0624,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF03,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O48   ,2172.0937,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF04,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O48   ,2200.125,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF05,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O48   ,2228.1563,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF06,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O48   ,2256.1876,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF07,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O48   ,2226.1407,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CF08,-,Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O48   ,2254.172,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG00,Fuc-GD1b,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG01,-,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O38   ,1792.9459,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG02,-,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O38   ,1820.9772,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG03,-,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O38   ,1849.0085,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG04,-,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O38   ,1877.0398,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG05,-,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O38   ,1905.0711,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG06,-,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O38   ,1933.1024,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG07,-,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O38   ,1903.0554,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CG08,-,Fucalpha1-2GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O38   ,1931.0867,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH00,Sialyl-Lea,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH01,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O35   ,1663.9033,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH02,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O35   ,1691.9346,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH03,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O35   ,1719.9659,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH04,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O35   ,1747.9972,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH05,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O35   ,1776.0285,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH06,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O35   ,1804.0598,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH07,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O35   ,1774.0128,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CH08,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O35   ,1802.0441,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI00,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI01,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C65H117N3O27   ,1371.7875,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI02,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C67H121N3O27   ,1399.8188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI03,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C69H125N3O27   ,1427.8501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI04,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C71H129N3O27   ,1455.8814,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI05,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C73H133N3O27   ,1483.9127,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI06,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C75H137N3O27   ,1511.944,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI07,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C74H133N3O27   ,1495.9127,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CI08,-,GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C75H135N3O27   ,1509.9283,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ00,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ01,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O32   ,1533.8403,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ02,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O32   ,1561.8716,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ03,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O32   ,1589.9029,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ04,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O32   ,1617.9342,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ05,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O32   ,1645.9655,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ06,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O32   ,1673.9968,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ07,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O32   ,1643.9498,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CJ08,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O32   ,1671.9811,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK00,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK01,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C84H146N4O40   ,1850.9513,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK02,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C86H150N4O40   ,1878.9826,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK03,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C88H154N4O40   ,1907.0139,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK04,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C90H158N4O40   ,1935.0452,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK05,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C92H162N4O40   ,1963.0765,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK06,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C94H166N4O40   ,1991.1078,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK07,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C92H160N4O40   ,1961.0609,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CK08,-,9-OAc-NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C94H164N4O40   ,1989.0922,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL00,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL01,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H164N4O49   ,2133.0464,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL02,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H168N4O49   ,2161.0777,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL03,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H172N4O49   ,2189.109,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL04,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H176N4O49   ,2217.1403,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL05,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H180N4O49   ,2245.1716,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL06,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H184N4O49   ,2273.2029,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL07,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H178N4O49   ,2243.156,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CL08,-,Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H182N4O49   ,2271.1873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM00,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C94H164N4O48   ,2117.0515,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C96H168N4O48   ,2145.0828,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C98H172N4O48   ,2173.1141,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C100H176N4O48   ,2201.1454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C102H180N4O48   ,2229.1767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C104H184N4O48   ,2257.208,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C102H178N4O48   ,2227.1611,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CM08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C104H182N4O48   ,2255.1924,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN00,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN01,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN02,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN03,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN04,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN05,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN06,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN07,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CN08,-,Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO00,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO01,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO02,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO03,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO04,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO05,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO06,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO07,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CO08,-,GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP00,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP01,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C87H153N5O41   ,1924.0041,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP02,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C89H157N5O41   ,1952.0354,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP03,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C91H161N5O41   ,1980.0667,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP04,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C93H165N5O41   ,2008.098,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP05,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C95H169N5O41   ,2036.1293,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP06,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C97H173N5O41   ,2064.1606,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP07,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C95H167N5O41   ,2034.1137,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CP08,-,GalNAcalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C97H171N5O41   ,2062.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ00,GD1a (NeuGc/NeuGc),NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ01,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O41   ,1840.9306,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ02,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O41   ,1868.9619,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ03,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O41   ,1896.9932,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ04,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O41   ,1925.0245,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ05,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O41   ,1953.0558,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ06,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O41   ,1981.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ07,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O41   ,1951.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CQ08,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O41   ,1979.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR00,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR01,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O42   ,1898.9725,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR02,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O42   ,1927.0038,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR03,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O42   ,1955.0351,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR04,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O42   ,1983.0664,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR05,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O42   ,2011.0977,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR06,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O42   ,2039.129,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR07,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O42   ,2009.082,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CR08,-,Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O42   ,2037.1133,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS00,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS01,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O47   ,2100.0362,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS02,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O47   ,2128.0675,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS03,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O47   ,2156.0988,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS04,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O47   ,2184.1301,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS05,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O47   ,2212.1614,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS06,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O47   ,2240.1927,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS07,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O47   ,2210.1458,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CS08,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O47   ,2238.1771,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT00,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O47   ,2100.0362,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O47   ,2128.0675,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O47   ,2156.0988,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O47   ,2184.1301,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O47   ,2212.1614,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O47   ,2240.1927,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O47   ,2210.1458,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CT08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O47   ,2238.1771,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU00,GQ1b,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C104H178N6O55   ,2391.1316,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C106H182N6O55   ,2419.1629,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C108H186N6O55   ,2447.1942,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C110H190N6O55   ,2475.2255,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C112H194N6O55   ,2503.2568,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C114H198N6O55   ,2531.2881,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C112H192N6O55   ,2501.2412,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CU08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C114H196N6O55   ,2529.2725,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV00,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV01,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O40   ,1824.9357,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV02,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O40   ,1852.967,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV03,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O40   ,1880.9983,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV04,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O40   ,1909.0296,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV05,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O40   ,1937.0609,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV06,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O40   ,1965.0922,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV07,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O40   ,1935.0452,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CV08,-,NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O40   ,1963.0765,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CW08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX00,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C87H153N5O41   ,1924.0041,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C89H157N5O41   ,1952.0354,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C91H161N5O41   ,1980.0667,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C93H165N5O41   ,2008.098,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C95H169N5O41   ,2036.1293,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C97H173N5O41   ,2064.1606,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C95H167N5O41   ,2034.1137,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CX08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C97H171N5O41   ,2062.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY00,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY01,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C83H147N3O40   ,1825.9561,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY02,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C85H151N3O40   ,1853.9874,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY03,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C87H155N3O40   ,1882.0187,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY04,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C89H159N3O40   ,1910.05,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY05,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C91H163N3O40   ,1938.0813,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY06,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C93H167N3O40   ,1966.1126,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY07,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C91H161N3O40   ,1936.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CY08,-,Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C93H165N3O40   ,1964.0969,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ00,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ01,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O40   ,1866.9826,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ02,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O40   ,1895.0139,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ03,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O40   ,1923.0452,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ04,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O40   ,1951.0765,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ05,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O40   ,1979.1078,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ06,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O40   ,2007.1391,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ07,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O40   ,1977.0922,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601CZ08,-,Fucalpha1-3GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O40   ,2005.1235,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DA00,-,GalNAcbeta1-4(9-OAcNeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC00,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC01,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C63H114N2O26   ,1314.766,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC02,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C65H118N2O26   ,1342.7973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC03,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C67H122N2O26   ,1370.8286,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC04,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C69H126N2O26   ,1398.8599,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC05,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C71H130N2O26   ,1426.8912,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC06,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C73H134N2O26   ,1454.9225,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC07,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C71H128N2O26   ,1424.8755,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DC08,-,Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C73H132N2O26   ,1452.9068,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD00,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD01,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C69H124N2O31   ,1476.8188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD02,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C71H128N2O31   ,1504.8501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD03,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C73H132N2O31   ,1532.8814,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD04,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C75H136N2O31   ,1560.9127,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD05,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C77H140N2O31   ,1588.944,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD06,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C79H144N2O31   ,1616.9753,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD07,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C77H138N2O31   ,1586.9284,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DD08,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C79H142N2O31   ,1614.9597,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE00,KDNGD1a,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE01,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C78H138N2O39   ,1726.8877,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE02,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C80H142N2O39   ,1754.919,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE03,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C82H146N2O39   ,1782.9503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE04,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C84H150N2O39   ,1810.9816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE05,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C86H154N2O39   ,1839.0129,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE06,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C88H158N2O39   ,1867.0442,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE07,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C86H152N2O39   ,1836.9972,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DE08,-,KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C88H156N2O39   ,1865.0285,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF00,KDN-GM1,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF01,-,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C69H124N2O31   ,1476.8188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF02,-,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C71H128N2O31   ,1504.8501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF03,-,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C73H132N2O31   ,1532.8814,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF04,-,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C75H136N2O31   ,1560.9127,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF05,-,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C77H140N2O31   ,1588.944,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF06,-,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C79H144N2O31   ,1616.9753,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF07,-,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C77H138N2O31   ,1586.9284,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DF08,-,Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C79H142N2O31   ,1614.9597,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG00,KDN-GM2,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG01,-,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C63H114N2O26   ,1314.766,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG02,-,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C65H118N2O26   ,1342.7973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG03,-,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C67H122N2O26   ,1370.8286,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG04,-,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C69H126N2O26   ,1398.8599,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG05,-,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C71H130N2O26   ,1426.8912,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG06,-,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C73H134N2O26   ,1454.9225,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG07,-,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C71H128N2O26   ,1424.8755,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DG08,-,GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C73H132N2O26   ,1452.9068,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH00,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH01,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C55H101NO21   ,1111.6866,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH02,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C57H105NO21   ,1139.7179,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH03,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C59H109NO21   ,1167.7492,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH04,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C61H113NO21   ,1195.7805,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH05,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C63H117NO21   ,1223.8118,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH06,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C65H121NO21   ,1251.8431,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH07,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C63H115NO21   ,1221.7962,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DH08,-,KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C65H119NO21   ,1249.8275,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI00,KDN GD1a 2,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI01,-,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C78H138N2O39   ,1726.8877,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI02,-,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C80H142N2O39   ,1754.919,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI03,-,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C82H146N2O39   ,1782.9503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI04,-,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C84H150N2O39   ,1810.9816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI05,-,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C86H154N2O39   ,1839.0129,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI06,-,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C88H158N2O39   ,1867.0442,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI07,-,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C86H152N2O39   ,1836.9972,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DI08,-,KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C88H156N2O39   ,1865.0285,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DJ00,-,9-OAc-KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK00,sialyl-lactotetraosylceramide,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK01,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK02,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK03,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK04,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK05,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK06,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK07,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DK08,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL00,sialyl-Lea,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL01,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O35   ,1663.9033,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL02,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O35   ,1691.9346,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL03,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O35   ,1719.9659,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL04,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O35   ,1747.9972,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL05,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O35   ,1776.0285,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL06,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O35   ,1804.0598,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL07,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O35   ,1774.0128,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DL08,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O35   ,1802.0441,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM00,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM01,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O40   ,1866.9826,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM02,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O40   ,1895.0139,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM03,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O40   ,1923.0452,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM04,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O40   ,1951.0765,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM05,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O40   ,1979.1078,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM06,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O40   ,2007.1391,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM07,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O40   ,1977.0922,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DM08,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O40   ,2005.1235,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN00,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN01,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O45   ,2029.0355,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN02,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O45   ,2057.0668,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN03,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O45   ,2085.0981,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN04,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O45   ,2113.1294,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN05,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O45   ,2141.1607,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN06,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O45   ,2169.192,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN07,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O45   ,2139.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DN08,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O45   ,2167.1763,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO00,sLea -Lex,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO01,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C97H170N4O49   ,2175.0934,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO02,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C99H174N4O49   ,2203.1247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO03,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C101H178N4O49   ,2231.156,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO04,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C103H182N4O49   ,2259.1873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO05,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C105H186N4O49   ,2287.2186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO06,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C107H190N4O49   ,2315.2499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO07,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C105H184N4O49   ,2285.2029,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DO08,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C107H188N4O49   ,2313.2342,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP00,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DP08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ00,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C87H153N5O41   ,1924.0041,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C89H157N5O41   ,1952.0354,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C91H161N5O41   ,1980.0667,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C93H165N5O41   ,2008.098,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C95H169N5O41   ,2036.1293,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C97H173N5O41   ,2064.1606,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C95H167N5O41   ,2034.1137,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DQ08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C97H171N5O41   ,2062.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR00,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H163N5O46   ,2086.0569,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H167N5O46   ,2114.0882,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H171N5O46   ,2142.1195,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H175N5O46   ,2170.1508,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H179N5O46   ,2198.1821,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H183N5O46   ,2226.2134,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H177N5O46   ,2196.1665,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DR08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H181N5O46   ,2224.1978,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS00,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS01,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O35   ,1663.9033,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS02,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O35   ,1691.9346,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS03,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O35   ,1719.9659,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS04,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O35   ,1747.9972,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS05,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O35   ,1776.0285,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS06,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O35   ,1804.0598,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS07,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O35   ,1774.0128,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DS08,-,Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O35   ,1802.0441,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT00,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DT08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU00,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU01,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU02,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU03,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU04,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU05,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU06,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU07,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DU08,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV00,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV01,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV02,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV03,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV04,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV05,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV06,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV07,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DV08,-,NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX00,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX01,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O44   ,2013.0406,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX02,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O44   ,2041.0719,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX03,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O44   ,2069.1032,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX04,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O44   ,2097.1345,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX05,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O44   ,2125.1658,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX06,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O44   ,2153.1971,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX07,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O44   ,2123.1501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DX08,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O44   ,2151.1814,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY00,sialyl(2-6)lactotetraosylceramide,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY01,-,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY02,-,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY03,-,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY04,-,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY05,-,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY06,-,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY07,-,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DY08,-,NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ00,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ01,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ02,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ03,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ04,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ05,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ06,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ07,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601DZ08,-,Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA00,disialyl Lea,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA01,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C88H154N4O43   ,1954.9987,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA02,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C90H158N4O43   ,1983.03,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA03,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C92H162N4O43   ,2011.0613,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA04,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C94H166N4O43   ,2039.0926,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA05,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C96H170N4O43   ,2067.1239,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA06,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C98H174N4O43   ,2095.1552,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA07,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C96H168N4O43   ,2065.1082,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EA08,-,NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C98H172N4O43   ,2093.1395,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB00,KDN-lactotetraosylceramide,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB01,-,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C69H124N2O31   ,1476.8188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB02,-,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C71H128N2O31   ,1504.8501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB03,-,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C73H132N2O31   ,1532.8814,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB04,-,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C75H136N2O31   ,1560.9127,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB05,-,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C77H140N2O31   ,1588.944,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB06,-,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C79H144N2O31   ,1616.9753,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB07,-,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C77H138N2O31   ,1586.9284,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EB08,-,KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C79H142N2O31   ,1614.9597,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC00,KDN(2-6)lactotetraosylceramide,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC01,-,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C69H124N2O31   ,1476.8188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC02,-,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C71H128N2O31   ,1504.8501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC03,-,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C73H132N2O31   ,1532.8814,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC04,-,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C75H136N2O31   ,1560.9127,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC05,-,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C77H140N2O31   ,1588.944,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC06,-,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C79H144N2O31   ,1616.9753,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC07,-,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C77H138N2O31   ,1586.9284,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EC08,-,KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C79H142N2O31   ,1614.9597,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED00,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED01,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED02,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED03,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED04,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED05,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED06,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED07,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ED08,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE00,sialyl-Lex,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE01,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O35   ,1663.9033,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE02,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O35   ,1691.9346,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE03,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O35   ,1719.9659,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE04,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O35   ,1747.9972,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE05,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O35   ,1776.0285,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE06,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O35   ,1804.0598,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE07,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O35   ,1774.0128,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EE08,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O35   ,1802.0441,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF00,sialosylparagloboside,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O31   ,1517.8454,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O31   ,1545.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O31   ,1573.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O31   ,1601.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O31   ,1629.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O31   ,1658.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O31   ,1627.9549,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EF08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O31   ,1655.9862,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG00,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EG08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH00,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH01,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH02,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH03,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH04,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH05,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH06,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH07,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EH08,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI00,"Sialosyllactosaminyl-paragloboside, G6 ganglioside",NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EI08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ00,"XO ganglioside, sLex-8, sialyl Lex",NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ01,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O45   ,2029.0355,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ02,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O45   ,2057.0668,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ03,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O45   ,2085.0981,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ04,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O45   ,2113.1294,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ05,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O45   ,2141.1607,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ06,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O45   ,2169.192,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ07,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O45   ,2139.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EJ08,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O45   ,2167.1763,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK00,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK01,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C65H117N3O26   ,1355.7925,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK02,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C67H121N3O26   ,1383.8238,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK03,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C69H125N3O26   ,1411.8551,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK04,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C71H129N3O26   ,1439.8864,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK05,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C73H133N3O26   ,1467.9177,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK06,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C75H137N3O26   ,1495.949,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK07,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C73H131N3O26   ,1465.9021,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EK08,-,NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C75H135N3O26   ,1493.9334,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL00,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL01,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL02,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL03,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL04,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL05,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL06,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL07,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EL08,-,NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM00,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM01,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O45   ,2029.0355,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM02,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O45   ,2057.0668,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM03,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O45   ,2085.0981,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM04,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O45   ,2113.1294,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM05,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O45   ,2141.1607,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM06,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O45   ,2169.192,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM07,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O45   ,2139.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EM08,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O45   ,2167.1763,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN00,sLea-x,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN01,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C97H170N4O49   ,2175.0934,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN02,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C99H174N4O49   ,2203.1247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN03,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C101H178N4O49   ,2231.156,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN04,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C103H182N4O49   ,2259.1873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN05,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C105H186N4O49   ,2287.2186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN06,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C107H190N4O49   ,2315.2499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN07,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C105H184N4O49   ,2285.2029,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EN08,-,NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C107H188N4O49   ,2313.2342,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO00,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO01,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O42   ,1898.9725,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO02,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O42   ,1927.0038,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO03,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O42   ,1955.0351,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO04,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O42   ,1983.0664,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO05,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O42   ,2011.0977,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO06,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O42   ,2039.129,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO07,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O42   ,2009.082,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EO08,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O42   ,2037.1133,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP00,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP01,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H163N5O47   ,2102.0519,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP02,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H167N5O47   ,2130.0832,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP03,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H171N5O47   ,2158.1145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP04,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H175N5O47   ,2186.1458,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP05,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H179N5O47   ,2214.1771,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP06,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H183N5O47   ,2242.2084,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP07,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H177N5O47   ,2212.1614,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EP08,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H181N5O47   ,2240.1927,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ00,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ01,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C99H173N5O52   ,2264.1047,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ02,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C101H177N5O52   ,2292.136,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ03,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C103H181N5O52   ,2320.1673,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ04,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C105H185N5O52   ,2348.1986,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ05,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C107H189N5O52   ,2376.2299,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ06,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C109H193N5O52   ,2404.2612,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ07,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C107H187N5O52   ,2374.2142,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EQ08,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C109H191N5O52   ,2402.2455,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER00,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER01,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C99H173N5O51   ,2248.1098,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER02,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C101H177N5O51   ,2276.1411,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER03,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C103H181N5O51   ,2304.1724,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER04,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C105H185N5O51   ,2332.2037,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER05,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C107H189N5O51   ,2360.235,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER06,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C109H193N5O51   ,2388.2663,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER07,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C107H187N5O51   ,2358.2193,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ER08,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C109H191N5O51   ,2386.2506,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C105H183N5O55   ,2394.1677,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C107H187N5O55   ,2422.199,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C109H191N5O55   ,2450.2303,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C111H195N5O55   ,2478.2616,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C113H199N5O55   ,2506.2929,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C115H203N5O55   ,2534.3242,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C113H197N5O55   ,2504.2772,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ES08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C115H201N5O55   ,2532.3085,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET00,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET01,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H161N5O47   ,2100.0362,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET02,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H165N5O47   ,2128.0675,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET03,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H169N5O47   ,2156.0988,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET04,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H173N5O47   ,2184.1301,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET05,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H177N5O47   ,2212.1614,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET06,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H181N5O47   ,2240.1927,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET07,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H175N5O47   ,2210.1458,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601ET08,-,NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H179N5O47   ,2238.1771,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU00,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU01,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU02,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU03,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU04,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU05,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU06,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU07,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EU08,-,NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW00,sialyl dimeric Lex,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW01,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C97H170N4O49   ,2175.0934,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW02,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C99H174N4O49   ,2203.1247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW03,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C101H178N4O49   ,2231.156,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW04,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C103H182N4O49   ,2259.1873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW05,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C105H186N4O49   ,2287.2186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW06,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C107H190N4O49   ,2315.2499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW07,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C105H184N4O49   ,2285.2029,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EW08,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C107H188N4O49   ,2313.2342,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX00,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX01,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O45   ,2029.0355,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX02,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O45   ,2057.0668,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX03,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O45   ,2085.0981,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX04,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O45   ,2113.1294,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX05,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O45   ,2141.1607,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX06,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O45   ,2169.192,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX07,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O45   ,2139.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EX08,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O45   ,2167.1763,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H163N5O46   ,2086.0569,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H167N5O46   ,2114.0882,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H171N5O46   ,2142.1195,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H175N5O46   ,2170.1508,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H179N5O46   ,2198.1821,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H183N5O46   ,2226.2134,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H177N5O46   ,2196.1665,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EY08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H181N5O46   ,2224.1978,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C99H173N5O51   ,2248.1098,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C101H177N5O51   ,2276.1411,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C103H181N5O51   ,2304.1724,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C105H185N5O51   ,2332.2037,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C107H189N5O51   ,2360.235,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C109H193N5O51   ,2388.2663,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C107H187N5O51   ,2358.2193,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601EZ08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C109H191N5O51   ,2386.2506,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FA00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucx1-xGalbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C110H190N6O59   ,2539.2052,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C112H194N6O59   ,2567.2365,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C114H198N6O59   ,2595.2678,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C116H202N6O59   ,2623.2991,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C118H206N6O59   ,2651.3304,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C120H210N6O59   ,2679.3617,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C118H204N6O59   ,2649.3147,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FB08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C120H208N6O59   ,2677.346,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C105H183N5O55   ,2394.1677,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C107H187N5O55   ,2422.199,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C109H191N5O55   ,2450.2303,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C111H195N5O55   ,2478.2616,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C113H199N5O55   ,2506.2929,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C115H203N5O55   ,2534.3242,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C113H197N5O55   ,2504.2772,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FC08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galx1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6}Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C115H201N5O55   ,2532.3085,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD00,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD01,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD02,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD03,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD04,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD05,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD06,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD07,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FD08,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE00,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE01,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE02,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE03,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE04,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE05,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE06,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE07,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FE08,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF00,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF01,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C71H127N3O32   ,1533.8403,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF02,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C73H131N3O32   ,1561.8716,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF03,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C75H135N3O32   ,1589.9029,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF04,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C77H139N3O32   ,1617.9342,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF05,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C79H143N3O32   ,1645.9655,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF06,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C81H147N3O32   ,1673.9968,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF07,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C79H141N3O32   ,1643.9498,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FF08,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C81H145N3O32   ,1671.9811,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG00,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG01,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O41   ,1840.9306,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG02,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O41   ,1868.9619,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG03,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O41   ,1896.9932,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG04,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O41   ,1925.0245,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG05,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O41   ,1953.0558,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG06,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O41   ,1981.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG07,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O41   ,1951.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FG08,-,NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O41   ,1979.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH00,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH01,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O40   ,1824.9357,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH02,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O40   ,1852.967,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH03,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O40   ,1880.9983,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH04,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O40   ,1909.0296,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH05,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O40   ,1937.0609,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH06,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O40   ,1965.0922,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH07,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O40   ,1935.0452,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FH08,-,NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O40   ,1963.0765,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI00,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI01,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI02,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI03,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI04,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI05,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI06,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI07,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FI08,-,GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ00,VIM-II,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O45   ,2029.0355,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O45   ,2057.0668,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O45   ,2085.0981,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O45   ,2113.1294,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O45   ,2141.1607,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O45   ,2169.192,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O45   ,2139.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FJ08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O45   ,2167.1763,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C99H173N5O51   ,2248.1098,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C101H177N5O51   ,2276.1411,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C103H181N5O51   ,2304.1724,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C105H185N5O51   ,2332.2037,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C107H189N5O51   ,2360.235,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C109H193N5O51   ,2388.2663,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C107H187N5O51   ,2358.2193,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FK08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C109H191N5O51   ,2386.2506,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C119H206N6O65   ,2759.2999,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C121H210N6O65   ,2787.3312,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C123H214N6O65   ,2815.3625,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C125H218N6O65   ,2843.3938,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C127H222N6O65   ,2871.4251,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C129H226N6O65   ,2899.4564,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C127H220N6O65   ,2869.4094,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FL08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C129H224N6O65   ,2897.4407,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM00,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM01,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O45   ,2029.0355,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM02,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O45   ,2057.0668,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM03,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O45   ,2085.0981,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM04,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O45   ,2113.1294,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM05,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O45   ,2141.1607,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM06,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O45   ,2169.192,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM07,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O45   ,2139.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FM08,-,NeuAcalpha2-3Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O45   ,2167.1763,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN00,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN01,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN02,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN03,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN04,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN05,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN06,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN07,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FN08,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO00,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO01,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H163N5O46   ,2086.0569,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO02,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H167N5O46   ,2114.0882,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO03,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H171N5O46   ,2142.1195,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO04,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H175N5O46   ,2170.1508,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO05,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H179N5O46   ,2198.1821,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO06,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H183N5O46   ,2226.2134,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO07,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H177N5O46   ,2196.1665,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FO08,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H181N5O46   ,2224.1978,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP00,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP01,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C105H183N5O55   ,2394.1677,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP02,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C107H187N5O55   ,2422.199,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP03,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C109H191N5O55   ,2450.2303,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP04,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C111H195N5O55   ,2478.2616,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP05,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C113H199N5O55   ,2506.2929,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP06,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C115H203N5O55   ,2534.3242,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP07,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C113H197N5O55   ,2504.2772,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FP08,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C115H201N5O55   ,2532.3085,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ00,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ01,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C110H190N6O59   ,2539.2052,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ02,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C112H194N6O59   ,2567.2365,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ03,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C114H198N6O59   ,2595.2678,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ04,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C116H202N6O59   ,2623.2991,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ05,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C118H206N6O59   ,2651.3304,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ06,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C120H210N6O59   ,2679.3617,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ07,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C118H204N6O59   ,2649.3147,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FQ08,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C120H208N6O59   ,2677.346,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C105H183N5O56   ,2410.1626,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C107H187N5O56   ,2438.1939,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C109H191N5O56   ,2466.2252,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C111H195N5O56   ,2494.2565,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C113H199N5O56   ,2522.2878,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C115H203N5O56   ,2550.3191,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C113H197N5O56   ,2520.2721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FR08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C115H201N5O56   ,2548.3034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU00,X3 ganglioside,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU01,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C111H193N5O59   ,2540.2256,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU02,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C113H197N5O59   ,2568.2569,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU03,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C115H201N5O59   ,2596.2882,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU04,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C117H205N5O59   ,2624.3195,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU05,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C119H209N5O59   ,2652.3508,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU06,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C121H213N5O59   ,2680.3821,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU07,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C119H207N5O59   ,2650.3351,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FU08,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C121H211N5O59   ,2678.3664,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV00,X3 ganglioside,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV01,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C111H193N5O59   ,2540.2256,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV02,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C113H197N5O59   ,2568.2569,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV03,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C115H201N5O59   ,2596.2882,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV04,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C117H205N5O59   ,2624.3195,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV05,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C119H209N5O59   ,2652.3508,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV06,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C121H213N5O59   ,2680.3821,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV07,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C119H207N5O59   ,2650.3351,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FV08,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C121H211N5O59   ,2678.3664,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW00,X4 ganglioside,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW01,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C117H203N5O63   ,2686.2835,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW02,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C119H207N5O63   ,2714.3148,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW03,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C121H211N5O63   ,2742.3461,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW04,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C123H215N5O63   ,2770.3774,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW05,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C125H219N5O63   ,2798.4087,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW06,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C127H223N5O63   ,2826.44,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW07,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C125H217N5O63   ,2796.393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FW08,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C127H221N5O63   ,2824.4243,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX00,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX01,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C79H140N4O36   ,1720.9247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX02,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C81H144N4O36   ,1748.956,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX03,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C83H148N4O36   ,1776.9873,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX04,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C85H152N4O36   ,1805.0186,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX05,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C87H156N4O36   ,1833.0499,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX06,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C89H160N4O36   ,1861.0812,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX07,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C87H154N4O36   ,1831.0343,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FX08,-,NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C89H158N4O36   ,1859.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C105H183N5O55   ,2394.1677,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C107H187N5O55   ,2422.199,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C109H191N5O55   ,2450.2303,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C111H195N5O55   ,2478.2616,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C113H199N5O55   ,2506.2929,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C115H203N5O55   ,2534.3242,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C113H197N5O55   ,2504.2772,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FY08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C115H201N5O55   ,2532.3085,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C111H193N5O60   ,2556.2205,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C113H197N5O60   ,2584.2518,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C115H201N5O60   ,2612.2831,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C117H205N5O60   ,2640.3144,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C119H209N5O60   ,2668.3457,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C121H213N5O60   ,2696.377,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C119H207N5O60   ,2666.33,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601FZ08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C121H211N5O60   ,2694.3613,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcb 6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C113H196N6O60   ,2597.247,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C115H200N6O60   ,2625.2783,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C117H204N6O60   ,2653.3096,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C119H208N6O60   ,2681.3409,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C121H212N6O60   ,2709.3722,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C123H216N6O60   ,2737.4035,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C121H210N6O60   ,2707.3566,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GA08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C123H214N6O60   ,2735.3879,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB00,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB01,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C96H167N5O49   ,2174.073,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB02,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C98H171N5O49   ,2202.1043,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB03,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C100H175N5O49   ,2230.1356,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB04,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C102H179N5O49   ,2258.1669,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB05,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C104H183N5O49   ,2286.1982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB06,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C106H187N5O49   ,2314.2295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB07,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C104H181N5O49   ,2284.1825,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GB08,-,NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C106H185N5O49   ,2312.2138,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC00,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC01,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C99H173N5O51   ,2248.1098,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC02,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C101H177N5O51   ,2276.1411,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC03,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C103H181N5O51   ,2304.1724,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC04,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C105H185N5O51   ,2332.2037,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC05,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C107H189N5O51   ,2360.235,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC06,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C109H193N5O51   ,2388.2663,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC07,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C107H187N5O51   ,2358.2193,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GC08,-,NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C109H191N5O51   ,2386.2506,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD00,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD01,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C188H316N12O115   ,4581.9248,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD02,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C190H320N12O115   ,4609.9561,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD03,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C192H324N12O115   ,4637.9874,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD04,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C194H328N12O115   ,4666.0187,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD05,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C196H332N12O115   ,4694.05,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD06,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C198H336N12O115   ,4722.0813,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD07,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C196H330N12O115   ,4692.0344,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GD08,-,NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-6(NeuAcbeta2-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C198H334N12O115   ,4720.0657,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE00,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE01,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C69H124N2O31   ,1476.8188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE02,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C71H128N2O31   ,1504.8501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE03,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C73H132N2O31   ,1532.8814,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE04,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C75H136N2O31   ,1560.9127,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE05,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C77H140N2O31   ,1588.944,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE06,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C79H144N2O31   ,1616.9753,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE07,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C77H138N2O31   ,1586.9284,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GE08,-,KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C79H142N2O31   ,1614.9597,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF00,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF01,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C75H134N2O35   ,1622.8767,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF02,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C77H138N2O35   ,1650.908,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF03,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C79H142N2O35   ,1678.9393,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF04,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C81H146N2O35   ,1706.9706,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF05,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C83H150N2O35   ,1735.0019,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF06,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C85H154N2O35   ,1763.0332,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF07,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C83H148N2O35   ,1732.9863,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GF08,-,KDNalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C85H152N2O35   ,1761.0176,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG00,KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG01,-,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C69H124N2O31   ,1476.8188,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG02,-,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C71H128N2O31   ,1504.8501,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG03,-,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C73H132N2O31   ,1532.8814,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG04,-,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C75H136N2O31   ,1560.9127,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG05,-,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C77H140N2O31   ,1588.944,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG06,-,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C79H144N2O31   ,1616.9753,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG07,-,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C77H138N2O31   ,1586.9284,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GG08,-,KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C79H142N2O31   ,1614.9597,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH00,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH01,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C83H147N3O40   ,1825.9561,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH02,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C85H151N3O40   ,1853.9874,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH03,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C87H155N3O40   ,1882.0187,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH04,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C89H159N3O40   ,1910.05,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH05,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C91H163N3O40   ,1938.0813,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH06,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C93H167N3O40   ,1966.1126,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH07,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C91H161N3O40   ,1936.0656,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GH08,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C93H165N3O40   ,1964.0969,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI00,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI01,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C91H160N4O45   ,2029.0355,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI02,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C93H164N4O45   ,2057.0668,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI03,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C95H168N4O45   ,2085.0981,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI04,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C97H172N4O45   ,2113.1294,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI05,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C99H176N4O45   ,2141.1607,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI06,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C101H180N4O45   ,2169.192,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI07,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C99H174N4O45   ,2139.145,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GI08,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C101H178N4O45   ,2167.1763,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GJ00,-,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK00,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK01,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK02,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK03,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK04,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK05,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK06,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK07,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GK08,-,NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL00,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL01,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL02,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL03,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL04,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL05,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL06,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL07,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GL08,-,NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM00,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM01,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0),C82H144N4O39   ,1808.9408,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM02,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0),C84H148N4O39   ,1836.9721,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM03,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0),C86H152N4O39   ,1865.0034,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM04,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0),C88H156N4O39   ,1893.0347,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM05,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0),C90H160N4O39   ,1921.066,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM06,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0),C92H164N4O39   ,1949.0973,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM07,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C90H158N4O39   ,1919.0503,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GM08,-,Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C92H162N4O39   ,1947.0816,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO00,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO01,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C101H176N6O51   ,2289.1363,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO02,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C103H180N6O51   ,2317.1676,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO03,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C105H184N6O51   ,2345.1989,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO04,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C107H188N6O51   ,2373.2302,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO05,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C109H192N6O51   ,2401.2615,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO06,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C111H196N6O51   ,2429.2928,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO07,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C109H190N6O51   ,2399.2459,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GO08,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C111H194N6O51   ,2427.2772,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP00,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP01,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H163N5O46   ,2086.0569,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP02,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H167N5O46   ,2114.0882,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP03,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H171N5O46   ,2142.1195,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP04,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H175N5O46   ,2170.1508,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP05,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H179N5O46   ,2198.1821,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP06,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H183N5O46   ,2226.2134,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP07,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H177N5O46   ,2196.1665,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GP08,-,GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H181N5O46   ,2224.1978,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ00,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ01,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ02,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ03,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ04,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ05,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ06,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ07,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GQ08,-,GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR00,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR01,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR02,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR03,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR04,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR05,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR06,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR07,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GR08,-,Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS00,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS01,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS02,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS03,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS04,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS05,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS06,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS07,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GS08,-,Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT00,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT01,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C99H173N5O51   ,2248.1098,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT02,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C101H177N5O51   ,2276.1411,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT03,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C103H181N5O51   ,2304.1724,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT04,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C105H185N5O51   ,2332.2037,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT05,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C107H189N5O51   ,2360.235,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT06,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C109H193N5O51   ,2388.2663,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT07,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C107H187N5O51   ,2358.2193,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GT08,-,NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C109H191N5O51   ,2386.2506,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU00,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU01,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C105H183N5O57   ,2426.1575,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU02,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C107H187N5O57   ,2454.1888,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU03,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C109H191N5O57   ,2482.2201,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU04,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C111H195N5O57   ,2510.2514,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU05,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C113H199N5O57   ,2538.2827,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU06,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C115H203N5O57   ,2566.314,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU07,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C113H197N5O57   ,2536.2671,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GU08,-,NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C115H201N5O57   ,2564.2984,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV00,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV01,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C85H150N4O41   ,1882.9776,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV02,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C87H154N4O41   ,1911.0089,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV03,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C89H158N4O41   ,1939.0402,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV04,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C91H162N4O41   ,1967.0715,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV05,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C93H166N4O41   ,1995.1028,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV06,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C95H170N4O41   ,2023.1341,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV07,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C93H164N4O41   ,1993.0871,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GV08,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C95H168N4O41   ,2021.1184,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW00,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW01,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0),C77H137N3O36   ,1679.8982,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW02,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0),C79H141N3O36   ,1707.9295,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW03,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0),C81H145N3O36   ,1735.9608,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW04,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0),C83H149N3O36   ,1763.9921,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW05,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0),C85H153N3O36   ,1792.0234,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW06,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0),C87H157N3O36   ,1820.0547,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW07,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C85H151N3O36   ,1790.0077,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GW08,-,NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C87H155N3O36   ,1818.039,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX00,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX01,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0),C93H163N5O46   ,2086.0569,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX02,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0),C95H167N5O46   ,2114.0882,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX03,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0),C97H171N5O46   ,2142.1195,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX04,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0),C99H175N5O46   ,2170.1508,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX05,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0),C101H179N5O46   ,2198.1821,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX06,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0),C103H183N5O46   ,2226.2134,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX07,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)),C101H177N5O46   ,2196.1665,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP0601GX08,-,NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)),C103H181N5O46   ,2224.1978,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Gangliosides [SP0601]
LMSP06020000,Galactosylceramide sulfate,(3'-sulfo)Galbeta-N-(acyl)-sphing-4-enine,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020001,(3'-sulfo)Galbeta-Cer(d18:1/18:0),N-octadecanoyl-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C42H81NO11S   ,807.553,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020002,(3'-sulfo)Galbeta-Cer(d18:1/16:0),N-hexadecanoyl-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C40H77NO11S   ,779.5217,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020003,(3'-sulfo)Galbeta-Cer(d18:1/16:0(2OH)),N-(2-hydroxy-hexadecanoyl)-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C40H77NO12S   ,795.5167,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020004,(3'-sulfo)Galbeta-Cer(d18:1/18:0(2OH)),N-(2-hydroxy-octadecanoyl)-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C42H81NO12S   ,823.548,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020005,(3'-sulfo)Galbeta-Cer(d18:1/20:0(2OH)),N-(2-hydroxy-eicosanoyl)-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C44H85NO12S   ,851.5793,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020009,(3'-sulfo)Galbeta-Cer(d18:1/22:0),N-docosanoyl-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C46H89NO11S   ,863.6156,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020010,(3'-sulfo)Galbeta-Cer(d18:1/20:0),N-eicosanoyl-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C44H85NO11S   ,835.5843,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020011,(3'-sulfo)Galbeta-Cer(d18:1/22:0(2OH)),N-(2-hydroxy-docosanoyl)-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C46H89NO12S   ,879.6106,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020013,(3'-sulfo)Galbeta-Cer(d18:1/24:0),N-tetracosanoyl-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C48H93NO11S   ,891.6469,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020014,(3'-sulfo)Galbeta-Cer(d18:1/24:0(2OH)),N-(2-hydroxy-tetracosanoyl)-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C48H93NO12S   ,907.6419,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020015,(3'-sulfo)Galbeta-Cer(d18:1/24:1(15Z)),N-(15Z-tetracosenoyl)-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C48H91NO11S   ,889.6313,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06020016,(3'-sulfo)Galbeta-Cer(d18:1/24:1(15Z)(2OH)),N-(2-hydroxy-15Z-tetracosenoyl)-1-beta-(3'-sulfo)-glucosyl-sphing-4-enine,C48H91NO12S   ,905.6262,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AA00,SM3,HSO3-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AB00,Globopentaosylceramide sulfate,HSO3-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AC00,Sulfoglobotetraosylceramide,HSO3-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AD00,-,Galbeta1-3GalNAcbeta1-4HSO3-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AE00,SB1a,HSO3-3Galbeta1-3GalNAcbeta1-4HSO3-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AF00,-,HSO3-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AG00,III6SO3-Lc3Cer,HSO3-6GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AH00,-,HSO3-3GlcAbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AI00,-,Galbeta1-4HSO3-6GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AJ00,-,HSO3-3GlcAbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AK00,SMiGb4Cer,HSO3-3GalNAcbeta1-4Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AL00,SMiGb5Cer,HSO3-3Galbeta1-3GalNAcbeta1-4Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AM00,-,HSO3-3Galalpha1-4Galbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AN00,SM4,HSO3-3Galbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AO00,-,HSO3-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP0602AP00,-,HSO3-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer,-   ,-,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Sulfoglycosphingolipids (sulfatides) [SP0602]
LMSP06030001,-,GlcAbeta-Cer(d18:1/18:0),C42H79NO9   ,741.5755,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Glucuronosphingolipids [SP0603]
LMSP06040001,GlcNalpha1-6Ins-1-P-Cer(t18:0/26:0),N-(hexacosanoyl)-4R-hydroxysphinganine-1-phospho-(1'-[2-amino-2-deoxy-D-glucopyranosyl-alpha1-6-D-myo-inositol]),C56H111N2O16P   ,1098.7671,Sphingolipids [SP],Acidic glycosphingolipids [SP06],Phosphoglycosphingolipids [SP0604]
LMSP07000001,Psychosine,1-beta-galactosyl-sphing-4-enine,C24H47NO7   ,461.3353,Sphingolipids [SP],Basic glycosphingolipids [SP07],
LMSP08000001,-,EtnP-6GlcNAcbeta1-3Manbeta1-4Glcbeta-Cer,-   ,0,Sphingolipids [SP],Amphoteric glycosphingolipids [SP08],
LMSP08000002,psychosine sulfate,"(2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl beta-D-galactopyranoside 6-(hydrogen sulfate)",C24H47NO10S   ,541.2921,Sphingolipids [SP],Amphoteric glycosphingolipids [SP08],
